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ABSTRACT
The gradual elucidation of the oculogenital syndrome over the last
two hundred years is reviewed in association with recent recognition of
the importance of Chlamydia trachomatis as a primary pathogen in both
sites. The development of microbiological knowledge of chlamydiae leading
to facilities for exact and rapid diagnosis is outlined. Due to increasing
doubts of the validity of conventional laboratory investigations, when
applied to clinical work, the susceptibility of C. trachomatis to certain
antibiotics was measured under less artificial conditions than before.
These experiments helped to reveal the stage of the growth cycle where
these antibiotics act and explained some previous incongruities.
455 contacts of men with nongonococcal urethritis and 129 babies
with neonatal conjunctivitis and their mothers were examined. There was
a highly significant correlation between the presence of C. trachomatis
and clinical signs of cervical inflammation. The significance of the
association of a number of factors with chlamydial infection was studied;
these included symptoms, hormonal factors, concurrent infection, clinical
signs and the number of partners and their history. The interaction of
several variables upon chlamydial infection in the cervix was investigated.
The severity of infection in the cervix was related only to the presence
of endocervical mucopus. Appropriate chemotherapy was found to eradicate
chlamydial infection in the cervix, conjunctivae and pharynx simultaneously
with, in almost all cases, the disappearance of signs of inflammation.
Epidemiological studies established the prevalence of C. trachomatis in
selected populations.
An association of pelvic inflammation, particularly in the puerperium,
and chlamydial endocervicitis was found. A significant association of
this infection with pre-term deliveries suggests the possibility that
chorioamnionitis occurs and may be responsible for antepartum infection
in some babies delivered by caesarian section. Discrepancies between
mothers' and babies' isolates were not always attributable to previous
chemotherapy. In some cases, following prolonged premature rupture of
membranes, antibacterial activity in amniotic fluid may have been
responsible.
As a large proportion of chlamydia-positive women are asymptomatic
and without abnormal clinical signs and since chlamydial infection is
sexually transmitted, these patients can only be recognised when they
present as contacts of men with nongonococcal urethritis and as mothers
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INTRODUCTION
Preliminary Note
Recent statistics show that nongonococcal urethritis (NGU) in the
male is becoming the commonest sexually transmitted disease (STD)1.
Nongonococcal urethritis is merely urethritis where Neisseria
gonorrhoeae cannot be found on smears or cultures2. Over 70 causes
were identified by Harkness (1950)3 including Trichomonas vaginalis,
herpes simplex virus, trauma, chemicals and bacterial urinary
infections. Once these have been excluded, the entity nonspecific
urethritis (NSU) remains and, with nonspecific cervicitis in women,
has been reported to the Department of Health and Social Security
(DHSS) since 1971 as nonspecific genital infection (NSGI).
However, in many cases NSU is used synonymously with NGU, little
or no attempt having been made to exclude the other causes of
urethritis. The term used by the original author has been adhered to
in reporting previous work in this thesis.
Since 1951, when notification of cases to the DHSS began, the
incidence of NGU in Britain has been seen to rise steadily and has
overtaken that of gonorrhoea. Although data is unavailable anywhere
else in the world for such a long period, similar trends are to be
seen wherever records exist and our unit in Liverpool reflects these
national and international patterns. (See graphs p.3a and 3b).
Factors which may be responsible are an increasing awareness of
the diagnosis of NGU, quicker eradication of gonococcal infection and
probably a true increase in NGU due to a rise in STD generally
following the spread of promiscuity and the preferential use of oral
over barrier contraception. Certainly, since 1971 when it was generally
acknowledged that both sexes were involved and figures for NSGI in
both men and women have been published by the DHSS, the incidence has
risen markedly.
NGU can mimic gonorrhoea and must be independently diagnosed for
evidence1*-3. (which will be discussed later) has accumulated in men
that Chlamydia trachomatis is the main pathogen. It is epidemiologi-
cally probable that the female is the reservoir for infection in the
male (analogous to gonorrhoea) and she should, on these grounds alone,
be treated. In fact, many female contacts do have chlamydiae in the
cervix1*'7'8'9 and evidence of this will be reviewed in this introduc¬
tion.
It becomes important to decide whether, as in gonorrhoea, this
infection may be a positive risk to women.
Cervical dysplasia and its sequelae, ascending infection possibly
leading to salpingitis or chorioamnionitis and, finally, the spread of
infection to the eyes of the patient herself, consort or ts§£. infant may
all result from cervical chlamydial infection.
Evidence, reviewed later in this introduction or presented in the
results section, confirms that C. trachomatis does behave as a primary
pathogen in women and infants. It is important however to state at the
outset that these syndromes are not new but .were clearly and accurately
defined in the past. In general medical circles, however, the wider
social and health implications of the findings of pioneers in this
field have often been disregarded. The first part of this introduction
will consist of a historical review of work suggesting the existence
and importance of nongonococcal syndromes in genital and neonatal
ophthalmic disease in Europe and indirect evidence that chlamydiae
played an important role in their aetiology.
It will become obvious from this historical review that early
clinical and epidemiological observations were hampered and limited by
a lack of background scientific knowledge of the intrinsic properties
and biological nature of chlamydiae and other organisms that might be
involved (e.g. Ureaplasma urealyticum) and that no reliable diagnostic
tests for suspected patients were available. The second part of the
introduction will give an outline of the development of microbiological
knowledge of chlamydiae and the present state of knowledge and the
manner in which it has led to facilities for exact and rapid
diagnosis.
In the third part, recent clinical and laboratory observations
on chlamydial infections (mainly in women and children) will be
evaluated against the large body of evidence of earlier years with
the conclusion that chlamydial STD is an entity which has long been
with us and merits attention and treatment.
This account includes work by the present author with her
colleagues in the Liverpool group, of which she is a member, before
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*cases of nonspecific genital infection in women were first
reported in 1971
**until and including 1968, data in the report of the Chief Medical
Officer of the Department of Health and Social Security (from
which these figures are taken) referred to clinics in both England
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INTRODUCTION: PART I
HISTORICAL REVIEW OF CHLAMYDIAL INVESTIGATIONS
The fact that maternal genital disease led to ophthalmia neo¬
natorum has been suspected for many years, long before any microbial
aetiology of the disease was considered. Quellmaltz16, in 1750,
postulated that it originated from the vaginal secretions of the
mother, and Piringer11 in 1841 demonstrated that genital discharges
were infective for the human eye. Much of this disease was probably
gonorrhoea and undiagnosable until 1879 when Neisser12 identified
the gonococcus in the mother's vagina and the child's eye.
Historically, attention was drawn to chlamydial infection by
evidence of conjunctivitis in babies of mothers later found to be
infected.. Women did not show clinical signs of chlamydial infection
but mothers, later found to be without gonorrhoea, gave birth to babies
presenting with nongonococcal neonatal conjunctivitis.
From 1881, the incidence of gonococcal ophthalmia neonatorum was
reduced by Crede's manoeuvre13 - the instillation of 2% silver nitrate
solution in the eye of the newborn. However, as this does not affect
chlamydiaellt'13, nongonococcal ophthalmia neonatorum continued. In
1884, Kroner16 investigated nongonococcal ophthalmia neonatorum and
thought that this also was due to infection from the mother's genital
secretions. In 1890, Schmidt-Rimpler1 , finding gonorrhoea in neither
the baby's eye secretions nor mother's genital secretions in some
cases of acute conjunctivitis of the newborn, observed "not all
blennorrhoea is gonococcal". This was supported by Sattler16 who, in
1881, had described a case of conjunctivitis in a baby whose mother
(in a trachoma-free area) had had slight signs of genital infection
but later developed typical clinical trachoma when accidentally
infected by secretions from the infant's eye. He concluded that there
was a close relationship between the infective agents of infantile
conjunctivitis, vaginal discharge and trachoma.
In 1899, Schultz19 suggested that genital secretions could
o r\
contaminate public pools resulting in "swimming bath conjunctivitis"*^
which was distinct from trachoma and from infections due to N. gonorrhoea
which does not survive in bath water. Later, inclusions were found2-1
in the cytoplasm of conjunctival cells of adults with this condition.
Chlorination of swimming pools has since eliminated this infection.
In 1897, Guiard22 claimed that a sexually transmitted urethritis
due to "microbes as yet unknown to us" existed and quoted Diday who had
noted that this responded much more slowly than gonorrhoea to treatment.
Waelsch (1901)23 described nongonococcal urethritis as a distinct
clinical entity marked by its relatively long incubation period, slight
subjective symptoms and almost complete resistance to treatment. In
1903, Morax2Lt recognised that maternal genital infections other than
gonorrhoea could cause types of ophthalmia neonatorum called "conjuncti¬
vitis amicrobienne" from which no bacteria could be cultivated or seen
on microscopic examination of stained smears. Thus, only when
gonorrhoea could be defined, was it possible to understand the
epidemiology of nongonococcal conditions.
In 1907, this epidemiological theory, was confirmed by Halber-
staedter and von Prowazek25. They had first described their eponymous
inclusion bodies in conjunctival epithelial scrapings from experimental
trachoma in orang-utans in Java and from patients there with trachoma.
Later, they found similar inclusion bodies in Germany in newborn
babies with ophthalmia neonatorum and in adults with some forms of
conjunctivitis26 and others confirmed this27'28'23. These inclusion
bodies, when stained with Giemsa, consisted of small reddish bacteria-
like particles embedded in a blue matrix. They were called "chlamydiae"
or "mantle bodies" because they crested the cell nucleus like a
mantle. Their aetiological importance was not widely believed at the
time because this form of intra-cellular parasitism did not seem to
conform to the theory of bacteria as then known and they were said to
be, among other things, nonspecific reaction products of the epithelial
cell, phagocytosed bacteria or intracellular changes due to viral
activity30.
It was obvious, however, that if ophthalmia neonatorum was due to
Chlamydia trachomatis then, like gonorrhoea, the infection must
originate in the mother, as so many previous workers had postulated.
Halberstaedter and von Prowazek's (1909)26 findings of similar inclusions
in the genito-urinary tract (albeit the urethral orifice) of the mother
of a baby with inclusion conjunctivitis were soon followed by other
confirmatory work31. The most important indications that the baby's
infection derived from a genital disease of the mother came from
(a) Fritsch, Hofstatter and Lindner (1910)32 when follicular conjuncti¬
vitis was experimentally produced in baboons with (i) material from
vaginal secretions of mothers whose babies had neonatal conjunctivitis,
(ii) material from men with urethritis where gonococci could not be
found, (iii) direct transfer of discharge from the eyes of infants with
neonatal conjunctivitis and (b) Heymann (1910)33 who transmitted
material from the genito-urinary tracts of parents of babies with
inclusion blennorrhoea and produced a similar blennorrhoea in monkeys.
In all these examples, inclusions were present and so Koch's postulates
were already partially fulfilled.
Lindner34'35 talked of "genital trachoma" and, considering trachoma
and inclusion conjunctivitis to be identical, quoted Arlt who had said
conjunctivitis in the adult, originating from genital infection, could
progress to trachoma. Wolfrum35 in 1910, having twice experimentally
inoculated an adult's eye with secretion from an infant's inclusion
conjunctivitis, said that, on one occasion, trachoma had ensued -
however, Gebb37 (1914) on repeating the experiment said this was not
trachoma but a self-limiting conjunctivitis healing without the pannus
and scarring typical of trachoma.
By 1911 Lindner34 suggested that 30% of NGU was d\ae to the same
agent as inclusion blennorrhoea and, following the finding of chlamydia'
inclusions in the female genital tract (urethra and genital secretions)
Lindner said the agent of inclusion conjunctivitis was spread in
temperate regions mainly via -the genital tract and only rarely affected
the adult eye. Lindner further said that the sub-clinical nature of
cervical infection was probably due to the small area of susceptible
cervical epithelium involved and the scanty exudate produced. By
1926, Linder38 was postulating that genital infecting agents were
attenuated forms of the trachoma agents which had lost the ability to
produce cicatrisation when they had become adapted to the genital tract
Hamburger (1934)33 denied that there could be cervical chlamydial
infection because, when gonococcal cervicitis was present in cases of
premature rupture of membranes or prolonged labour, children were born
with fully developed gonococcal conjunctivitis. This was due to the
ease of spread of the gonorrhoea from the mother's infected cervix to
the child's conjunctival sac. As this did not happen in similar
circumstances with chlamydial infection, he postulated that only
vaginal and not cervical infection occurred. (In 1975, the birth of
a child with established chlamydial conjunctivitis following rupture
of the membranes for over 18 hours was reported40).
However, Thygeson and Meingert (1936)41 emphasised the importance
of cervical infection. They examined the cervical discharge of mothers
of babies with nongonococcal conjunctivitis and found inclusions in
8 out of 10 but only in the cervix, not in other parts of the genital
tract. They proved that adult conjunctivitis (the counterpart of the
neonatal infection) was due to auto-inoculation from the genital tract
with fingers or to hetero-inoculation by the sexual partner. Thus
some adults with inclusion conjunctivitis or their sexual contacts
were found to have genital tract infections.
Thygeson and Meingert inoculated the cervix of baboons and of
women with material from the eyes of a baby with inclusion conjunctivitis
to produce cervical inflammation with, in one woman, demonstrable
inclusions. They found no■inflammation was produced when the vagina
was similarly inoculated.
They concluded (as Lindner had in 1911) that the epidemiology of
inclusion conjunctivitis was that of a genito-urinary disease, unlike
trachoma with eye to eye transmission. They said that elimination of
the genito-urinary disease would cause inclusion conjunctivitis to die
out and they pointed out that, although no clinical entity due to
chlamydial infection of the female genito-urinary tract was then
recognised, it was analogous to NSU in the male.
Braley (1938)42 studying the cervical biopsies from mothers of
babies with inclusion conjunctivitis noticed that the inclusions were
confined to the transitional zone (i.e. metaplastic cells) of the
cervical epithelium.
It was thus recognised that inclusion conjunctivitis of the new-
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born and adult inclusion conjunctivitis were pointers to female genital
tract infection but, in general, no further investigation and certainly
no treatment was forthcoming for the suspected woman. This was because,
whereas the diagnosis of ocular infections may be adequately made by
finding inclusions by direct microscopy in conjunctival epithelial cells
from scrapings stained with Giemsa, iodine or, even better, fluorescent
antibody (q.v.), genital chlamydial infections require cultural methods
for their routine detection due to the difficulty in differentiating
inclusions there from local debris.
When Jones, Collier and Smith, in 1959^3, first isolated the
agent (a) from the conjunctiva of a baby with inclusion conjunctivitis
and (b) from the cervix of the mother, they followed the method of
inoculation of clinical material into the yolk sac of the chick embryo
which had been successfully used by T'ang, Chang, Huang and Wang
(1957)41t to isolate chlamydiae from cases of trachoma. They recognised
that the agents of inclusion conjunctivitis and those of trachoma were
closely similar and for many years they were known collectively as
TR-IG (trachoma-inclusion conjunctivitis) agents.
Thus, the epidemiological and microscopical findings of Halber-
staedter and von Prowazek in 1907 were now elegantly confirmed by
cultural means fifty years later. The early cytological studies
whereby the presence of oculo-genital infection was deduced by finding
inclusions in smears from babies' eyes and from the genital tract of
their parents followed by inoculation of primates' eyes from these
or o *7 qo
sites, with the production of inclusion conjunctivitis D'', were
then repeated using chick embryo isolation methods. Thus direct
evidence of the agent in these sites was obtained.
It is now necessary to look at the laboratory evidence and see
how it can support clinical observation and routine diagnostic
processes in chlamydial infection as in gonorrhoea.
INTRODUCTION: PART II
THE MICROBIOLOGICAL NATURE OF CHLAMYDIAS
Halberstaedter and von Prowazek's first observations concerned
trachoma in Java. Later, they investigated agents producing genital
and ocular infections in temperate countries. All the agents they
investigated were known as C. trachomatis.
The microbiology is discussed here because it was mostly discovered
from eye infections long before adult genito-urinary chlamydial
infections were studied.
It was obvious later that there were other human diseases in which
inclusion bodies similar to those of trachoma described by Halber¬
staedter and von Prowazek could be found in the tissues. For example,
in 1929, an apparent "pandemic" of pneumonitis in adult humans occurred
synchronously with a lethal epizootic in psittacine birds (e.g. parrots)
and apparently originated in South America spreading from Argentina to
Europe. Similar inclusions were found in men and birds with this
condition and the agent was isolated in 1930, in eggs45. Even later,
it was realised that similar infections (sometimes called "ornithoses")
were common in non-psittacine birds and could also be transmitted to
man causing pneumonia. The agents are similar and until recently were
called "psittacosis-ornithosis agent" but now are known as Chlamydia
psittaci.
C. psittaci are thus primarily animal pathogens, only occasionally
transmitted to man but, in contrast, Gamna (1923)1+6 discovered similar
chlamydial inclusions in patients with lymphogranuloma venereum (LGV)
which is purely a human infection, not naturally found in animals.
The LGV agent was cultured by Rake47 in the yolk sac of the developing
chicken embryo in 1940 and is now classified with C. trachomatis.
These agents were "fast killers" of chick embryos. Later, when
grown in tissue culture, there were dramatic and cytopathic effects
due to multiple cycles of growth.
However, trachoma agents had a single growth cycle and were
either "slow killers" (up to six weeks) or "non-killers" of the eggs
and staining was required to demonstrate their presence.
Culture
T'ang first isolated trachoma in the yolk sac of chick embryos
in 195744 by previously treating conjunctival scrapings from early
endemic trachoma in Peking with streptomycin to suppress bacterial
contamination. This had foiled earlier attempts to isolate the agent
by killing the embryo before C. trachomatis had had time to grow.
Despite the successful work of Jones et al, yolk sac culture was
soon found too insensitive for routine use in European conjunctivitis
and genital tract infections. Isolates were made in only 7 of 28
mothers of babies with neonatal inclusion conjunctivitis48. Further¬
more, egg inoculation is cumbersome; a high titre of infected
particles is produced, which is not only potentially dangerous but
produces a risk of cross-contamination; chick embryos vary in
susceptibility to C. trachomatis infection not only seasonally but even
within batches; definite results may take up to six weeks. Thus as
tissue culture had been used for many years with C. psittaci and,
latterly, LGV48, attempts were made to grow C. trachomatis on similar
tissue cultures. Unfortunately, no gross cytopathic changes occurred,
unlike C. psittaci-infected cultures and time had to be spent in close
microscopical examination as in gonorrhoea, looking in this case for
small intracellular inclusions formed in a single-step growth cycle.
There were however, also problems specific to C. trachomatis.
Many routine tissue culture lines are insensitive to C. trachomatis or
need special treatment. However, the McCoy cell culture line (MCC)
similar to the L cell line of mouse fibroblasts used for C. psittaci
for many years is susceptible and it is not unique since tumour or
transformed cell lines such as Hela or BHK (baby hamster kidney) are
also satisfactory50.
These tumour or transformed cell lines, which are widely used for
C. trachomatis, divide rapidly with no contact inhibition and produce
sheets of tiny cells. Central problems in C. trachomatis growth were,
firstly, competition between host cell and chlamydiae for available
nutrients and, secondly, recognition of inclusions. To cut down rapid
cell multiplication, thus producing larger and more slowly metabolizing
host cells, various anti-replicative methods were used, attempting to
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inhibit the eukaryotic host cell and not the prokaryotic chlamydiae.
The first was irradiation of the cell sheet before inoculation of the
clinical specimen as in Gordon and Quan's modification (1965)51,52
although this requires sophisticated facilities. Later, chemical anti-
replicative agents were employed such as 5-Iodo-2 deoxyuridine (IUdR)53
or cytochalasin B5l+. More commonly, cycloheximide (an anti-metabolite
used in research for many years with C. psittaci) has been found
preferable for routine diagnosis55. Added with the clinical specimen
to the tissue culture, it reduces the biochemical activity of the host
and not the parasite. The final effect of all these forms of treatment
is to produce monolayers of large non-dividing cells with abundant
cytoplasm persisting unchanged for 48-72 hours after incubation
following infection with C. trachomatis so that the inclusions are
larger and more easily recognisable.
To enhance C. trachomatis growth in tissue culture, close attention
is given to pH, carbon dioxide concentration and temperature of the
tissue culture monolayer while ensuring a sufficiency of nutrients in
excess of that for tissue culture alone56, particularly of amino acids.
Further, with C. trachomatis, unlike C. psittaci and LGV strains, uptake
of the parasite must be improved by increasing the effective collisions
between chlamydial particles with tissue culture by (1) centrifugation,
when the number of inclusions produced increases with the force and
duration of centrifugation57, (2) by modifying the electrostatic effects
and increasing phagocytosis using diethylaminoethyl (DEAE)-dextran58.
In all current tissue culture techniques, C. trachomatis gives a
single step growth cycle, i.e. one input-infective C. trachomatis part¬
icle produces one inclusion and no secondary growth cycles occur58.
The number of inclusions in tissue culture thus corresponds directly
with the number of viable chlamydial inclusions in the orignal
inoculum60.
Taxonomy
It is now realised that the growth cycle of all chlamydiae, whether
derived from cases of trachoma or inclusion conjunctivitis or LGV or
psittacosis, is similar and is complex61'62'63. The similarities of
behaviour are close enough to suggest that all belong to a single genus.
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Chlamydiae are members of the order Chlamydiales64, the family
Chlamydiaceae and the genus Chlamydia. Within the genus, are the two
species, Group A (Chlamydia trachomatis) and Group B (Chlamydia
psittacci)65 which share a common antigen, detectable by complement
fixation tests.
Group A contains 15 serotypes; in brief, C. trachomatis serotypes
A, B and C cause trachoma, C. trachomatis serotypes D to K cause
oculo-genital infection and C. trachomatis LGV serotypes I, II and III
cause lymphogranuloma venereum (this is discussed more fully elsewhere).
In Group B, the number of serotypes is unknown (i.e. it is not known
whether diseases of psittacine and non-psittacine birds, sheep and
cattle are manifestations of infection by different serotypes or
different manifestations of a single serotype infection).
The main laboratory differences between Groups A and B may be
summarised as follows:
Group A (.1) Form compact micro-colonies (inclusions) within the
cyoplasm of the host cell.
(la) Possess a single-step growth cycle (as discussed above)
(2) Produce an iodine-staining carbohydrate matrix
(glycogen).
(3) Lipid is produced in the vesicle.
(4) Sulphonamides inhibit growth.
Group B (1) Form micro-colonies which tend to rupture and the
elementary bodies become distributed throughout the
host cell cytoplasm.
(la) Possess a multistep growth cycle.
(2) Do not produce iodine staining carbohydrate or lipid.
(3) Growth is not affected by sulphonamides.
Obviously the most important difference between Group A and B is
that Group A (C. trachomatis) are primary human pathogens producing no
natural infection in animals and it has been found difficult to induce
infection in laboratory animals. In the tropics, where these diseases
are endemic, this group causes Trachoma and lymphogranuloma venereum
and in temperate zones, in developed countries, oculogenital
infections (such as NGU and neonatal conjunctivitis).
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Group B (C. psittaci) cause natural infections, generalised and
often chronic, in many birds and animals with frequent asymptomatic
shedding of the agent in secretions. Man is infected by C. psittaci
only following contact with infected animals or birds and so there is an
occupational hazard for bird-fanciers and veterinary surgeons. The
infections are usually manifest as pneumonia and vague respiratory
tract diseases diagnosed as 'flu. Spread from man to man is rare apart
from involvement of medical officers or post-mortem attendants.
The general characteristics of chlamydiae will be briefly discussed,
their microbiology and structure being well described elsewhere56-®^.
It must be emphasised however, that they are bacteria and not viruses
by virtue of possessing a discrete cell wall similar to that of bacteria
and are stainable by Giemsa or even by Gram stain. They contain both
ribonucleic acid and deoxyribonucleic acid, and primitive enzyme systems
and are susceptible to standard antibacterial antibiotics. They have,
however, adapted to an intracellular environment and are obligate
intracellular parasites.
Growth cycle
For survival and adaptation, a growth cycle has evolved with two
distinct morphological forms. The first, the infectious particle or
elementary body possesses a rigid cell wall and can survive for long
periods extracellularly and enters the host cell by phagocytosis. The
intracellular phase is necessary due to the chlamydiae's restricted
metabolic activity, in particular, their inability to manufacture
adenosine triphosphate. For this reason, they are "energy" parasites
of mammalian and other tissue cells. Once intracellular infection
has occurred, the original elementary body is transformed to the non-
infective initial or reticulate body with a fragile highly permeable
cell membrane in place of the rigid cell wall. These are much more
active metabolically and multiply by binary fission and, about 24 hours
after infection, they resume the elementary body's form, after
re-secretion of a rigid cell wall.
Latency
In addition to overt multiplication and rapid destruction of the
cell in which they are growing, latent persistent infection of certain
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cells in the culture or in the body is a universal biological character¬
istic of chlamydiae, most marked in such subclinical infections as
human LGV and avian psittacosis and a well balanced and chronic host-
parasite relationship may occur.
In a balanced salt solution, Morgan and Bader maintained TC cells
infected with C. psittaci for three days70. Neither cell death nor
infectious chlamydiae could be detected after 24 hours and yet, when
complete medium was added, infectious particles could be seen on the
following day. Apparently healthy birds may shed C. psittaci in faeces
and have been implicated as sources of human infection. Meyer and
Eddie71 (1951) documented the isolation of C. psittaci in a man with a
persistant cough 8-10 years after the original severe acute attack.
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Hanna ^ (1968) using immuno-fluorescent staining for C. trachomatis
showed these agents, too, fitted into the same pattern. Indian
children in boarding school, originally with active trachoma, rapidly
improved clinically with (or even without) chemotherapy but, in the
majority of cases, the agent was not eliminated. Schachter5a has
postulated that the behaviour of chlamydial genital infection may be
similar and, where found in the absence of clinical disease, must not
be assumed to be normal flora. As chlamydiae are true intracellular
parasites, they are pathogens and cannot merely persist on mucous
membrane or cell surfaces. Latent or subclinical infections are low
level multiplicates held in check by host defences.
Antigens
To analyse the antigenic content of C. trachomatis, two problems
must be overcome:
(1) contamination by the host cell,
(2) the very small quantity of material produced on tissue
culture.
Results from two types of culture method are used to overcome the
former (either two different tissue cultures or tissue and yolk sac
culture) and microtechniques are used.
(a) Group antigen
Both members of the genus (C. psittaci and C. trachomatis) share
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a common heat-stable antigen demonstrable by the lymphogranuloma
venereum complement fixation test (LGVCFT)70. It is widely used in
the diagnosis of LGV and psittacosis where antigen stimulus is
considerable and antibody levels are high enough to be detected by such
an insensitive test but it is unsuitable for chlamydial infections
limited to the epithelial surface where antibody response is poor.
The same group-specific antigen was found responsible for the
Frei test71+ demonstrating delayed hypersensitivity to chlamydial
infection in LGV. There was an unacceptable incidence of both false
negatives and false positives and it was found unsatisfactory in
differentiating trachoma from LGV25.
The radio-isotope precipitation test (RIP)76 also measures group
antibody and is more sensitive than the LGVCFT and more resistant to
anti-complementary factor. However, it is less specific than the micro-
immunofluorescence (MIF) test (q.v.) and is complicated to perform.
(b) Species antigens
These are heat-labile and more difficult to study. Immunological
differences between species have been demonstrated by a form of
complement-fixation test once the group antibody was removed and also
by double immunodiffusion whereby the species antigens and also group
antigens were demonstrated by two-dimensional Immunoelectrophoresis77.
(c) Type antigens
In the mouse toxicity test, intravenous injection of a large dose
of live LGV or trachoma organisms into mice causes death within
24 hours. Death can be prevented by prior immunisation with live or
formalinised organisms.
This was utilized to classify C, trachomatis into different
immunotypes78. Ultimately 125 agents were classified into 6 types
(A to F). This was a cumbersome method and has been replaced by
immuno-fluorescent typing79 '88 . Micro methods using direct immuno¬
fluorescence (MIF test) have been developed and 15 immunotypes
identified and classified81. Coversely, the type-specific serological
response to chlamydial infection of the eye and genital tract in man
has been measured. The micro-immunofluorescence and mouse toxicity
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tests correlate82.
The Group A chlamydia strains fall into 12 immuno-types (A to L,
plus Ba) and three LGV strains83. Using the appropriate antigens,
Group A chlamydial infections can now be clearly distinguished from
Group B (C. psittaci) 8tt.
A, B, Ba and C are the predominant types found in the eyes of
populations in areas where trachoma is endemic and there is eye to eye
transmission. However, only A and C have not also been isolated from
the genital tract. Type A is found almost exclusively in the Middle
East and North Africa, Ba among the American Indians, and B and C
throughout the world. Generally, in Europe and the United Kingdom,
types D to K are found in patients with genital infections and ocular
strains from non-trachoma-endemic countries share immuno-types similar
to the genital isolates85.
Antibody response - serological and local
There is a regular pattern of serological antibody response in
most bacterial infections. Transient immunoglobulin M (IgM) appears
soon after the initial infection and is followed by IgG which persists.
Further IgG is produced by recurrent homologous serotype infections.
IgM serum antibodies have been demonstrated in patients with chlamydial
conjunctivitis and in those attending STD clinics and may help in the
diagnosis of acute chlamydial infections83'85.
Locally produced antichlamyd.ial antibody (IgA and IgG) has been
found in association with infection of the eye by C. trachomatis sero-
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types A-C in trachoma-endemic areas and in neonatal conjunctivitis00
and in cervical infections involving serotypes D-K87'88.
Antichlamydial antibody levels in sera and tears from school¬
children in Southern Tunisia with hyperendemic trachoma correlated
well with the isolation of chlamydias from the conjunctivae. Tear
antibody reflected serum antibody in titre and type but disappeared
sooner.
McComb et al, in a series of 185 women, found cervical antibody
in 8 out of 9 women with chlamydial infections of the cervix and in
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18 of 176 where chlamydiae had not been isolated. No local antibody
was found in the 25 sexually inexperienced women in the study. Serum
antibody was found in 38% of 185 women examined but also in 23% of the
sexually inexperienced. Cervical antibody, therefore, was more closely
correlated with chlamydial isolation rates and sexual experience than
was serum antibody.
However, Treharne found significant serum IgG levels in 41% of 272
women with a C. trachomatis isolation rate of 13%. There were signifi¬
cant serum IgM levels in 49% of the chlamydia-positive but only in 23%
of the chlamydia-negative women, whereas only 26 out of 35 with
isolation positive chlamydial cervicitis had significant cervical
antibodies.
80% men and more than 90% women with chlamydial genital tract
infection have serum antibodies measured by this technique. Mean levels
in men are low due to modest antigenic stimuli as chlamydial urethritis
is only a superficial infection whereas titres are higher in women and
patients with LGV89. In general, results are nonspecific in the sense
that they are not correlated with the present illness. 23-40% "normal"
adults have antibody as do 10-76% men with chlamydia-negative NGU and
30-50% chlamydia-negative STD clinic women patients and these percent¬
ages increase with age. This may be due to failure to isolate
C. trachomatis or to antibody from a previous infection'*'6.
For epidemiological screening purposes, the MIF antibody test is
invaluable. However, due to chose high background levels, for diagnosis
in individual patients, it is not sufficiently specific. It may
however, be used to confirm the diagnosis in women and, possibly,
babies already receiving treatment or to follow the course of the
disease. Further investigation of serum IgM activity and local anti¬
body levels might give more specific diagnostic help90.
A single antigen modification91 of the MIF test has been developed
using either genital serotype D (60-90% of all genital chlamydial
infections in the U.K. are type D/E) or an LGV serotype which has been
shown to cross-react with antibodies to most genital serotypes.
Immunofluorescence staining
Fluorescein-labelled hyperimmune sera are used, mainly in
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conjunctival and urethral infections, for this most sensitive
and highly specific method"2 of demonstrating inclusions. Again,
antibody against a single LGV antigen is used.
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INTRODUCTION: PART III
RECENT DEVELOPMENTS IN DETERMINING THE AETIOLOGICAL ROLE OF C. TRACHOMATIS
(a) Nongonococcal urethritis and cervicitis
Diagnosis by scrapes of epithelial cells from the affected area
(as for hyperendemic trachoma) is unsatisfactory in genital infection
partly because specimens are too small and also because normal cervical
bacteria obscure and contaminate Giemsa and fluorescein stains,(Iodine
staining to identify inclusions by their glycogen matrix is not
practicable owing to the high glycogen content of many cervical cells).
Previously it was only suspected that C. trachomatis was a genital
pathogen, and, until reproauceable isolation methods were used, there
was no proof. As previously described in detail, Jones1*3, j_n 1959,
isolated C. trachomatis from the conjunctiva of an infant and the
cervix of his mother. Dunlop began to apply this method to routine
diagnosis and isolates were obtained from conjunctival material from
affected babies, cervical material from their mothers and urethral
discharge from their fathers, who were suffering from NSU93'91*. In four
out of 28 mothers, salpingitis was diagnosed95. By 1967, Dunlop had
isolated chlamydiae from 21% of men presenting with NSU and from genital
material from their sexual partners1*8. Chlamydiae were also isolated
from the genital tract in adults in developed countries who had fresh
chlamydial eye infections and from their sexual partners' genital
tract9 5-99.
When blind volunteers' eyes were inoculated, it was found that an
isolate from the eye of a baby with neonatal conjunctivitis and an
isolate from the eye of a trachoma patient produced an inflammation
indistinguishable by all contemporary means of investigation190. The
concept of a continuous spectrum of clinical appearances and the
usage "TRIC" agent was introduced. (TR-trachoma, IC-inclusion
conjunctivitis)101. From similar human inoculation experiments in
California, with a trachoma and an inclusion conjunctivitis strain,
the opposite conclusion was reached, namely that these were two distinct
clinical entities102'103. However, previous damage to the eyes may
have modified that result.
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The term "TRIC agents" has been superseded by "chlamydiae".
Further studies of the epidemiology of chlamydial infection and its
transmission routes in various environments and later demonstration
of the different serotypes have helped to relate trachoma to inclusion
conjunctivitis. Also, it is now accepted that corneal vascularisation
(pannus) and conjunctival scarring (previously considered unique to
classical trachoma) do occur in genitally acquired chlamydial eye
infections and were reported from Denmark10^ both in children and
adults105 probably initially infected from their mothers' birth
canal and re-infected from their own or their mothers' genital tract." ^
The term "trachoma" is now used only for the hyperendemic eye
disease caused by eye to eye transmission. Sexually transmitted
chlamydial eye infections are described as "chlamydial inclusion
conjunctivitis" and the term "genital trachoma" has fallen into disuse.
9
Gordon and Quan's replacement of yolk sac culture by tissue
culture52 (with later modifications previously discussed) allowed more
sensitive and quicker cultural methods. Using them, by 1972, the
urethral C. trachomatis isolation rate had risen to around 40% for
men with NSU7'106'107. It was slightly higher (45%) in men presenting
with conjunctivitis, who were later found to have urethritis108. When
controls, without urethritis, were tested, chlamydiae were not
isolated7'107.
Richmond106 found the chlamydial isolation rate in men with
gonorrhoea (32%) was very similar to that in NGU (39%) which led her to
believe that acute NGU was not primarily due to chlamydiae but that
urethritis of any origin (including gonorrhoea) may reactivate a
quiescent chlamydial infection.
However, evidence for a direct chlamydial aetiology for NGU in men
was increased by King Holmes^ who found a significantly higher chlamydial
isolation rate in men with NGU (42%) than men with gonorrhoea (19%) or
men without NGU (7%). Sero-conversion (MIF technique) occurred in 9
of 17 originally sero-negative chlamydia-positive patients. Endo-
cervical C. trachomatis isolation rate was higher in female contacts
of chlamydia-positive men (15 of 22) than of chlamydia-negative (2 of
2.4) . The incidence of Trichomonas vaginalis, Ureaplasma urealyticum,
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herpes simplex virus or anaerobic bacteria was found neither signifi¬
cant nor aetiologically important in NGU.
Bowie (1976)10^ investigating the differential response of
chlamydial and non-chlamydial urethritis to different antibiotics
supported the aetiological importance both of C. trachomatis and
U. urealyticum. He had previously found a higher incidence of
ureaplasmas in chlamydia-negative NGU than in chlamydia-positive NGU
and was looking at the response of NGU, where ureaplasmas had been
isolated, to anti-ureaplasma chemotherapy. He grouped NGU patients
according to whether C. trachomatis or U. urealyticun was isolated and
then randomly treated members of each group with a sulphonamide
(inhibitory to chlamydias) or an aminocyclitol, spectinomycin or
streptomycin (effective against ureaplasmas). Chlamydia-positive NGU
responded to the sulphonamides and not the aminccyclitols. Ureaplasma-
positive NGU responded only to the aminocyclitols. When neither or
both infectious agents were isolated, in a high percentage of cases
(73%, 79%) NGU failed to respond to either chemotherapeutic agent
singly. This, while confirming that both chlamydiae and ureaplasmas
are possible causes of NGU, did not definitely prove that either was
aetiologically responsible.
C. trachomatis had been isolated from 12 of 187 and 15 of 22^
sexual partners of chlamydia-positive men with urethritis; the rates
were much lower in chlamydia-negative man (1/237, 2/241+) . This
suggested that chlamydiae were sexually transmitted and further evidence
of this came in 1974 when two important studies on NGU contacts were
published110'111. Cervical chlamydial isolation rates of 33-34% in
NGU contacts, 18-31% in the STD clinic overall and only 3% in Family
Planning Association (F.P.A.) clinic attenders who might be considered
less promiscuous were found.
Oriel found the incidence was higher in primary (62%) than
secondary (25%) contacts and also higher in contacts of men having
their first attacks of NGU (33%) than in recurrent episodes (14%)111.
Hilton and Richmond noted that, in patients taking oral contra¬
ception, the C. trachomatis infection incidence was highest in the
first and fourth weeks of menstrual cycle (42%) (i.e. when the oral
contraception was withdrawn). The isolation rate did not vary through¬
out the menstrual cycle in patients not taking the pill, but it was
generally raised in women taking the pill (45%) compared with women not
taking it (24%). The incidence of chlamydial infection was also raised
in the presence of gonorrhoea (63%). It was suggested that a normally
quiescent chlamydial infection was reactivated not only by gonorrhoea
as in men but also by the use of oral contraception*10.
Both Oriel and Hilton et al found that, (as Dunlop had first said
in 196493, and confirmed in 196634'95) there was an association between
the isolation of chlamydiae from the cervix and nonspecific inflammatory
changes there. Following these studies, the advisability of treating
the sexual partners of men with NGU was generally accepted on an
epidemiological basis, without a firm diagnosis.
In 1971, Dunlop had also observed that inflammatory changes in the
conjunctivae, the genital tract, and the anorectal area associated with
chlamydial infection both in the parents of babies with chlamydial
conjunctivitis and in adults with chlamydial conjunctivitis and their
sexual partners closely resembled each other in these different sites112.
Chlamydial inclusions had previously been seen in a cervical
biopsy from a mother whose baby had inclusion conjunctivitis1*2. Later,
in cervical biopsies from twTo patients with chlamydial cervical
infection (diagnosed by isolation and high serum chlamydial antibody
levels) using light and electron microscopy, chlamydiae were found in
intra-epithelial vesicles in the cervical mucosa associated with a
marked inflammatory response113. (Unfortunately, these latter women
also had cervical gonorrhoea). The frequency of such multiple
infections not only with gonorrhoea but also with other sexually
transmitted agents had been recorded previously114 and, in that study
also, the isolation rate of C. trachomatis was found to be twice as
high in the presence of cervical abnormality115.
Burns et al (1975)116 pointed out that the diagnosis of nonspecific
genital infection in women was usually made on epidemiological grounds;
contrary to findings in men, polymorphonuclear leucocytes were frequently
found in the lower genital tract in varying amounts according to the
stage of the menstrual cycle and were not diagnostic of nongonococcal
cervicitis. They found the chlamydial isolation rate in 638 women (12%
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in the STD clinic population, 22% in NSU contacts, 44% in gonorrhoea)
was higher in the presence of cervical erosions and of cytological
cervical inflammatory changes, in the primary contacts of men with NSU
and in the absence of symptoms.
It was now obvious that there was a genital reservoir of chlamydial
infection, mainly asymptomatic, mainly amongst women and possibly
associated with cervical inflammatory changes. While the pathogenicity
of chlamydiae in NGU in men was under consideration, its role in women
had not been properly investigated, although an association with a
nonspecific and undefined "cervicitis" had been noted.
In Liverpool, in 1975, the author of this thesis worked in the
laboratory, in which all our subsequent investigations were made, for
three months during the development here of a method56 modified and
simplified from that of Gordon and Quan (1965)52. McCoy cells, untreated
by irradiation or by chemical anti-replicative agents, were used. The
method will be described later with laboratory work performed by the
present author. We investigated the association of clinical signs in
the cervix with chlamydial infection and the effect of chemotherapy
on them. These results will be discussed in detail in the body of the
thesis but the main findings will be considered here in relation to the
historical development of our knowledge of chlamydial infection.
For the first time, endocervicitis was defined8. Hypertrophic
ectopy (or hypertrophic erosion) indicating oedema and congestion of
the cervix was, with endocervical mucopus, considered abnormal.
However, simple ectopy or erosion (i.e. ectopic columnar epithelium)
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and the absence of ectopy are normal physiological appearances
(This definition was supported by findings at an Edinburgh FPA clinic
where no less than 37% of 1400 women had cervical ectcpy and ectopy
was associated with youth (under 35 years), parity and the use of
oral contraceptives119).
We selected 127 chlamydia-positive NGU contacts on epidemiological
grounds and compared them with an equal number of chlamydia-negative
contacts8. Patients with gonorrhoea were excluded from this study.
There was a significant association between endocervicitis and the
presence of chlamydiae. There was, however, no correlation between the
clinical findings and the severity of infection as measured by the
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number of inclusions per coverslip. The highest count was from a
cervix without ectopy but containing mucopus.
The presenting symptoms in these chlamydia-positive women were
compared with the symptoms in 326 women with gonorrhoea,(Simultaneous
C. trachomatis infection had not been excluded and it was thought that
the relatively few with a double infection would not invalidate the
comparison). There was a similarly high incidence of asymptomatic
patients (49% with chlamydial infection and 53% with gonorrhoea).
However, more patients with gonorrhoea (9%) than with chlamydial
infection (3.9%) had abdominal pain indicating pelvic inflammation.
Similarly, in both chlamydial infection and gonorrhoea, there was a
large number of women without inflammatory signs but the number was
greater in gonorrhoea.
The signs of chlamydial endocervicitis responded to chemotherapy
and most women in this selected group were free from any other
infection. According to the patients' histories, during the post-
treatment surveillance period (up to 20 months) of a larger group of
161 previously chlamydia-positive STD clinic patients, there was a
high probability of re-infection in the 16 women with re-isolates.
The stress of pregnancy in four and gonorrhoea in another caused no
relapse. These results did not support Hilton's110 theory that
chlamydiae were latent and were reactivated by other infections nor, as
will subsequently be discussed, did the later investigation of the
present author and colleagues on the quantitative aspects of chlamydial
*
infection with and without concomitant gonorrhoea.
By contrast, Nayyar (1976)120 failed to find any association
between cervical changes and chlamydial infebtion in 300 women attend¬
ing an STD clinic where the overall chlamydial isolation rate was 20%
(30% in NSU contacts, 27% in gonorrhoea patients or contacts).
Oriel (1978)121 isolated C. trachomatis from 20.4% of 284
unselected women attending an STD clinic. This was the sole pathogen
in only 48% but no other pathogen was significantly linked with
C. trachomatis. Oriel said that certain-factors indicated the
possibility of chlamydial infection of the cervix. These were
cervical discontinuity, antibodies to C. trachomatis, pus in the
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cervical exudate, (either observed with the naked eye or microscopically
in Gram-stained cervical smears) and signs of inflammation in cervical
cytology. In Oriel's terms, "cervical discontinuity" was replacement
of "normal" cervical epithelium and was graded to indicate its extent
(no variation in the character of this replacement epithelium was
described). He found that a history of sexually transmitted disease,
the method of contraception, the phase in the menstrual cycle and
promiscuity had no effect on the C. trachomatis isolation rate.
In 1978, Terho122 found chlamydiae in 42% of female contacts of
men with NSU but in only two of 22 contacts of chlamydia-negative men.,
again showing the sexual transmissibility of the agent.
This was in keeping with the results of Paavonen et al123 (1978)
who isolated C. trachomatis from 13 of 144 (9%) women in a gynaecolo¬
gical out-patient clinic. These women might be expected to be less
promiscuous than those in STD clinics. Seven (54%) of these chlamydia-
positive patients had antibodies on LGVCFT testing and 11 (85%) by the
single antigen MIF test compared with 21 (16%) and 70 (53%) of the 131
chlamydia-negative. Eight chlamydia-positive patients showed "cervi¬
citis" but this was a very nonspecific inflammatory picture. They
claimed that a significantly higher proportion of ocular and urethral
symptoms occurred in the chlamydia-positive patients; C. trachomatis
cultures were only taken from the cervix.
Ripa et al (19 78) 121+ investigated the frequency of sexually
transmitted agents in 170 women with symptoms suggesting lower genito¬
urinary tract infection (discharge, dysuria, irritation and burning,
metrorrhagia and pelvic pain). Such organisms were isolated in 56
(32.9%) patients. (C. trachomatis in 31 (19.3%), N. gonorrhoea in 8
(4.7%) and T. vaginalis in 44 (25.9%). In women under 25 years,
chlamydiae were found significantly more often in those taking oral
contraceptives than in those who did not. In those not using oral
contraception, cervical ectopy was found more often in chlamydia-
positive than in chlamydia-negative. They found no distinguishing
signs between gonorrhoea and chlamydial infections.
(These results will be discussed later in conjunction with the
parallel investigations by the author and her colleagues in Liverpool).
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McCormack (1979)125 carried out a prospective study investigating
the persistence of untreated chlamydial infection. Chlamydiae were
isolated from the cervix in 20 (4.6%) of 439 college students but 62
(14%) had either cervical chlamydial infection or local cervical anti¬
body (micro-immunofluorescence test); only two had gonorrhoea. Fifteen
to 25 months later, 25 of these 62 (40.3%) were re-examined. Chlamydiae
were then isolated from 7 women. Excluding 11 who had had chemotherapy,
re-isolates were made from 4 of 7 originally infected, of whom 3 denied
sexual re-exposure. Three of 6, previously possessing cervical anti¬
bodies only, were ncwisolate-positive. Chlamydial infection, present
earlier but not detected due to sampling failure or latency could not be
differentiated from interim infection.
In view of the possible complications of spread and the risks of
infection to sexual partners, such a project where chemotherapy was
withheld after already proven chlamydial infection might not be
considered advisable. An alternative way of obtaining information
about persistent chlamydial infection was provided by studies undertaken
by the present author and her colleagues. Nineteen of our chlamydia-
positive patients failed to re-attend for varying intervals of up to
one year following their first visit or treatment had been withheld
during investigation of other conditions. They were re-examined for
C. trachomatis and isolates were obtained in all 19®.
Having established a significant association between our criteria
for endocervicitis and chlamydial infection, the present author and
• her colleagues in Liverpool proceeded to a pilot study of 202 female
contacts of men with NGU. The clinical signs of cervical chlamydial
infections, their response to chemotherapy and the incidence of
cervical infection in the presence of ectopy and oral contraception
were examined®.
Previous studies by the Liverpool group had shown that: (1) When
a single culture of C. trachomatis was inoculated on 48 replicate
tissue cultures (McCoy cell monolayers), 93% of the inclusion counts
fell within ± 20% of the mean value over the whole series60.
(2) When cervical swabs from 153 chlamydia-positive women were
repeated 7 days later before treatment, 141 (92.5%) women were again
positive with similar inclusion counts per swab60. (3) In a series
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of 175 chlamydia-positive women, 72% of the swabs yielded inclusion
counts of over 100 and only 8% had inclusion counts of 10 or le£s55.
For the first time, the effect of certain factors on whole coverslip
counts was recorded.
The C.trachomatis isolation rate was 35%. Mucopus was found in
37% chlamydia-positive and 7% chlamydia-negative women, and hyper¬
trophic ectopy in 19% chlamydia-positive and 3% chlamydia-negative.
Although 17 patients complained of abdominal pain, only 4 (two
chlamydia-positive) had clinical signs of salpingitis. In the presence
of oral contraception, ectopy was found to be associated with a
significant increase in the chlamydial isolation rate. The latter was
also higher in the presence of T. vaginalis but was unrelated to any
particular symptom or to any stage of the menstrual cycle.
The signs cleared after chemotherapy in all but one patient.
Furthermore, there was in 4 of 5 re-isolates a strong possibility
of re-infection. Quantitative isolation studies showed higher counts
in the presence of cervical mucopus and in those using oral contracep¬
tion but not in the presence of hypertrophic ectopy.
Following these results, we made an investigation126 in Liverpool
of the wide variation of counts reflecting high and low grade infections
in 580 patients with particular reference to clinical signs in the
cervix, the use of oral contraception, the presence of concurrent
infections and the patients' age. In 34%, counts were less than 100
per monolayer and in 36% counts were more than 1,000. When the counts
were related to above variables, the degree of infection was found bo
be significantly higher in the presence of cervical ectopy, endocervical
mucopus and oral contraception (but only in the presence of ectopy)
and in the under 20 age group. Neither the use of oral contraceptives
alone nor concurrent gonorrhoea (or any other infection) affected the
severity of chlamydial infection as indicated by inclusion counts.
(b) Pelvic infection
Signs of pelvic inflammation associated with the isolation of
chlamydiae from the cervix were first reported in mothers of babies
with chlamydial conjunctivitis93'10^.
27.
Similarly, in Liverpool, we found pelvic inflammation in 3.9% (5
of 127) NGU contacts with chlamydial cervical infection8 and, amongst
mothers of babies with neonatal chlamydial conjunctivitis in 53% (9
of 17)8 and 35% (11 of 31) 127. We had excluded mothers already
receiving chemotherapy, possibly for pelvic inflammatory disease (PID)
and noted the high incidence of upper genital tract inflammation in the
puerperium, particularly in mothers whose diagnosis was only established
three to four weeks post-partum.
The later effects of pelvic inflammation had been discussed by
Westrom and colleagues128'128 who used laparoscopy for confirmation of
the presumptive diagnosis and later follow-up. After a mean 9 years,
of 415 women with a history of acute salpingitis, 21% were involuntarily
childless and, in 17% tubal obstruction was responsible. Tubal
occlusion was commoner following non-gonococcal (17.3%) then gonococcal
(6.1%) salpingitis and commoner too after second (35%) and third (75%)
attacks, than after the first. The ratio of ectopic to normal
pregnancy was one in 24 (12.8%) following pelvic inflammation and one
in 147 in healthy controls. 18% of these women had chronic abdominal
pain.
The same workers (1977)180, in a study of 53 women with acute
salpingitis, isolated C. trachomatis from the cervix in 36% (19) and
from tubal biopsy using laparoscopy in 6 of 20 (30%)^ C. trachomatis
was isolated from only one of another group of 18 women with lower
genital tract infection and not from any of 12 control women without
signs of tubal infection. N. gonorrhoeae was isolated in 5 of 19 (26%)
also harbouring C. trachomatis in the cervix and in 6 of 34 (18%)
chlamydia-negative and from the tube in one of 14 chlamydia-positive
cases. They had found an increasing prevalence of acute salpingitis
but the proportion associated with cervical gonorrhoea had decreased
from 50% to 10% within six years. It was suggested that as
C. trachomatis was such a common aetiological agent, salpingitis should
be treated primarily with an antibiotic to which C. trachomatis and
N. gonorrhoeae were both susceptible.
In 1979, this group inoculated the fallopian tubes of two grivet
monkeys with C. trachomatis isolates from the tubes of two women with
salpingitis181. On examination of the tubes of these monkeys,
inflammatory changes similar to those in gonococcal salpingitis were
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found and sero-conversion occurred and so Koch's postulates were
fulfilled. Similar changes were found in tubes removed from two
patients with acute salpingitis and chlamydial cervical infection132.
C. trachomatis was isolated from the tube in one patient and was found
on immunoflu.orescent staining of tubal cells in the other. This
contradicts previous general teaching that histological appearances
in gonococcal and nongonococcal salpingitis differ.
Paavonen et al (1979) 133 investigated 106 women with salpingitis
(not confirmed by laparoscopy). Their findings supported the
aetiological importance of chlamydiae. 26% harboured it in the urethra
or cervix or both; 43% of 72 from whom paired sera were obtained showed
either positive cultures for or sero-conversion in single antigen MIF
test to C. trachomatis. The incidence of gonorrhoea was low (26%) and,
in 38% of these, concurrent chlamydial infection was present.
In a study of 143 women with salpingitis, verified laparoscopically,
high anti-chlamydial antibody titres were found by Treharne (1979) 131*
both in serum and in fluid aspirated from the posterior vaginal fornix.
62% had raised serum IgG titres correlating with the clinical severity
of the tubal inflammation, whereas only 2 of 19 controls without
salpingitis had elevated serum levels. IgM levels were raised in 23%
women with salpingitis and one of 19 controls. Raised IgG levels
were found in 18 of 27 women with, and only 2 of 9 without,
salpingitis who had had fluid aspirated from the posterior fornix.
Sero diagnosis of chlamydial infection by MIF test was used by
Simmons et al (1979)135 to determine the aetiological agent in women
with pelvic inflammatory disease without laparoscopy where chlamydial
cultures were not taken. Antichlamydial antibody levels (IgM and IgG)
were higher where there was salpingitis (particularly in the more
severe cases) than in control patients with gonococcal cervicitis and
patients with uncomplicated nonspecific genital infection (either NSU
contacts or classified on the basis of excess urethral or cervical
leucocytes without other pathogens.)
(c) Urethral investigations in women
Dunlop (1972)136 reported the first isolation of C. trachomatis
from the female urethra in a patient who was examined because her
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husband had a six-month history of chlamydial kerato-conjunctivitis.
She had recurrent dysuria and frequency.
A possible association between the urethral syndrome (recurrent
increasing frequency and dysuria in the absence of bacteria or signi¬
ficant pyuria) and chlamydial infection was first reported by the
present author and her colleagues137. Cytoscopic examination in such
a woman aged 21 years had revealed intense urethritis and basal
cystitis. There was oedema along the length of the urethra palpable
through the anterior vaginal wall. Hypertrophic cervical ectopy and
endocervical mucopus were present and C. trachomatis was isolated from
the urethra and cervix. The urethral oedema and abnormal cervical signs
cleared after a three weeks course of tetracycline.
Paavonen (1979)138 examined both urethral and cervical cultures in
99 chlamydia-positive partners of men with NGU. In 25%, chlamydiae
were recovered from the urethra only, in 46% from both urethra and
cervix and in 28% from the cervix only. Significantly more women with
chlamydial urethral isolates (54%) had urethral symptoms than those
where chlamydiae were only obtained from the cervix (21%). In three
women with signs of cervical inflammation, chlamydiae were isolated
from the urethra but not from the cervix and serum antichlamydial
antibody titres were high. It was suggested that cervical chlamydial
isolation at that time had been inhibited by high local cervical anti¬
body levels (although these were not tested) and that cultures not only
from the cervix but also from the urethra should be taken in chlamydial
investigations in women.
However, the. Liverpool group found, in a study138 of 393 women,
mainly random STD clinic patients (chlamydial isolation rate 33V3%)
that only in 5% of chlamydia-positive patients was the isolate from
the urethra alone. In 37%, only the cervix was infected and, in 58%,
C. trachomatis was isolated from both sites. Urethral isolates were
not necessarily associated with urinary symptoms. Results suggested
that, contrary to Paavonen's conclusions, even in the presence of
urinary symptoms, chlamydial tests on the cervix alone were sufficient
for the diagnosis in most cases.
The results of tests from 34 chlamydia-positive mothers in the
puerperium, previously included in the above series, were examined
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separately140. It was interesting that a similarly small proportion
5.8% (2) had positive isolates from the urethra alone.
The cause of the "acute urethral syndrome" in 59 female patients
was investigated by Stamm et al141 (1980) and compared with findings in
35 women with typical cystitis and in 66 without urinary symptoms.
Bacteria at low counts (mainly coliforms) were found in 27 women with
the urethral syndrome on catheterisation or supra-pubic catheterisation.
In 11 of the other 32 urethral syndrome patients, chlamydial infection
was deduced, either by isolation or significant antichlamydial antibody
changes. C. trachomatis was present in only one of 35 with cystitis and
3 of 66 without symptoms.
(d) Chlamydial infection in babies with neonatal conjunctivitis and in
their parents
As previously discussed in this thesis, the origin of neonatal
conjunctivitis by infection from the maternal genitalia had been
suspected since the 18th century10. First with respect to gonococcal
and later to chlamydial infection, this pattern of infection has been
confirmed repeatedly16'18. The presence of chlamydial or gonococcal
neonatal conjunctivitis implies infection in the mother's cervix and
probable recent urethritis in the father. Examination of the parents
as an epidemiological group who might be asymptomatic is essential to
prevent further spread of infection in the community. Furthermore,
maternal sequelae such as post-partum infection, in particular, pelvic
inflammatory disease, long recognised in gonorrhoea, had already been
associated with chlamydial infections05'104.
Whereas, using yolk sac culture, chlamydiae were isolated from
the cervix in only 7 of 2848 mothers of babies with chlamydial conjuncti¬
vitis, with tissue culture methods, isolates were made in 23 of 25 such
mothers. Nineteen of 25 had cervical isolates, ten of 20 were positive
in the urethra and 5 of 25 in the rectum. Eight had pelvic inflammatory
disease in the puerperium. Six of nineteen fathers had a history of
urethritis and, in fourteen, urethritis was present (chlamydia-positive
in eight)142.
/—
In Liverpool, on the basis of a preliminary investigation142 by
127
the present author and her colleagues, we made a more intensive study
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of the clinical patterns of neonatal conjunctivitis on a selected group
of babies referred to us, because there had been no response to routine
treatment with saline bathing or neomycin or chloramphenicol eye drops.
Cultures were taken from the conjunctivae only. Of 103 babies referred,
N, gonorrhoeae was isolated in 10.6%, C. trachomatis in 32% and both
were present in 3 cases. There were chlamydial reisolates from 6 babies'
conjunctivae after local tetracycline therapy for two to six weeks.
42.4% of chlamydia-positive babies were premature but only 15.5%
babies from whom neither gonococci nor chlamydiae were isolated were
pre-term deliveries. This difference in prematurity is significant
(X2 =6.7, 1 d.f.**). Chlamydial conjunctivitis may have been more
readily diagnosed because these premature babies were still in hospital
or chlamydial cervicitis may have been an aetiological factor in
producing prematurity by spreading to cause chorioamnionitis.
N. gonorrhoeae was isolated from all mothers (10) of babies with
gonococcal conjunctivitis and all but one of their fathers who were not
already on chemotherapy. Half these women had post-partum infections
(pyrexia in one, infected lochia in another and pelvic infection in
three).
Where babies had had chlamydial conjunctivitis, chlamydiae were
isolated from 20 (87%) of 23 mothers not already taking antibiotics
and from 4 of 10 fathers examined, who were all asymptomatic. Post¬
partum infections were present in 19 of all 31 (61%) mothers examined
(pyrexia in 3, infected lochia in 4, pelvic infection in 11 and wound
infection in one). Antichlamydial antibodies measured by the LGVCFT
test were found to be significantly raised in all nine mothers examined
who had evidence of pelvic infection.
Local treatment only-, for four weeks, with tetracycline eye
ointment, was given to the babies. Of 24 followed up, re-isolates
were obtained from six, of whom two had been inadequately treated for
three weeks or less.
Neonatal conjunctivitis has often been considered a self-limiting
mild condition, but on more careful ophthalmological examination, signs
usually associated with classical trachoma, including pannus and
conjunctival scarring have been reported as. occasional sequelae1^4'11*5.
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A distinctive chlamydial pneumonitis in neonates born of infected
mothers has subsequently begun to be recognised but there was no
evidence of this in our Liverpool series.
In Schachter's single case in 1975146, where pneumonitis followed
local treatment for chlamydial conjunctivitis, C. trachomatis was the
only pathogen isolated from the infant's upper airway and antichlamydial
serum antibody levels were raised. Incidentally, both parents had
chlamydial genital infections.
Beem and Saxon (1977) 11+7 confirmed the association between chlamydiae
and this syndrome, a non-toxic afebrile pneumonia developing the first
twelve weeks of life. The clinical picture was of tachypnoea and a
distinctive cough with x-ray findings of a diffuse bilateral interstitial
pneumonia. C. trachomatis was isolated from tracheo-bronchial aspirates
and high serological levels of anti-chlamydial antibody were found. They re¬
ported asymptomatic naso-pharyngeal shedders amongst infants with
chlamydial conjunctivitis11*8.
Harrison et al (1978) 11+9 estimated C. trachomatis accounted for one
third of pneumonias in infants requiring in-patient treatment in Seattle,
U.S.A. and found the serotypes were those of typical genital infection.
They suggested systemic treatment might eliminate orpharyngeal infection
but possibly at the cost of depressing the immune response. Prospective
studies50, had suggested 5-13% pregnant women in U.S. cities had
chlamydial cervicitis and 40-50% of their infants would acquire chlamy¬
dial infection during birth so that, by extrapolation, up to 6% of all
infants might have neonatal chlamydial conjunctivitis)
Mardh (1980)150 found that the incidence of chlamydial cervicitis
was 6.1% in 231 pregnant women and 8.4% in 273 puerperal women in
Sweden. Studying cord blood into which maternal antichlamydial IgG
can freely pass, he found 33% of specimens (i.e. five to six times
those culture-positive) had antibodies. Only 22% (5 of 23) babies
from chlamydia-positive mothers developed chlamydial conjunctivitis.
Nasopharyngeal cultures were not taken.
Three prospective studies were carried out in the United States in
1979 in which pregnant women were investigated for chlamydial infection
and treatment was withheld until after delivery.
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Hammerschlag1 51 in Boston examined 322 pregnant women and found a
2% cervical chlamydial isolation rate; 47% had cervical antichlamydial
antibodies and 73% were seropositive (i.e. high back-ground positivity).
Chlamydiae were later isolated from four of the six babies whose mothers
had chlamydial cervicitis. One baby had chlamydial pneumonitis; from
another a naso-pharyngeal isolate was obtained; the other two had
chlamydial conjunctivitis. Three of 61 babies whose mothers had
cervical antibodies had chlamydial conjunctivitis. Of a group of 28
mothers who had neither cervical isolates nor local cervical anti¬
chlamydial antibodies, 48% were sero-positive but none of their babies
had chlamydial infections.
In 81% of 47 babies tested, significant titres of serum anti¬
bodies were found at two to four weeks old, possibly due to passive
transplacental transfer of maternal IgG antibodies with which they
correlated well.-
Schachter152, in San Francisco, recovered chlamydiae from the
cervix in 4% of 900 women in the fourth month of pregnancy. Twenty
babies from chlamydia-positive mothers and eighteen control babies were
followed up. Significantly more conjunctivitis and pneumonia occurred
in babies exposed to infection. Chlamydiae were isolated from half
these babies and none of the controls. 70% of the babies of these
chlamydia-positive mothers had serological evidence of infection, i.e.
the incidence of chlamydial infection in the new-born was 2.8%.
Frommell153 screened 340 women in Colorado. Their chlamydial
isolation rate was 8.8%. 18 children born to chlamydia-positive women
were compared with 16 control babies born to chlamydia-negative women.
The overall chlamydial infectivity of mothers for babies (assessed by
culture from the conjunctivae and nasopharynx and from anti-chlamydial
tear antibody levels) was' 61% and there was infant pathology (conjuncti¬
vitis or pneumonitis) in 44% of the offspring of chlamydia-positive
mothers. The cord blood IgM was not raised, suggesting intrauterine
infection had not occurred. As the incidence of chlamydial infection
in bottle-fed babies was lower than in breast-fed in those exposed, the
possibility of post-partum infection during breast-feeding was suggested.
The risk of pelvic infection in pregnancy and the puerperium to
mothers in such studies, quite apart from that of sexual transmission
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to their consorts is unacceptably high and, in Liverpool, retrospective
studies127'3 ' 1 have been undertaken instead, where the baby with
chlamydial neonatal conjunctivitis is the index case, enabling the
diagnosis and treatment of the mother and consort to be carried out
simultaneously.
The present author and others in the Liverpool group investigated
the incidence of pharyngeal chlamydial infection in 23 babies with
C. trachomatis conjunctivitis and the post-treatment chlamydial isola¬
tion rate from eyes and nasopharynx in 34151t. Babies were treated
either (a) with chlortetracycline eye ointment 1%, inserted 5-6 times
daily for 28 days or (b) for 14 days (initially only seven) with
concurrent erythromycin syrup (30 mg/kg daily in divided doses).
Following a reisolate, babies were recalled and given the combined
treatment.
Chlamydiae were isolated from the pharynx in 12 of 23 (52%) before
treatment and reisolated from the eyes of 4 of 34 (11.8%) and the
pharynx of 14 of 34 (41.1%) after treatment. Chlamydiae were reisolated
significantly more often (75%) from those who had had only topical
treatment than from those given systemic treatment as well (32%).
Clinical signs in the eyes were minimal when the reisolates were made.
Routine radiological examination of the chest in babies with
cough was carried out latterly and 8 were so examined. Radiological
signs of inflammation in the chest were found in two of these babies.
Chlamydial antibody levels were raised in neither, although chlamydiae
werereisolated from one baby's eye and pharynx, leaving the aetiology
of the lower respiratory tract infection unclear in both.
It was obvious that without routine follow-up pharyngeal swabs,
the efficiency of treatment would be overestimated. Even the 32%
failure rate following combined treatment was not good. Compliance
failure may have been responsible as no reisolates were obtained from
premature babies whose treatment was carried out in hospital. On the
other hand, more reisolates were obtained from the pharynx, whence
both anaerobic and aerobic bacterial are difficult to eradicate after
standard chemotherapy, than from the eye.
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Our Liverpool studies, involving clinical observation, epidemiology,
isolation, serotypes and the use of chemotherapy, have confirmed that
C. trachomatis is an aetiological agent in oculo-genital infection,
similar to N. gonorrhoeae whose pathogenic behaviour it mimics so
closely.
Koch's postulates had been reasonably well fulfilled even from the
original work of Halberstaedter and von Prowazek25'26 and later by Jones
et al^3 (1959). Further verification of these postulates has come
indirectly from clinical experience but even more directly in two
sites of infection from animal models.
Firstly, urethritis was produced by experimental inoculation of
the urethra of a baboon by an agent isolated from the rectum of the
mother of a baby with chlamydial conjunctivitis155. The agent was
reisolated from the subsequently inflamed urethra of the baboon.
These results were later confirmed156 and extended using genital
chlamydiae isolated from men with NGU to infect other baboons1
urethras. Urethral lesions, sero-conversion and chlamydial shedding
for three.months ensued.
Secondly, chlamydial isolates from the fallopian tubes of two
patients with acute salpingitis were inoculated directly into the tubes
in two grivet monkeys and via the cervical canal in another, resulting
in acute salpingitis in all three monkeys131. Typical lesions of




THE SENSITIVITY OF C TRACHOMATIS TO ANTIBACTERIAL CHEMOTHERAPEUTIC
AGENTS IN VITRO AND IN VIVO
When its classification was still uncertain, Gordon and Quan157
suggested that C. trachomatis' sensitivity to chemotherapy was an
indication of the agents' biochemical complexity and their relation to
bacteria rather than viruses. Thus chemotherapeutic agents which
affect the synthesis of bacterial cell walls or activity of bacterial
enzymes are often active against chlamydiae. Penicillin is bactericidal
and irreversibly destroys sensitive multiplying agents by interfering
with cell wall synthesis158. Chlamydiae have a cell wall which contains
peptidoglycans like bacteria and, in tissue culture, with increasing
concentrations of penicillin, normal inclusions are replaced by
abnormal ones which do not fluoresce or develop normally. They are
arrested at the initial stage and cannot proceed to form elementary
bodies with a normal cell wall159r56r5>6r81. Other antibiotics,
tetracycline, chloramphenicol and erythromycin interfere with protein
synthesis in various ways at ribosomal level and are bacteriostatic,
temporarily inhibiting bacterial growth. Chlamydiae with
their own enzyme systems are sensitive to these antibiotics,
erthromycin and tetracycline being very effective against chlamydial
genital infections150'181.
However, clinical practice and conclusions drawn from in vitro
experiments do not always agree. Penicillin152 and chloramphenicol150
were found inhibitory to certain laboratory-adapted strains of
chlamydiae in chick-embryo or tissue culture. However, in Liverpool,
in clinical practice, we have found them ineffective.
In a series of 22 women152, with proven concurrent gonococcal and
chlamydial infection, treated with a single injection of procaine
penicillin (1.2 mega units intramuscularly) plus amoxycillin (500 mg
orally) although gonorrhoea was eradicated in them all, we reisolated
C. trachomatis from 17.
19 7
Of 106 babies with presumptive chlamydial conjunctivrtis
(C. trachomatis were isolated either from the baby's eye or its
mother's cervix or both) 24 had been treated with local chloramphenicol
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(for 1-17 days, mean 6.3) before conjunctival chlamydial cultures were
taken. C. trachomatis was isolated from 20 of 24 and these all
responded either to local tetracycline alone or in combination with
systemic erythromycin.
The clinical appearance of chlamydial conjunctivitis was usually
modified by chloramphenicol in that the discharge often ceased and
mucosal oedema persisted but to a lesser decree, and the signs recurred
during or after stopping treatment with chloramphenicol.
It may be that as intra-cellular parasires, chlamydiae are not
affected by antibiotics because the host cell wall, inclusion or matrix
may be impermeable and related antibiotics' variation in effects may be
due to variable cell penetration. Conversely, antibiotics may succeed
against chlamydiae because of an indirect effect via the host cell's
metabolism. Chlamydiae need amino-acids, nucleic acids and energy from
the host cell. Chemotherapeutic agents affecting the host cell
nutrition alone may thus arrest chlamydial infection although they are
not effective against the organism itself.
As in much of the history of the investigation of chlamydial
infection, it was in trachoma that treatment was first described, with
copper sulphate and other chemical cauterizing agents by the Egyptians
and later with scarification and the expression of follicles in Greek
and Roman times1614. The first effective treatment was with oral sul-
phonamides in 1938165 to cure trachoma in American Indians. When wide
spectrum antibodies were introduced, the dramatic effects of local
and systemic tetracycline were noted166 and now, provided that it is
long-term, (six weeks or, if intermittent, six months) systemic or
local therapy with tetracycline or erythromycin is considered
satisfactory by the World Health Organisation (W.H.O.) for endemic
trachoma, although failure of patient compliance and re-infection may
cause persistent or recurrent infection167. (To rifampicin, previously
recommended, resistant strains have been found to develop).
Although Crede's method of prophylaxis against gonococcal neonatal
conjunctivitis (using 2% silver nitrate) has been known since 1881,
it is quite ineffective against chlamydial infection and is, in any
case, no longer used in British obstetric practice. Where it is
employed, the true incidence of gonorrhoea in these babies and their
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contacts and the sensitivity of the gonococci so killed will not be
known and infection in their mothers and possibly their mothers1
consorts will not be treated. Furthermore, it has recently been shown
to be ineffective in some cases of gonococcal infection17^ /lt+.
Meanwhile, despite a widely held belief that the signs and
symptoms of NGU eventually resolve in the majority of cases with no
active treatment171 ^ue to a high remission rate (in 50-70% of men,
the disease slowly regresses in 1-3 months) the patient's discomfort,
anxiety and, occasional complications and spread to others, were strong
indications for active treatment. Various trials, with antibiotics
empirically chosen and placebos, were carried out. Criteria for
diagnosis and cure were often unclear and studies were not controlled.
However, placebo trials, unacceptable today, indicated the untreated
course of the disease and some useful guidance about possible therapy
was obtained173'1714.
Treatment with a combination of streptomycin and sulphonamides
was cheap and gave reasonable results and was synergistic, for
neither was effective alone. Lyall, in 1953175, in this department in
Liverpool, was looking for a method of treatment for urethritis where
preliminary microscopic diagnosis was impracticable (i.e. both gonococcal
and nongonococcal). In a large series of 540 patients, he found
success rates with this regime of 93% in gonorrhoea and 85% in NGU.
Subsequently, oral medication with tetracycline alone seemedto
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have a beneficial effect in early trials and Holmes ° (1967) confirmed
this in a classic double-blind trial of tetracycline and a placebo in
the closed community of an aircraft-carrier at sea, where heterosexual
re-exposure was eliminated. Of 96 men with NGU, there was 86% failure
rate in the placebo group and 10-35% failure rate where tetracycline
was given from four to seven days, the better results corresponding to
the longer course.
Willcox, in a review of NSU therapy in 1977177, showed an 84%
success rate with tetracyclines falling to 68% with a placebo; the
streptomycin plus sulphonamides regime was less successful than Lyall
had found, at 75% compared with 85% in 1953.
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An exhaustive trial of six treatment regimes178, using three
different tetracyclines, was carried out by colleagues in the Liverpool
group on 756 men with NGU. This was diagnosed by finding in their
urethral discharge or urine threads, more than 15 polymorphonuclear
leucocytes in more than five high power fields in the absence of gonorrhoea
(cultures for C. trachomatis were not performed). Results of single-
dose chemotherapy were unacceptable and a longer (21 days) course
produced a better response than shorter courses although the results
were not significant. Considering the longer courses, (a) possible
effects on the bowel flora with the emergence of resistant organisms,
(b) unsuitability for third world countries and (c) the possible
failure of patient compliance were all noted. It was concluded that
it does not seem possible to exceed around 85% success rate.
A clinical comparison of the efficacy of tetracycline and erythro¬
mycin had not been recorded until a trial by Oriel (1977)179 and, in
that, dosage schedules differed. In a series of 148 men with NGU
(44% chlamydia-positive), 250 mg oxytetracycline was given every six
hours' for two weeks whereas 500 mg erythromycin stearate was given
12 hourly for the same period. Despite the variation, there was no
significant different in response. After two weeks treatment, only 5
of 35 (14%) treated with oxytetracycline and 4 of 30 (13%) treated with
erythromycin still had symptoms. Five weeks later, this was 23-25%
and three of four men from whom chlamydiae were then reisolated admitted
further exposure. Results did not differ significantly between
chlamydia-positive and chlamydia-negative groups.
However, earlier workers188 had found chlamydia-positive NGU
responded better than chlamydia-negative NGU to oxytetracycline.
Although chlamydiae had been isolated in about 40% of men with NGU,
other aetiological agents were obviously involved. These included the
ureaplasmas which had been found significantly more often in men with
chlamydia-negative NGU.
Differential chemotherapy studies189 on men with NGU to show the
aetiological importance of ureaplasmas as well as chlamydiae were done
using aminocyclitols (ureaplasma-effective) and sulphafurazole (chlamy-
dia-effective). Of 91 men, 40% were chlamydia-positive, 69% were
ureaplasma-positiv^ 23% had both infective agents and in 12% neither
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was isolated. There was no clinical response by the ureaplasma
infection to sulphafurazole nor of the chlamydial infection to the
aminocyclitols and very little improvement when either drug was given
singly to men from whom both or neither agent was isolated.
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A similar double-blind trial ox used minocycline, a tetracycline
to which ureaplasmas and chlamydiae were sensitive, and rifampicin,
which inhibited only chlamydiae. Of 217 men with NGU, chlamydiae were
isolated from 43%, ureaplasmas from 59%; 68% completely recovered after
minocycline, only 37.4% after rifampicin.
These results indicate that, whereas chlamydiae may be a major
factor, NGU has multiple aetiological agents and treatment will be more
successful if guided by diagnosis dependent on isolation results and may
indeed sometimes be an exercise in applied microbiology.
In some men, following treatment for gonorrhoea, their urethral
discharge recurs and polymorphonuclear leucocytes (> 10/high power
field) are seen on microscopic examination of a Gram-stained smear and
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gonococci are not found on smear or culture . This is postgonococcal
urethritis (PGU) and the chlamydial isolation rate ranges from 15183
to 81%106.
In 32 cases, Oriel182 (1977) isolated C. trachomatis and
N. gonorrhoeae before single dose therapy with gentamicin (an amino¬
glycoside similar to streptomycin) (in 11 men), ampicillin (in 11 men)
and spectinomycin (not effective against chlamydiae) (in 10). Gonorrhoea
was eradicated in all 32 and in 31 chlamydiae were reisolated and PGU
had developed.
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Willcox estimated that 44-56% of men with gonorrhoea also had
NGU and that 20-30% patients treated with penicillin for gonorrhoea
subsequently require treatment for PGU.
These are manifest cases but unfortunately, in women where post¬
gonococcal cervicitis occurs, there is frequently no recurrence of
symptoms to alert suspicion.
In a previously mentioned study182 by the Liverpool group, 22
women with gonorrhoea, later found to have concurrent chlamydial
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infection, had been given a single treatment with intra-muscular and
oral penicillin. Gonorrhoea was eradicated but C. trachomatis was
reisolated in 17 (77%). In a later Liverpool survey185 of a similar
group with the double infection who had followed that same treatment
regime, chlamydiae were reisolated in 84%.
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Oriel also found single dose therapy unsuccessful when gonococcal
and chlamydial infection coexisted. In only 5 of 23 such women treated
with ampicillin (2 g) and probenecid (1 g) and in only 4 of 18 treated
with spectinomycin, were both eradicated.
In a later Liverpool study185, 262 women with gonorrhoea were given
either single dose penicillin treatment (procaine penicillin 1.2 mega
unit and either probenecid 1 g or ampicillin 1 g) or a week's course of
tetracycline (250 or 500 mg six hourly for seven days). Pelvic
infection developed in 11 of 129 treated with penicillin (previous
chlamydial isolation rate 52%) and in only one of 133 given tetracycline
(previous chlamydial isolate rate 54%). These differences in pelvic
infection rate were significant (y2 = 7.24, 1 d.f.**). N. gonorrhoeae
was not reisolated but C. trachomatis was, in 4 of 8 originally chlamydia-
positive treated with penicillin who developed pelvic infection and in
the single case treated with tetracycline who developed pelvic infection
and who had also been chlamydia-positive originally.
Although tetracycline and erythromycin are effective against
chlamydial infection and gonorrhoea, N. gonorrhoeae is less susceptible
to these drugs, particularly at the. prolonged low dosage suitable for the
treatment of C. trachomatis infections. As mentioned previously, in an
attempt to treat either gonococcal or nongonococcal urethritis
satisfactorily, without differentiating between them, Lyall had, in
1953175, found streptomycin plus sulphathiazole a most effective regime.
However, many strains of N. gonorrhoeae developed resistance to
streptomycin and due to that, and its ototoxic effects, it is now an
unsuitable form of treatment.
Paavonen (1980)186 looked at trimethoprim-sulphadiazine, a combina¬
tion related to cotrimoxazole (trimethoprim-sulphamethoxazole). Sulpha-
methoxazole had been found satisfactory in gonorrhoea187 and genital
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strains of C. trachomatis had been found susceptible although it was
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said to be less effective in NGU than oxytetracycline and erythromycin199.
Paavonen compared the effect of the trimethoprim-sulphadiazine combina¬
tion in 75 men with NGU and their 75 female consorts, with that of a
placebo. Thirty-four of each sex had active treatment. Nineteen men
and 15 women were chlamydia-positive before active treatment and in one
of each sex, C. trachomatis was not eradicated after treatment. In the
placebo group, C. trachomatis was reisolated from over 80% of the
originally chlamydia-positive after treatment and five chlamydia-positive
patients developed complications. Trimethoprim-sulphadiazine is thus
effective in the treatment of chlamydial infections provided that the
sexual partner is treated simultaneously.
The frequent absence of symptoms and ill-defined signs in women
with nongonococcal cervicitis, making diagnostic criteria difficult to
assess, was the reason for carrying out most of these studies in men
but the need to treat their sexual partners to prevent re-infection has
been stressed111.
As it is likely that chlamydiae producing conjunctivitis in both
babies and adults in this country are also present at other sites, local
tetracycline alone is rarely satisfactory. Further, systemic tetracycline
must be avoided in pregnancy, lactation and in the treatment of young
children, due to the effect on bone and teeth formation and so systemic
erythromycin is used in the treatment of pregnant and lactating mothers
and infants.
The Liverpool group followed up 38 previously chlamydia-positive
contacts of men with NGU for 2-14 months after treatment with oxytetra¬
cycline hydrochloride 250 mg 6 hourly for 31 days, or, in the case of
pregnant women, erythromycin B.P. 250 mg 6 hourly for 21 days9.
(Treatment was given for 21 days as this had been found most satisfactory
in men and because, after only 7 days oral treatment with tetracycline
250 mg 6 hourly, C. trachomatis was reisolated by Dunlop (1980)199 from
the cervix of the mother of a baby with neonatal conjunctivitis) ,
C. trachomatis was reisolated in five and in four there had been a
strong possibility of re-infection. The distinction between relapse
and re-infection is notoriously difficult after treatment of sexually
transmitted disease, especially with long follow-up periods and, in
general, treatment failure rates make no distinction between the two.
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Work in Liverpool by the present author and her colleagues with NGU
contacts and mothers and babies has shown that chlamydial cervicitis
and neonatal conjunctivitis respond to treatment with tetracycline and
erythromycin as urethritis does. Post-treatment reisolates have
generally been due to re-infection or compliance failure. This is
supported by "our investigation (1980)9 of serum tetracycline levels in 26
women on a 21day course of oxytetracycline. They were adequate
therapeutically as the range was 0.53-2.01 yg per ml (mean = 1.21)
whereas the minimum inhibitory concentration (MIC) of oxytetracycline
hydrochloride for C. trachomatis = 0.2 yg/ml. (Minimum inhibitory
concentration (MIC) for C. trachomatis is the lowest concentration of
a chemotherapeutic agent preventing the appearance of any chlamydial
inclusions in the tissue culture cells). Similarly, when Thin (1979)191
estimated the vaginal oxytetracycline levels from washings in 20 NGU
contacts on a 10 day course of oxytetracycline dihydrate, they found
them to be 0.6-6.5 yg/ml, well above the MIC.
Earlier work with antibiotics has been extended and now the
susceptibility of C. trachomatis can be assayed quantitatively in
tissue culture systems 188 '188,194,195_ The most active agents are
erythromycin and oxytetracycline. Trimethoprim, sulphonamides and
chloramphenicol are also inhibitory but C. trachomatis is not killed
by aminoglycosides such as spectinomycin, kanamycin or gentamicin, nor
by penicillin, ampicillin, lincomycin, clindamycin or metronidazole.
Resistance can develop to rifampicin, previously thought most
effective188'169. However, studies in guinea pig conjunctivitis caused
by the related C. psittaci suggest that spiramycin may be even more
effective than the tetracyclines188.
It was noted that some related antibiotics had very different
effects on C. trachomatis but the different C. trachomatis serotypes
do not differ significantly in their sensitivity to chemotherapeutic
agents other than-sulphonamides196. There is little evidence that
resistance develops to the commonly used tetracyclines195. This
suggested that any patient from whom chlamydiae were isolated would
respond to tetracycline therapy and that this would permanently
eradicate the infection.
Studies195'197 had shown that the MIC and the minimum lethal
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concentration (MLC) (the lowest concentration of the agent required to
prevent (a) the tissue culture from being able to transmit infection to
further tissue culture on serial passage and (b) infection recrudescing
after the antibiotic is removed) may differ widely. This reflects the
property of latency previously observed72 in which there may be arrested
growth of the elementary body after adsorption under conditions of
nutritional inadequacy. Antibiotics may affect nutrition either by
their effect on enzymatic systems or cell wall systems of C■ trachomatis.
This work, together with our clinical experience with penicillin
and chloramphenicol led us to doubt the validity of MIC results in
clinical treatment. The author of this thesis had already worked in
the laboratory on the isolation of clinical specimens and routine MIC
determinations. We decided to use different laboratory techniques to
demonstrate the chemotherapeutic susceptibility of C. trachomatis.
Modifications to previous experiments to determine MIC
Previous tissue culture experiments to determine the MIC of chemo¬
therapeutic agents against C, trachomatis have been rather different
from antibiotic investigations in clinical infections. Tissue cultures
were infected with highly laboratory-adapted and uncloned (variant
containing) strains of C. trachomatis. C. psittaci and LGV and other
fast-growing strains were also used. These grow rapidly, producing
multiple growth cycles, and are very different in many respects, possibly
including antibiotic susceptibility, from genital strains or low
tissue culture pass strains of C. trachomatis which very few previous
laboratory workers have used.
On the other hand, with clinical isolates of genital strains there
is only a single cycle of growth^®® and there are no secondary growth
cycles so all inclusions are at the same stage of development and
growth is synchronous. It is likely that chemotherapeutic agents may
have widely varying effects according to the stage of the tissue culture
infection at which they are added.
However, in previous laboratory work, simultaneously with infection
of the tissue culture with test chlamydiae, the trial antibiotic was
inoculated and remained present at a constant level for the whole single
step growth cycle.
Yet, in a clinical case of, for example, conjunctivitis, before any
antibiotic is given, the chlamydial infection is likely to be well
established with chlamydial inclusions in different developmental phases.
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Bowie (1978) 3 described how incubation of infected tissue cultures
for 48 hours, prior to the addition of antibiotics, decreased the sus¬
ceptibility of C. trachomatis so that much higher concentrations than
usual of tetracycline, erythromycin and rifampicin were required. It
was suggested that these methods would give a much better prediction of
the antibiotics' efficacy, particularly in chronic trachoma. A similar
plea for laboratory methods more relevant to clinical needs had been
made by Jawetz and Hanna in 1961"99.
In clinical practice, the antibiotic level falls between doses and,
if not taken regularly or in the case of local treatment not reaching
the site of infection, this trough may be even lower. Temporary-
addition of antibiotic at varying intervals after tissue culture
infection, followed by washing of the tissue culture and incubation
with fresh antibiotic-free medium, may be used to give a "pulse"
effect more similar to clinical dosage and so affect different ages
of inclusion153'198.
Preliminary incubation of tissue culture with the antibiotic
before infection with C. trachomatis enables (a) any slowness of the
antibiotic in penetrating the tissue culture cell to be compensated
for before the infection occurs or (b) any direct effect on cell
metabolism to be magnified. Passage after exposure to the antibiotic
allows multiplication in tissue culture which is fresh and totally
antibiotic free and allows the MLC to be compared with the MIC.
The possibility of mere suppression of infection or "escape" in
the form of latent organisms where MLC differs from the MIC or even of
resistant forms must be considered when there is a lack of response to
conventional treatment or apparent recurrence of infection without
re-exposure.
These modifications of the MIC investigation can be used to explain
clinical failures with apparently efficacious drugs. (i) Further
incubation of duplicate infected cultures at the MIC may cause the
inclusions to reappear when chlamydistatic effects wear off.
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(ii) Failing that, duplicate cultures after incubation in identical
conditions should be washed to remove the antibiotic and inspected
after further incubation. (iii) Several passes after incubation of
such washed tissue cultures may be needed before some latent chlamydiae
multiply again, whereupon their antibiotic sensitivities should be
re-tested.
Quantitative assay of the susceptibility of C. trachomatis to
commonly used chemotherapeutic drugs was undertaken. The site of
activity on the ribosomal system of erythromycin, cxytetracycline and
chloramphenicol is similar although their clinical effects are very
different. With penicillin, there is a gross discrepancy in that,
while the MIC seems achieved well within conventional therapy levels,





Cervical epithelium may be either (i) original (native) (ii)
squamous metaplastic (physiological) (iii) atypical (dysplastic) .
Original epithelium may be stratified squamous or columnar. Columnar
epithelium lines the endocervical canal and associated glands with a
single layer of tall mucous-secreting epithelial cells. Squamous
epithelium continues upward from the vaginal lining to meet the
columnar epithelium at any point across the ecto- or endocervix118.
Ectopy or erosion is a cervical condition recognised since the
vaginal speculum was introduced. Fischel (1880)208 described it as
congenital, being present in the foetal cervix, absent in childhood,
and returning later. He and his contemporaries considered it resulted
from loss of squamous epithelium of the ectocervix due to the macerating
effects of exudates associated with post-abortal and puerperal dis¬
charges and colpo-vaginitis. Gonococcal infections and the trauma of
parturition were thought to be common causes. Myer281,282 (1910, 1930)
thought columnar epithelium grew out to cover the damaged area from the
os and later was replaced by an ingrowth of squamous epithelium from
the ectocervix. Myer based his view that ectopy was due to acute or
chronic inflammation on the presence of redness and leucocytic
infiltration there. Columnar epithelium is seen to be red, on
colposcopic examination, as it is only one cell layer thick overlying
the capillary bed. Leucocytic infiltration is universal in the cervix,
mainly due to plasma cells, and is associated with sperm destruction,
clearing of epithelial debris and antibody production. There need
therefore be no inflmmation present although "cervical erosion" and
"chronic cervicitis" were both terms used to label ill-defined
cervical appearances119. (Illustrations p.48a).
Using the colposcope, one finds either ectopic columnar epithelium
encroaching from the endocervix on to the ectocervix (previously called
"erosion") or columnar epithelium having undergone physiological squamous
metaplasia ("chronic cervicitis"). Neither of these is considered an
abnormal condition. As erosion and chronic cervicitis imply the
presence of inflmmation, the term "ectopy" and "metaplasia" are
preferred. "Erosion" is reserved for true erosions found accompanying
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Clinical Signs - Normal cervix with clear endocervical mucus in each case
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cervical infections with herpes genitalis or syphilis.
Various factors are thought responsible for the presence of ecto-
cervical columnar epithelium203. The boundary between the stratified
squamous epithelium and columnar epithelium internally may coincide with
the external os or be either just inside or outside it, the latter
producing congenital columnar epithelium on the ectocervix (i.e. ectopy).
This has been found in approximately one out of three baby girls.
Variations in the circulating oestrogen-progesterone ratio may be
responsible for the spontaneous appearance of ectopy in pregnancy
and conversely the rarity of post-menopausal ectopy. In pregnancy,
prolapse of the endocervix is partly responsible for the production of
ectopy. Another factor is the action of oestrogen in causing hyper¬
plasia of the cervix, in particular increasing the stromal volume.
Columnar epithelium is more receptive to infection by intracellular
parasites such as C. trachomatis and N. gonorrhoeae than stratified
squamous epithelium. The surface squamous epithelium consists of
desquamating dead cells 30 or so layers away from the blood supply and
is normally quite resistant to such infecting agents, whereas columnar
cells are phagocytic and actively metabolising, a single layer deep.
One may consider the frequency of vaginitis due to the gonococcus and
other bacteria in the pre-pubertal girl where the vaginal epithelium
is only 2-3 cell layers deep compared with that in the menstrual years
where superficial cells are prominent and there are many stratified
layers of squamous epithelium.
Squamous metaplasia is an irreversible physiological change
occuring in areas of columnar epithelium over a short transition period,
mainly in pregnancy and adolescence, and, to a lesser degree in late
intra-uterine development. The area of metaplasia is known as "the
transformation zone" (previously "transition zone"). The commonest
form of metaplasia is an essentially physiological process and typical
metaplastic squamous epithelium results. Dysplasia and carcinoma-
in-situ are forms of abnormal metaplasia where genetic change has
occurred1^' 118,204 _
Studies in adolescence showed that the area of metaplasia in
promiscuous girls with accompanying dysplastic features was significantly
more than in virgins where only limited change had occurred, suggesting
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that coital activity stimulates the development of metaplasia2®®'2®®.
In pregnancy, there is a high incidence of metaplastic change in
the ectocervix2®7. The pH of vaginal secretions bathing it in early
pregnancy drops significantly and this may stimulate metaplasia in
ectopic columnar epithelium. Metaplastic islands may so enlarge as to
merge with the squamo-columnar junction in later pregnancy. Atypical
metaplasia has been observed, with variable neoplastic potential, in
pregnancy. However, following the trauma of delivery and the
puerperium, the atypical epithelium may be partially or completely
removed. After childbearing, there is little alteration in the area of
metaplasia until the menopause, when there is shrinkage of the whole
cervix.
Coppleson and Reid think that the period of transition from
columnar to metaplastic squamous epithelium may be short, hours, days
or weeks and it is then that environmental factors may exert their
mutagenic action by alteration of the nucleic acids in the dividing
cells. Possibly mutagenic nucleic acids may originate from infectious
agents or spermatozoa2®®.
Much has been written about factors in the genesis of carcinoma
of the cervix but Gagnon's report2®8 in 1950 of the freedom of virgin
women from this condition is surely fundamental. Rotkin (1973)209
enumerated factors distinguishing cervical carcinoma patients. These
included an early age at first coitus, a large number of consorts,
sexual promiscuity and a high incidence of sexually transmitted disease.
Indeed/ carcinoma of the cervix has many characteristics in common with
sexually transmitted diseases. In their review of the pathogenesis of
cancer of the cervix, Novak and Woodruff21® state that the evidence is
very strongly in favour of the theory that infection, possibly viral,
plays a major role in the production of cervical neoplasm.
Herpes simplex virus (HSV) type II fulfills several important
9 11
criteria as an aetiological agent of cervical carcinoma (a) Naib^11
found an association between viral cervicitis and the presence of
919 919
pre-malignant lesions of the cervix, (b) Several groups^1*'^° in
U.S.A. found significantly higher levels of antibody titres to genital
herpes in women with carcinoma of the cervix than in matched controls.
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(Others214 in Israel, New Zealand, Taiwan and Colombia did not but the
populations they studied differed from those in the original studies in
race, age, socio-economic level and other respects), (c) Herpes
genitalis viral antigens have been found in cervical cancer tissue215,
(d) Fragments of herpes genitalis DNA have been found in cervical
neoplastic arid preneoplastic cell nuclei215. (DNA from the sperm head,
commoner, more abundant and less transient than viral sources, has also
been postulated as a cervical carcinogenic agent217'218).
The cervix was confirmed as the site of chlamydial infection in
the female genital tract when inclusions were reported in smears41 and
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biopsy^ . Accompanying local inflammatory changes were noted in mothers
of babies with neonatal chlamydial conjunctivitis82, women with fresh
chlamydial eye infection and female sexual contacts of men with chlamydial
conjunctivitis112. Hilton and Oriel confirmed this in female contacts
of NSU patients110'111.
Naib (1970)218 had found a high incidence of atypical cells in
cervical smears taken from mothers of babies with chlamydial conjunctivitis.
Alexander (1973)217 in his review, however, considered that while
C. trachomatis was twice as prevalent in the cervix as herpes simplex
virus (HSV) and its relationship to sexual activity well known, he had
been unable to recognise a clear cut relationship between cervical
chlamydial infection and dysplasia.
When Schachter (1975)220 studied women with cervical dysplasia he
found the rate of sero-reactivity to chlamydial antigens (77.6% MIF
test, 21.5% LGVCFT), higher than with other clinic populations. The
chlamydial isolation rate was not raised in this group and the high
antibody levels were unchanged on re-testing, suggesting that this
reflects previous exposure to chlamydiae and not recent infection.
Paavonen (1979)221 found the chlamydial isolation rate in 177
gynaecological patients with cervical dysplasia (Papanicolaou groups
III-V, moderate to severe) was 16% and in a control group of
gynaecological out-patients 9%. Seruig antichlamydial antibody levels
in 93 dysplasia patients were significantly more often positive, and
at higher levels, by LGVCFT and micro-immunofluorescence testing, than
in controls. No such difference was found in_ testing for anti-HSV type
II or cytomegalic antibodies.
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Carr (1979)222 examined cervical secretions for chlamydial anti¬
body by immuno-fluoresence. Where antibody was present, 11 of 15 (73%)
had Papanicolaou II or III smears. In the absence of antibody, these
abnormal smears were found in only 3 of 18 (16.7%) patients. Following
tetracycline treatment, the smears reverted to Class I and antibody
disappeared.
These studies do not clarify whether dysplasia and eventually
carcinoma of the cervix is related to the long-term effects of latent
chlamydial infection or to other consequences of sexual promiscuity.
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MATERIALS AND METHODS
PART 1: CLINICAL INVESTIGATIONS
(a) Nongonococcal urethritis contacts
Patients
The group of women consisted of 455 contacts of men with NGU.
They had attended Liverpool Royal Infirmary consecutively on specified
days between January 1974 and December 1977. All the male contacts
had been diagnosed on the basis of finding 10 polymorphonuclear
leucocytes per high power field (x 100 objective) in a urethral smear
with no evidence of N. gonorrhoeae. In those male STD clinics,
facilities for the isolation of C. trachomatis were not available.
Patients who had received antibiotics recently were excluded and the
last occasion on which they had taken antibiotics was recorded for all
patients.
404 women presented with contact slips. The others either attended
of their own accord or were referred by another doctor and gave a
history that their sexual contact was attending a male STD clinic (the
diagnosis was then always obtained from the clinic named).
Clinical examination
A routine genital examination was carried out. Swabs for
detection of N. gonorrhoeae were taken from the urethra and endocervix
on at least two separate occasions and used to inoculate on to a
selective medium containing antibiotics (London Analytical and Bacter¬
iological Media Ltd. London) and make a smear for Gram staining.
Specimens were obtained with cotton tipped swabs. Endocervical swabs
were taken after a Cusco's vaginal speculum had been inserted into the
vagina and all the vaginal discharge had been removed. The cervix was
wiped with sterile cotton and a cotton tipped swab was inserted into
the cervical canal and rotated firmly round the mucosa. The swab for
C. trachomatis culture was also taken from the endocervix in this
manner and preceded that taken for gonorrhoea.
In this group of women and in the mothers of babies with neonatal
conjunctivitis, cultures for C. trachomatis were only taken from the
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cervix. Concurrent and subsequent investigations in Liverpool
(mentioned in the introduction139) had shown that little more would
have been achieved by taking urethral cultures as well, as only 5%
were positive only in the urethra.
Swabs taken for C. trachomatis were immersed at once in 3.0 ml
transport medium in screw-topped bottles and stored at 4°C until
inoculated on to tissue culture (as will be described in "Laboratory
methods") usually between two and four hours later but occasionally
after storage for 24 hours. All patients were investigated for
syphilis, trichomoniasis and candidiasis by conventional means.
Clinical signs
Clinical signs were recorded on the specially designed request
form as well as the case sheet at the time of sampling.* The state of
the ectocervix was recorded in three categories: no ectopy, simple
ectopy and hypertrophic ectopy. This latter was an area of ectopy
which was oedematous, congested and bled. When the area of ectopy was
irregular with peninsulae and islands of squamous epithelium and
Nabothian follicles, it indicated metaplasia, usually physiological-but
possibly dysplastic. The contents of the endocervix were recorded as
clear mucus, cloudy mucus, mucopus (yellow) and mucoid discharge
(white). When examining the cervix, care was taken to remove discharge
extruding from the cervix before the contents of the canal were
assessed so that vaginal flora might not contaminate clear endocervical
mucus. Mucoid or mucopurulent endocervical discharge combined with
hypertrophic ectopy indicated cervical inflammation.
Treatment
Routine treatment of chlamydia-positive women was with oxytetra-
cycline hydrochloride tablets 250 mg 6-hourly for 21 days. Pregnant
women were not given oxytetracycline but received erythromycin B.P.
250 mg six-hourly. Treatment was given for 21 days as this is the
longest course advised for men with NGU and we did not want possible
inadequate treatment to be a cause of persisting clinical signs or




























As mentioned in the introduction, a reisolate had been reported
after only 7 days treatment with oxytetracycline 250 mg six-hourly, from
the cervix of a women in the puerperium whose baby had neonatal
chlamydial conjunctivitis190.
Follow up
All chlamydia-positive patients were asked to attend for review to
check whether or not candidiasis had developed and to assess the
clinical response, on the 14th day of treatment, on day 28 (seven days
after completion of treatment), twice more at three weekly intervals
and subsequently at six weeks i.e. a total of three months post-
treatment observation. Some patients continued to attend at three
monthly intervals and others returned within that time with fresh
symptoms and requesting re-investigation. On each post-treatment
visit, specimens were taken for culture for C. trachomatis, N. gonorrhoeae,
Trichomonas vaginalis and Candida species.
(b) Mothers and Babies
Patients (babies)
129 babies were examined between January 1974 and November 1979.
They had been referred by paediatricians because of failure to respond
to routine treatment with saline bathing and neomycin or chloramphenicol
eye drops or because no bacterial growth was reported by the laboratory.
Clinical examination
Specimens were obtained with cotton tipped swabs, as used for the
women patients' investigations, from the mucosal surface of the lower
lids in all cases and from the upper lids, if possible. Pharyngeal
specimens were taken with the same type of swabs by gently stroking the
posterior pharyngeal wall.
Other sexually transmitted diseases
These were examined microscopically and by culture for gonococci,
other bacteria and for Candida. Stuart's, medium was used for transport
of bacteria but most swabs for gonococcal culture were inoculated
directly on to the selective medium described above. Swabs for chlamydial
culture were placed in transport medium and processed as before.
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Patients (parents)
Mothers were investigated in the maternity unit where possible but
mothers of premature babies and those whose babies had late-onset
conjunctivitis were asked to attend as out-patients. Their clinical
examination was as described above for NGU contacts. They were
investigated for syphilis, gonorrhoea, chlamydial cervicitis, tricho¬
moniasis, candidiasis and, in a few cases genital herpes, by
conventional methods.
If possible, fathers were similarly investigated if the mother and/
or baby had gonococcal, chlamydial or syphilitic infection.
Follow-up
Babies were examined during treatment and swabs were taken at each
subsequent out-patient attendance. Each mother was asked to bring her
baby for examination at ages 4, 8, 12, 18 and 24 weeks. This period
of observation was longer if a reisolate was obtained. Babies were
treated with either (a) 1% chlortetracycline ointment inserted into
both eyes 5-6 times daily for 28 days or (b) for 14 days with
concurrent erythromycin syrup 30 mg/kg daily in divided dosage.
Treatment was initially given to most babies by nursing staff in the
maternity units and was continued at home by their mothers on discharge
from hospital.
PART II: LABORATORY METHODS
In essence, the procedures for the isolation of C. trachomatis are
similar to those developed by Richmond223 using irradiated cultures,
with modifications by the Liverpool group. The isolation procedures
and the methods used for subsequent counts of the total number of
chlamydial inclusions recovered have been previously described in
detail55'224'225.■
Preparation of McCoy cells
McCoy cells (initially obtained from FLOW laboratories, Irvine,
Scotland) have since been serially propagated in "Medium 199"
(Wellcome) plus 10% foetal calf serum (FLOW laboratories) and 0.02 M
sodium bicarbonate with vancomycin and streptomycin, each at 100 yg/ml.
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Preparation of monolayers
Cell suspensions of 1.5 x 105 cells per ml, obtained from confluent
monolayer cultures by conventional trypsinisation techniques, were
dispensed in 2 ml amounts in 5 ml (universal) screw-topped glass bottles
containing a 16 mm circular glass coverslip covering the bottom of the
bottle. Low speed centrifugation was used to disperse the MCC on the
coverslip. After incubation at 37°C for 24 hours, the medium was
replaced by 3 ml of the same medium plus 0.5% final concentration of
glucose and 50 y per ml nystatin just before inoculation of the
clinical specimen.
Initially, and for approximately half the period of this study,
MCC which had not been previously treated by x-irradiation or any anti-
replicative chemical agents were used. In the latter half, however,
cells treated with cycloheximide (BDH) were used. Immediately before
inoculation of the clinical specimens, 0.1 ml of an aqueous solution
of cycloheximide was added to each culture to give a final concentra¬
tion of 1.0 yg/ml. Parallel titrations in cycloheximide-treated and
untreated cultures with clinical specimens and known laboratory strains
of C. trachomatis confirmed that there were no significant differences
in the isolation rate between the two types of cell. The purpose of
adding cycloheximide was to slow down but not prevent further MCC
replication and the advantage was the ease of reading the cultures
subsequently.
Inoculation of clinical specimens
Swabs for chlamydial isolation had (as previously mentioned) been
taken into 2-3 ml transport medium, and stored at 4°C until inoculated
on to tissue culture. The inoculation usually took place between two
and four hours later but occasionally after 24 hours. The swab contents
were thoroughly dispersed into the transport medium using a mechanical
shaker for one minute and 0.4 ml was then inoculated into each of two
coverslip cultures of replicating MCC. These were centrifugated at
2500 g for one hour on the swing-out head of an MSE major centrifuge
o
at room temperature. Inoculated bottles were then incubated at 37 C
in a constant atmosphere of 5% carbon dioxide in air, with the bottle
tops loosened, to maintain the medium at a constant pH of 7.0-7.4.
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Inclusions
Under these conditions, C. trachomatis undergoes a single cycle of
growth. Each infective particle forms an intra-cytoplasmic inclusion
packed with new infective particles (elementary bodies). Inclusions are
first detectable after 18 to 24 hours of incubation and reach their
maximum number after 38 to 48 hours. Thereafter the size of the
inclusions and the number of particles increase and they begin to
rupture the host cells between 72 and 96 hours. However, the released
elementary bodies cannot establish a fresh growth cycle in other cells
in the MCC under these cultural conditions. Thus, the number of
inclusions countable in a given MCC is directly proportional to the
input number of elementary bodies which were capable of establishing
an ongoing intracellular infection.
After 48 hours, therefore, the tissue culture fluid was removed
and the coverslip stained by the Giemsa method. Large intracytoplasmic
inclusions packed with basophilic particles can easily be seen by light
microscopy with the 40 x objective and under dark-ground microscopy,
where chlamydia particles give an intense lemon-yellow fluorescence
sharply distinct from the dull green-brown appearance of McCoy cells.
Avoidance of cross-infection
Strict precautions were taken to minimise the risk of cross
infection. No standard reference strains of chlamydiae have been used
in this laboratory since this work began. Fresh clinical specimens
were inoculated at a different time and in a different laboratory from
that in which incubated specimens were harvested. During centrifugation,
bottletops were tightly sealed. Control McCoy bottles were inoculated
with transport medium, centrifuged and incubated with each batch of
specimens. All remained negative.
Counting procedure
The results of inoculating MCC with known laboratory strains of
C. trachomatis or with infected clinical material were assessed
quantitatively. Having been inoculated for 48 hours and Giemsa-stained,
the MCC were examined under dark-ground microscopy at 400 x magnification.
The total number of inclusions in the whole coverslip were counted
unless preliminary inspection had suggested that the count would be
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greater than 5,000-6,000 in which case, the inclusions in 60 microscope
fields (approx. l/15th of the coverslip area) were counted, and the
number per whole coverslip was derived by multiplication.
The statistical validity of the counting procedure has been
• } icqdiscussed by Johnson and Hobson of the Liverpool group . With the strain
"STU", it has been calculated that the 95% confidence limits of the
counts is ± 23.5%.
Growth of laboratory strains
The "STU" strain of C. trachomatis was isolated here in Liverpool
from the cervix of a seventeen-year old girl and the pool used was the
first passage in the yolk sac of chick embryos from the positive
primary MCC inoculated with the original clinical specimen.
The TC 691 strain was also a Liverpool cervical isolate. It had
had two tissue culture passages but had not passed through the yolk sac
pool and was of known serotype (D/E).
Preparation of antibiotics
The standard commercially available preparations for intravenous
therapy for each antibiotic were used, freshly obtained for the
hospital pharmacy. (Benzylpenicillin powder from Glaxo Laboratories,
Greenford, Middlesex; tetracycline hydrochloride powder from Pfizer Ltd,
Sandwich; erythromycin base powder from Abbott Laboratories, Kent;
chloramphenicol sodium succinate powder from Carlo Erba, U.K. Ltd,
London). Each antibiotic was freshly dissolved in sterile distilled
water from vials for each experiment and working dilutions were made in
tissue culture growth medium. Final concentrations of each antibiotic
in this medium were assayed in an agar cup-plate microbiological assay
system using Staphylococcus pyogenes NTC 6571 or Escherichia coli NTC
10418.
Chloramphenicol
In common with most other workers in this field, the intravenous
product chloramphenicol sodium succinate was chosen for convenience.
However, following subsequent work in the Liverpool group, it was
recognised that, the effectiveness of chloramphenicol sodium succinate
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in vitro is lower than in the body where the succinate radical must
be removed enzymatically for full activity. Subsequently, the Liverpool
group have found a convenient source of the pure base chloramphenicol
available in sterile ampoules in the form of 0.5% eye drops (Smith and
Nephew). The activity of this is approximately ten times that of the
succinate form in vitro (personal communication, Dr. Hobson).
Antibiotic sensitivity assays
To avoid any problem of synergy or antagonism with other anti¬
bacterial agents, all MCC used in the experiments with antibiotics
were maintained throughout in media which did not contain any other
antibiotic. Vancomycin and streptomycin (see above) are routinely used
at concentrations of lOO yg/ml in normal tissue culture work with
C. trachomatis and show no significant antichlamydial activity. However,
in the present work, they were used only during the initial preparation
of McCoy cells for the experimental MCC. After that, the growth medium
was removed and the coverslip washed in antibiotic-free medium three
times to remove extracellular vancomycin and streptomycin. The washed
coverslip cultures were then incubated with 2 ml antibiotic-free medium
for four hours to leach out vancomycin and streptomycin.
In the initial experiments, confluent MCC were washed and changed
to fresh growth medium containing various concentrations of the test
antibiotic. Control MCC were changed to fresh antibiotic-free medium.
All were immediately infected with C. trachomatis test strains (TC 691
or STU strain) at a dose calculated to yield 10,000 to 15,000 inclusions
per coverslip and centrifuged without further delay. .After varying
periods of incubation, these cultures and control antibiotic-free
infected cultures were removed, Giemsa-stained and examined under dark-
ground microscopy.
Subsequently, "pulses" of test antibiotic were added to infected
MCC by appropriate change of medium or removed at varying intervals
of incubation after centrifugation-assisted adsorption of C. trachomatis.
The medium of the infected controls, antibiotic-free, was changed at
the same time.
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PART III: USE OF THE COMPUTER
When the information had been abstracted from our case sheets, it
was transferred to the Opscan,R^ forms* so that the data could be stored
in the computer bank. Having written the appropriate programmes (some
with the help of the Biostatics Department) various comparisons regard¬
ing the incidence of chlamydial infection related to such factors as
age, parity, ectopy etc were made. Missing data including sets of
variables (e.g. weight of baby) omitted from the Opscan form was later
retrieved from the case sheets, in some cases that of the original
maternity hospital.
PART IV: STATISTICAL METHODS
In cases where the data had been reduced to four-fold contingency
tables, x2 with Yates's correction was used. If data had been reduced
to 2 x N contingency tables, ordinary x2 (N-l d.f.) was used to test
for any difference in proportions. Where appropriate, x2 for linear
trend was also applied to 2 x N tables. One-way analysis of variance
or unpaired t. tests were used on the logarithms of whole coverslip
chlamydial counts.
cSee p.61a and b
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RESULTS
PART I: CLINICAL RESULTS
(a) CONTACTS OF MEN WITH NONGONOCOCCAL URETHRITIS
C. trachomatis isolation rate
C. trachomatis was isolated from 160 of 455 women (35.2%) at their
first visit.
Reason for attendance - Table 1
394 attended as NGU contacts (C. trachomatis isolation rate 35.2%).
39 attending of their own accord and 22 referred by other doctors were
said to be NGU contacts and this diagnosis was confirmed by the rele¬
vant male sexually transmitted diseases (S.T.D.) clinic.
Age - Table 2
Their ages ranged from 16 to 62 years (mean 27). In the chlamydia-
positive group, the age range was 16 to 37 years (mean 25).
Comparing 5-year groupings from 16-40 years, the chlamydial
isolation rate declined significantly (49% to 14%, x2 = 8.06, 1 d.f.**)
and the total x2 was 23.9, 4 d.f.***. x2 f°r linear trend was 23.0,
1 d.f.*** which indicates a significant decline in the chlamydial
isolation rate with age.
Marital status - Table 3
50.3% women of the 455 women were single and 39% were married; the
remaining 10.7% were divorced or separated. 61.8% chlamydia-positive
women were single and 28% were married. The C. trachomatis isolation
rate was significantly higher in single (43%) than in married women
(26%) (x2 = 12.73, 1 d.f.***).
Obstetric history - Table 4
The majority of women (54%) were nulliparous and their isolation
rate (41%) was significantly higher than- that (26%) of the 38% women
who had had full-term vaginal deliveries (x2 = 9.47, 1 d.f.**). 62.5%
of chlamydia-positive women were nulliparous and 27.5% had had vaginal
deliveries.
62.
Of the 181 who had had full-terra pregnancies with either vaginal
or caesarian section deliveries (39.8% total), 154 (C. trachomatis
isolation rate 29.9%) had 1-3 children and 27 had 4-6 children. None
of these latter women were chlaraydia-positive. Compared with the women
who had few or no children, they were older and married. These factors
also affected the chlamydial isolation rate.
5.5% of patients had had miscarriages (C. trachomatis isolation
rate 32%) and 6.2% had terminations (C. trachomatis isolation rate 43%).
Two women had had ectopic pregnancies; one of them was chlamydia-positive.
Hormonal factors
(a) Present pregnancy - Table 5
Eleven were pregnant. One was in the first post-natal month and
four were possibly pregnant. Those numbers were too small for any
conclusions about the effect of pregnancy on the C. trachomatis
isolation rate in NGU contacts to be made.
(b) Menstrual cycle - Table 6
In 414 (91%) women who had a regular menstrual cycle (28 days ± 2)
and where the date of the last menstrual period was known, the month
was divided into four weeks. Week one started from the first day of
menstruation. The week in which the culture for C. trachomatis was
taken was recorded. There was no significant difference in the
isolation rates in successive weeks of the menstrual cycle. (Total
X2 = 1.06#3 d.f. (N.S.)).
This was repeated, only examining data from patients using oral
contraception and the rates again did not vary significantly throughout
the cycle. (Total x2 = 0.68, 3 d.f. (N.S.)).
(c) Contraception - Table 7
The types of contraception used and the chlamydial isolation rates
associated are shown in the table. The chlamydial isolation rate (48.1%)
in 233 women taking oral contraceptives (then or within the previous
month) was significantly higher than in (a) all those not taking oral
contraception, excluding those whose method was unknown or unrecorded,
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(24%, x2 = 25.2, 1 d.f.***) (b) those using barrier methods (24%, x2 =
4.1, 1 d.f.*) (c) those using contraceptive methods other than barrier
methods or oral contraception (21%, x2 = 23.5, 1 d.f.***). There was
no significant difference in chlamydial isolation rates between those
using barrier methods (24%) and those using no contraception (25%,
X2 = 0).
Amongst chlamydia-positive women, 66.2% used oral contraception,
16.9% used no contraception and 5% used barrier methods. Of the
remainder, equal proportions used an intrauterine contraceptive device,
had had tubal ligation or had within the previous month stopped using
oral contraception.
Symptoms - Table 8
The incidence of symptoms and their distribution appears in
Tab_le 8. The C. trachomatis isolation rate amongst NGU contacts was
significantly raised when any symptoms were present (41.2%, x2 = 5.87,
1 d.f.*) and when there was a vaginal discharge (45%, x2 = 7.27, 1 d.f.*
When, however, 260 women were examined in the absence of concurrent
infections which might cause these symptoms (trichomoniasis, candidiasis
gonorrhoea), the presence of any symptoms no longer significantly
increased the isolation rate (37%, x2 = 2.98, 1 d.f.) although discharge
did (46%, x2 = 7.11, 1 d.f.**) and post-coital bleeding was suggestive
(4/5, x2 = 3.78, 1 d.f. N.S.) (Table 9).
Similarly, in the absence of trichomoniasis, the chlamydial
isolation rate was higher in womenwith (44%) than without (29%) a
discharge (x2 = 7.23, 1 d.f.**) (Table 10).
Coital experience - Table 11
There are difficulties in taking an accurate history in relation
to coital experience.
(a) Last intercourse
62% women (isolation rate 39%) admitted having had intercourse
within the previous four weeks. Overall, there was no significant
difference in chlamydial isolation rates (38.5-39.8%) whether
64.
intercourse was one week or three weeks ago.
(b) Number of consorts (in the previous three months)
352 women (77% of total, C. trachomatis isolation rate 32.1%) had
only one consort. 52 (11%, 50% chlamydia-positive) admitted to two
consorts and two women (one chlamydia-positive) had several casual
consorts. The C. trachomatis isolation rate was significantly higher
in those with more than one consort than in those with only one
(X2 = 5.66, 1 d.f.*).
This correlates well with isolation rates in the male partners1
primary (55.3%) and secondary (37%) contacts.
(c) Known consorts
443 women (isolation rate 35%) had one or more consorts where
case sheets were available for study. Of these 443, 16 (isolation rate
75%) had two such contacts.
The remaining 12 of 455 total women were contacts of men with NGU
who had attended STD clinics in other towns whence we had been sent
summaries of their histories.
Clinical signs - Table 12 (Illustrations p.65a)
(a) Ectocervix
The appearance of the ectocervix in relation to the chlamydial
isolation rate is shown in the table. The isolation rate was signifi¬
cantly higher in those with any ectopy (46.1%, x2 = 28.0, 1 d.f.***),
in those with simple ectopy (38.5%, x2 = 12.7, 1 d.f.***) and in those
with hypertrophic ectopy (72.4%, x2 = 49.7, 1 d.f.***) than in those
with no ectopy (21.5%).
It was significantly higher in those with hypertrophic ectopy
than with superficial ectopy (x2 = 19.5 with 1 d.f.***) 26% chlamydia-
positive women and 51% chlamydia-negative women had no ectopy.
(b) Endocervix
The varying endocervical contents in relation to the chlamydial
65.
Clinical Signs - Pathological cervix - signs of inflammation





isolation rate are-shown in the table. The chlamydial isolation rate
was significantly higher in those with mucopus (72.4%) than with clear
and cloudy mucus (24.6%) (x2 = 72.6, 1 d.f.***). 44% of chlamydia-
positive women and 9% chlamydia-negative women had endocervical mucopus.
28% chlamydia-positive women and 46% chlamydia-negative women had clear
mucus.
In 325 women (71.4% total, chlamydial isolation rate 22.5%) there
were no signs of endocervicitis and 32 (7.0% total, 81.3% chlamydial
isolation rate) had both hypertrophic ectopy and endocervical mucopus.
(c) Bleeding on examination and post-coital bleeding - Tables 13 and 14
(Illustrations p.66a)
43 women bled when the cervix was examined. The chlamydial isolation
rate was significantly raised at 58.1% (x2 = 9.91, 1 d.f.**) 15.6%
chlamydia-positive women and 6.1% chlamydia-negative women bled on
examination.
Eight women had complained of post-coital bleeding. Five were
chlamydia-positive and in four of these, there had also been bleeding
on examination. There were no associated abnormal smears. Ectopy was
reported in all but three of these women.
(d) Abdominal pain and salpingitis - Table 13
27 women had complained of abdominal pain (isolation rate 40.7%)
o
and in 12 there were signs of salpingitis (isolation rate 50%, x =
0.62, 1 d.f.).
Cervical smears - Table 14a
Ayre smears were taken in 83 women; two were abnormal, both women
were chlamydia-negative.
Concurrent infections - Table 15
The presence of other infection in relation to the chlamydial
isolation rate is shown in the table. In 211 women, normal flora only
was found. (40% were chlamydia-positive). Only with trichomoniasis
o
was the chlamydial isolation rate significantly raised (60.5%, x =
10.51, 1 d.f.**).
66.
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- bleeding after mopping
(c) chlamydia-negative
- post-treatment
- no bleeding after mopping
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Although these women were NGU contacts, gonorrhoea was found in
seven (1.5% total). Three were chlamydia-positive.
Contraception and ectopy - Table 16
To assess the relationship between oral contraception and ectopy,
both of which had highly significant individual effects on the isolation
of chlamydiae, the four possible categories were compared and analysed
statistically (simple and hypertrophic ectopy were combined).
(1) The isolation rates in patients with (54.2%) and without
(35.5%) oral contraception in the presence of cervical ectopy
(X2 = 6.56, 1 d.f.*).
(2) The isolation rates in patients with (54.2%) and without
(34.3%) ectopy in those taking oral contraception (x2 = 6.51,
1 d. f. *) .
(3) The isolation rates in patients with (34.3%) and without
(16.2%) oral contraception in the absence of'ectopy (x2 =
6.72, 1 d.f.**).
(4) The isolation rates in patients with (35.5%) and without
(16.2%) ectopy in the absence of oral contraception (x2 =
8.4, 1 d.f.**).
Chlamydial isolation rate relative to age and ectopy - Table 17
As noted above (Table 2) the chlamydial isolation rate lessened
significantly with age. Ectopy also decreased significantly (total
X2 in age range 16-40 years = 21.6, 4 d.f.***, x2 f°r linear trend =
15.27, 1 d.f.***).
Comparing the chlamydial isolation rate in the presence and absence
of ectopy, over that age range, there was no significant difference in
the curve gradients. (Regression coefficient t = 2.2, 6 d.f.).
Chlamydial isolation rate relative to age and oral contraception - Table
The chlamydial isolation rate fell significantly from 37% in age
group 16-20 years to 19% in 31-35 years, in the absence of oral contra¬
ception (total x2 for range = 5.0, 3 d.f. (N.S.) but x2 f°r linear
67.
trend = 3.99, 1 d.f.*).
With oral contraception, the isolation rate fell only from 54% to
45% (total x2 = 1.51, 3 d.f. (M.S.), x2 f°r linear trend = 1.22 1 d.f.
(N.S.)). However, comparing the isolation rates in the presence and
absence of oral contraception in that age range, the curve gradients
did not differ significantly (regression coefficient t = 0.98,
4 d.f.).
Ectopy relative to age and oral contraception - Table 18
Without oral contraception, the percentage ectopy fell significantly
from 51% in age group 16-20 years to 25% in 31-35 years. (Total x2 =
7.06, 5 d.f. (N.S.); linear trend x2 = 6.33, 1 d.f.*).
With oral contraception, ectopy fell less in this age range,
from 71% to 55% (Total x2 = 3.27; 2 d.f. (N.S.); linear trend x2 =
0.54 1 d.f. (N.S.)). The curve gradients did not differ significantly
(regression coefficient t = 0.91, 4 d.f.).
Chlamydial isolation rate relative to oral contraception under and
over 25 years - Table 19
The isolation rate was significantly higher in those taking oral
contraception (48%) than in the others (28%, x2 = 7.24, 1 d.f.**) in
r\
those under 25 years, and in those over 25 years (45% and 19%, x = 11.8
1 d.f.***).
Chlamydial isolation rate relative to parity and ectooy - Table 20
With increasing parity, there was a significant fall in isolation
rate from 42% in nullipara to 11% in those with four children. (Total
X2 = 14.76, 4 d.f.**, x2 f°r linear trend = 11.07, 1 d.f.***).
Ectopy also decreased significantly with increased parity, from
62% in nullipara, to 39% in para 4. (Total x2 = 12.87, 4 d.f.; x2 f°r
linear trend = 9.26, 1 d.f.**).
Comparing the chlamydial isolation rate in the presence and absence
of ectopy over that parity range there was no significant difference in
the curve gradients (regression coefficient t = 1.23, 6 d.f.).
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Chlamydial isolation rate relative to parity and oral contraception -
Table 21
The chlamydial isolation rate fell slightly with increasing parity
in the absence of oral contraception 35-25% (x2 = 0.31, 1 d.f. (N.S.))
and rose slightly in the presence of oral contraception 47-57% (x2 =
0.014, 1 d.f. (N.S.)). A lower percentage of parous women (43%) than
nullipara (68%) used oral contraception (x2 = 18.4, 1 d.f.***). These curve
gradients did not differ significantly (t = 1.46, 4 d.f.).
Chlamydial isolation rate relative to parity and endocervical contents -
Table 22
The proportion of endocervical mucopus relative to other endo¬
cervical contents was not related to parity. Increasing parity had no
definite effect on the incidence of chlamydial infection accompanying
mucopus.
Chlamydial isolation rate relative to (a) age, ectopy and parity (Table 23)
(b) age, ectopy, parity and oral contraception (Table 24)
Numbers in each category were too small to compare different age
groups even when, to judge the effect of parity, nullipara were
contrasted with parous women. The groups were even smaller when the
effect of oral contraception was also considered. Nothing was added
from these studies to knowledge gained from previous comparisons.
Antibiotics - Table 25
56 NGU contacts (12.3% of all) had antibiotics in three months
preceding the first visit and chlamydial culture. Numbers were small
but the majority had been given them by their family doctors for 5-14
days. Penicillin other than procaine penicillin was the commonest
(22/56) (chlamydial isolation rate 36.4%). Of the ten who had taken
oxytetracycline or erythromycin, all were chlamydia-negative.
Whole coverslip count - Table 26
The inclusion counts ranged from 1-100,000. There were 158
records. The mean was 5780, median 312. The logarithmic form (LGWCC)
was used to compare the counts relative to certain variables.
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The count was significantly higher in the presence of mucopus
rather than clear or cloudy mucus.
The effects of oral contraceptives and of ectopy on the inclusion
counts were examined both separately and in combination. No significant
differences in the severity of chlamydial infection were found whatever
permutations of these variables were compared.
The counts were not significantly affected by age, parity, marital
state, symptoms, cervical ectopy, other concurrent infections, methods
of contraception or stage in the menstrual cycle.
These results differ from the other quantitative study125 in which
a significant association was found between high counts and not only
the presence of endocervical mucopus but also the under 20 age group,
the presence of cervical ectopy and the use of oral contraception (including
interaction,between these last two variables). In that study, 580 counts
were studied (including this 158) and a different hypothesis was being
tested namely that the proportions of high and low counts (excluding
the middle counts) were related to each factor. Whereas here, the
middle counts were included to obtain differences in geometric means of
the counts in each category. The two are therefore not directly
comparable.
Follow up - Table 27
(i) Repeat Swabs
Five to 7 days after the initial chlamydial cultures had been taken,
in a proportion of women, they were repeated before any treatment had
been given. Of 160 chlamydia-positive women, swabs were repeated in
128 (80%) and confirmed the previous result (100% positive). Of
285 chlamydia-negative, 38 were retested (13.3%). 36 were again
negative but positive swabs with low titre counts (< 10 inclusions
per coverslip) were now found in two (0.7% of previous negative women,
5.3% of those retested).
Thus total chlamydia-positive tests in the series was 162 (162 of
455, 35.6%) on twice swabbing. There is therefore little point in
taking double swabs as the' diagnosis can be firmly made in most instances
as a result of a single culture on the first visit.
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(ii) Follow up surveillance
Follow up surveillance was carried out on 130 of a possible 162
chlamydia-positive women (80.2%).
Nine were chlamydia-positive at each visit and either treatment
had not been completed or reinfection had occurred with no intervening
negative culture. The other 121, once positive, were later negative
on culture for C. trachomatis (a) following appropriate chemotherapy
in 110, (b) after chemotherapy elsewhere in two, (c) without any
recorded chemotherapy in 9.
From 18 of these 121 women, chlamydiae were reisolated. In three,
this reisolate was made at their final visit. The other fifteen
women had again become chlamydia-negative by their final visit.
Thirty-six originally chlamydia-negative women had second or
subsequent cultures which confirmed that first negative test.
(iii) Originally chlamydia-positive, later chlamydia-negative women
including false negatives (121 women)
Their period of surveillance ranged from 5-632 days (mean 198
days).
(a) Cervical signs (Illustrations p.71a,b)
In this group, when chlamydiae had been present, 27% had had hyper¬
trophic ectopy and 47.9% endocervical mucopus. Examined later, when
no reisolates were obtained, only 2.6% still had hypertrophic ectopy
and only 5.2% endocervical mucopus.
The cervices had reverted from hypertrophic ectopy either to simple
ectopy (i.e. mere disappearance of inflammation) or no ectopy. The
absence of ectopy, where there had previously been either hypertrophic
or simple ectopy, indicated that metaplasia had been completed.
Cervical mucopus changed to either clear or cloudy mucus, both
physiological appearances.
These changes in signs indicate a response to treatment of
chlamydial endocervicitis.
71.
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Candida sp. was isolated in 34% of all 455 women and in 36%
chlamydia-positive at their first visit. 38% of this follow-up group
had candidiasis at their first visit. By their final visit, this had
fallen to 12%. An increase following antichlamydial chemotherapy
might have been expected but follow-up surveillance and antifungal
treatment avoided this.
Reisolates - Table 28
In 18 women, chlamydiae were reisolated at some time after they
had apparently been eradicated. This happened twice with one woman.
(a) Coital activity
Fourteen of these 18 women had resumed intercourse. Nine were with
their previous partner and four of these men had recurrent NGU. Four
other women had new consorts and these men were said to be symptom free
but were not available for examination. The other woman had resumed
intercourse within the previous two weeks with a consort regarding whom
no information was obtained.
No information was recorded regarding recent intercourse in the
other four women with reisolates.
(b) Endocervicitis (Illustrations p.72a,,b)
Nine women with reisolates had originally had hypertrophic ectopy
and/or mucopus. In two cases, these same signs recurred at the time of
reisolation (370 and 87 days later, respectively). In one woman,
mucopus with simple ectopy had been present at her first visit and
hypertrophic ectopy accompanied the reisolate. Another woman having
had the endocervical contents obscured by menstrual bleeding on her
first examination, had endocervical mucopus when the reisolate was
made. These signs of cervical inflammation were absent when the
reisolate was made in the other 14 patients.
Male partners - Table 29
In 443 of these 455 NGU contacts, we had access to their male
partner's case sheets. Sixteen of these 443 women had two partners.
72.
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The first man to attend, whether he referred our patient, attended
simultaneously with her or was referred by her to the clinic with some
other condition and later was found to have NGU, was named as the first
partner (Ml). The second to attend, whether he was referred by our
patient or had also referred her to the clinic, was named as the second
partner (M2). The remaining 427 had only one partner (Ml).
(a) Symptoms
67.5% of all"women, 69% of the chlamydia-positive group, had
consorts who still had symptoms at the time of the woman's first visit.
(b) Diagnosis
427 men were first or only consorts (Ml) attending local clinics,
69.8% of these were diagnosed NGU and 27.9% recurrent NGU. However,
chlamydial isolation rates in female partners of these two groups
(35.6% and 29.4%) did not differ significantly (x2 = 1.18, 1 d.f. (N.S.)).
In the remaining 2.3% the final diagnosis was ill-defined or unclear.
Of the 16 second male consorts (M2), where two were named, seven
had NGU, none had recurrent NGU.
(c) Our patients' relationship with their male partners
154 men (34.8% of the total 443) denied having any other recent
partner. The information had not been recorded in 109 (24.6%) case
sheets. 38 (8.6% total 443) of our female partners were primary
contacts of their partners, 142 (32.1% total 443) were secondary. It
was not possible reliably to assess the others. The chlamydial
isolation rate amongst primary contacts (55.3%) was higher than amongst
secondary contacts (37%) although not significantly so (x2 = 3.3, 1 d.f.
(N.S.)). However, it was significantly higher than amongst patients
whose partner denied any other contact (chlamydial isolation rate
29%, x2 =8.5, 1 d.f.**).
Where there were two male partners^, this information was missing
from the second partner in over half but five of the other seven men
had two partners.
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(d) Chlamydial urethral culture
Although not routinely available, it was possible to take
chlamydial cultures from the urethra in a small group of 31 male
partners.
Of 28 first partners, 18 were chlamydia-postive as were all but
two of their female partners. These two negative women had had no
chemotherapy. The ten chlamydia-negative men (who also gave no history
of chemotherapy) had eight chlamydia-positive female consorts; one of
these women had a second male consort who was chlamydia-positive.
Three second male partners were tested. Two, including the
above-mentioned, were chlamydia-positive.
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(b) BABIES WITH NEONATAL CONJUNCTIVITIS AND THEIR PARENTS
C. trachomatis isolation rates - Table 30
129 selected babies with neonatal conjunctivitis and their mothers
were examined. C. trachomatis was isolated from 70 babies. Excluding
two chiamydia-negative babies, later found to have been receiving
chlamydial chemotherapy already, the isolation rate was 70/127 (55%) .
Chlamydiae were isolated from 57 mothers. Excluding those
chiamydia-negative mothers who had recently completed or were presently
receiving chemotherapy (21) , the chlamydial isolation rate was 57/108
(53%) and amongst mothers of chlamydia-positive babies 51/60 (85%)
(C. trachomatis pharyngeal cultures were routinely taken only in the
last year of the study and are mentioned where relevant).
Caesarian section - Table 31
In the two cases of chlamydial conjunctivitis where the child had
been delivered by caesarian section, the mothers were found to be
chiamydia-negative.
One mother, examined three weeks after delivery, had already had
oral penicillin for seven days (from the fifth to the twelfth post¬
natal day) for infected lochia. The onset of conjunctivitis was
delayed until the eleventh day. There, chorioamnionitis and subsequent
ascending infection might have introduced a small intra-uterine inoculum.
The other mother had not received chemotherapy and the onset of
conjunctivitis was on the seventh post-natal day. However, the membranes
had been ruptured for over 11 hours prior to delivery, the mother's
negative cultures, taken 25 days after delivery, were not confirmed
prior to chemotherapy and serological antibody testing (MIF test) was
indicative of chlamydial infection.
FINDINGS IN MOTHERS OF BABIES WITH NEONATAL CONJUNCTIVITIS
Age
Mean age of the mothers was 22.3 (range 15-34) and, in the
chlamydia-positive women, it was 20.6 (range 16-29 years).
75.
Marital status - Table 32
More chlamydia-positive (44%) than negative (28%) were single and
less (54%) chlamydia-positive than negative (68%) were married but the
differences were not significant (x2 =2.2, 1 d.f. (N.S.)). The other
mothers were separated, divorced or widowed.
Parity - Table 33
For most mothers, the affected baby was their first and had been
a vaginal delivery.
Contraception - Table 36
None of the chlamydia-positive and only seven of chlamydia-negative
were using any contraception at the time of their first examination
which for the majority (72%) was in the first month of the puerperium. (Tables
34,35).
Chemotherapy - Table 37
Only five women (3.9%) had had antibiotics in pregnancy, two were
chlamydia-positive and a further one had a chlamydia-positive baby.
26 (20.2%) 'had had chemotherapy in the puerperium. From 10,
although their babies were chlamydia-positive, no isolates were
obtained. Five remained chlamydia-positive despite the chemotherapy
and the remaining 11 and their babies were chlamydia-negative.
Premature rupture of membranes - Table 38
In eight cases, the membranes had ruptured 12 hours or more before
delivery (longest period - eight days). Chlamydiae were not isolated
from any of these mothers but from seven of their babies. Two of these
mothers were known to have had chlamydistatic chemotherapy. Two others
had had unknown chemotherapy. There was no history of chemotherapy for
the others.
Symptoms - Table 39
Symptoms were absent in 63% of all mothers (chlamydial isolation
rate 33%) and significantly more chlamydia-positive (53%) mothers than
chlamydia-negative (25%) had symptoms (isolation rate 62.5%, X2 =
9.2, 1 d.f.**) .
76.
There was an abnormal discharge in 16% of mothers, and
in significantly more chlamydia-positive (25%) than chlamydia-
negative (isolation rate 67%, x2 = 4.1, 1 d.f.*). This discharge
might in the puerperium be interpreted as the prolonged appearance of
lochia due to mild pelvic inflammation.
Seventeen mothers (13%) complained of abdominal pain. Significantly
more (15) had chlamydia-positive than chlamydia-negative babies (x2 =
7.61, 1 d.f.**). Nine of these mothers (all had chlamydia-positive
babies) were found to have salpingitis on clinical examination.
Cervical signs - Table 40
Simple ectopy was present in 51% of all mothers (36% were
chlamydia-positive). There was hypertrophic ectopy in 13% (82% were
chlamydia-positive) and mucopus in 40.3% (77% were chlamydia-positive).
Fifteen chlamydia-positive mothers (26%) showed no evidence of cervical
inflammation (neither hypertrophic ectopy nor mucopus) and so excluding
four who had had chemotherapy, which might have modified appearances,
11/53 (20.3%) had no abnormal cervical signs.
The chlamydial isolation rate was significantly higher in hyper¬
trophic ectopy (82%) than in any other appearance of the cervix (38.4%,
X2 = 10.1, 1 d.f.**), than in superficial ectopy (36%, x2 = 9.8, 1 d.f.**)
or than in the absence of ectopy (40%, x2 = 7.6, 1 d.f.**).
The chlamydial isolation rate was also significantly greater in
the presence of mucopus (77%) than in clear or cloudy mucus (26.7%,
X2 = 23.5, 1 d.f.***).
Other signs - Table 41 (Illustration p.77a)
Salpingitis (q.v.) was found in 9 women, all mothers of chlamydia-
positive babies (7% all mothers and 9% of chlamydia-positive).
(Chlamydial isolation rate 56%, x2 = 0-13, 1 d.f. (N.S.)).
Nineteen mothers (15% total, 21% of chlamydia-positive, isolation
rate 63.2%, x2 = 2.41, 1 d.f. (N.S.)) bled on examination. In the
puerperium as with the symptom of excessive discharge, this is not easy
to assess when lochia may have just ceased to flow.
77.
Clinical signs of chlamydial urethritis in the puerperium
(a) Mother B, 6 days after vaginal delivery
C. trachomatis isolated from both urethra and cervix
Mucoid urethral discharge, oedema of the urethral orifice and congestion
of the Skene's glands
(b) Mother D, 5 days after delivery; chlamydia-negative in urethra and cervix.
Normal urethra
77a
Other infections - Table 42
Few other infections were found in these women. Five, all
chlamydia-positive, had gonorrhoea as did three of their babies. Two
of these babies with gonorrhoea also had chlamydial infections. The
two babies without gonorrhoea also had chlamydial conjunctivitis although
the isolate in one, who had previously had tetracycline eye ointment
was from the pharynx only. These babies had had no chemotherapy.
Antibody estimations - Table 43
Serological specimens were examined for antibodies, either by the
lymphogranuloma venereum complement fixation test (LGVCFT) or by the
micro-immunofluorescence test (MIF) in 16 of the 70 mothers of chlamydia-
positive babies. Half of these women were themselves chlamydia-negative
but four of these eight had previously had chemotherapy.
Seven of these 16 (three chlamydia-positive, four chlamydia-negative)
had had signs and symptoms of pelvic inflammatory disease. In six,
there was a single titre of 1:20 or higher, or two or more rising titres.
Among the nine women who had no history of PID, significant titres
were found in only three, who were all chlamydia-positive. Rising
titres from 1:80 to over 1:1280 were reported in one of this latter
group in whom a post-partum. haemorrhage had necessitated curettage to
remove placental fragments.
Many of these rises in titre in LGVCFT were confirmed by MIF.
Follow-up - Table 44
Of 57 mothers with chlamydial cervicitis, 14 had hypertrophic
ectopy, 40 had endocervical mucopus, 42 had one or other sign and 11 had
both. Twenty-five of these 42 with signs of inflammation were re-examined
following appropriate chemotherapy.
The original signs of inflammation had cleared up after treatment
in all but two.
Reisolation - Table 45
Maternal reisolates were made after treatment in three originally
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positive women where there had been a failure to isolate chlamydias 42,
46 and 49 days previously. Signs of cervical inflammation had been
present in two of three at the original time of isolation and had not
recurred with the reisolate. Their babies remained chlamydia-negative.
Two of their partners examined at or after the reisolate was made were
chlamydia-positive and we failed to secure the third man's attendance.
FINDINGS IN BABIES WITH NEONATAL CONJUNCTIVITIS
Prematurity
There were significantly more premature babies amongst those with
chlamydial conjunctivitis. Sixteen of 67 chlamydia-positive babies,
whose birth weights were known, were of birth weight less than 2.5 kg.
Only three of 58 chlamydia-negative were so small (x2 = 6.7, 1 d.f.**).
Sex - Table 46
54% of babies were male and they comprised 60% of chlamydia-positive
babies.
Onset and referral dates
The time of onset of conjunctivitis varied between one and 21 days
after birth (mean 6.8 days) in chlamydia-positive and between one and
42 days (mean 5.3 days) in chlamydia-negative.
The mean age at onset in seven chlamydia-positive babies where the
membranes had ruptured 12 hours or more before delivery was 6.7 days
(range 3-12 days).
However, the age at referral was later in chlamydia-positive
(mean 13.3 days, range 3-42) than in chlamydia-negative babies (mean
11.0 days, range 1-42).
Signs of infection (Illustrations p.79a,b, 80a, 81a)
All babies with chlamydial conjunctivitis developed oedema of the
lids and a discharge. This was generally purulent but often thin and
profuse in the absence of concurrent bacterial infection. In the more
severe acute infections, it was bloodstained. Localised bubbling of
the mucosa was marked in severe cases but mucosal oedema was present
79.
Neonatal chlamydial conjunctivitis - early acute signs
Baby K





























Baby H, born at full term had signs of conjunctivitis at 5 days.
Left eye was worse than right, with palpebral oedema, severe
submucosal oedema with petechial haemorrhages, bubbling and mucopurulent
discharge. C. trachomatis was isolated from both eyes.
79b
in all but the most premature infants. In these, signs were minimal
with a slight muco-purulent discharge, and little if any oedema,
incidentally making examination more difficult.
Topical chloramphenicol had been given in nine cases. There,
examination was delayed because typical signs of chlamydial conjuncti¬
vitis had been modified but recurred when treatment was stopped.
Previous chemotherapy - Table 47
68% of all babies (88) had had chemotherapy before testing (83%
(58) of chlamydia-positive and 51% of chlamydia-negative).
Of the 58 chlamydia-positive, 16% had had systemic chlamydi-static
therapy (e.g. penicillin) 22% had local chlamydicidal ointment (tetra¬
cycline) or chlamydistatic drops (chloramphenicol). The remaining 62%
(36) had had neomycin which does not affect chlamydial isolation.
One-third of the 30 chlamydia-negative babies had had systemic
chlamydistatic treatment. Seven of the remaining 20 had chloramphenicol
eye drops or tetracycline (two babies) and the other 13 (43%) had
neomycin which would not affect chlamydial isolation.
Other infections - Table 48
N. gonorrhoea was isolated from three babies; one was chlamydia-
negative. All three mothers had both gonococcal and chlamydial cervi¬
citis. Two other babies were already on chemotherapy for presumptive
gonorrhoea (not subsequently confirmed) before being tested for
chlamydial infection. Their mothers were found to have chlamydial,
but not gonococcal infection.
In 30 babies (23%) with neonatal conjunctivitis, no pathogen was
isolated; no cultures were sterile but staphyloccus albus and other
commensals were grown and the abnormal eye signs resolved in these
babies without any change of treatment.





Baby R, born at full term; purulent
been present at 5 days. A five-day
completed just before examination,
left eye, from which C. trachomatis
persisted but had lessened.
discharge and palpebral oedema had
course of local chloramphenicol was
The discharge had ceased and in the
was isolated, peripheral oedema
80a
Follow-up - Table 49 (Illustrations p.81b,c)
Duration of follow-up varied in babies with no reisolate from less
than four weeks (one baby) to 36-52 weeks (nine)^ and from 8-11 weeks
(three) to 36-52 weeks (one)in those from whom reisolates had been made.
Reisolates - Table 50
As the Liverpool group had found in a previous study, before
routine pharyngeal cultures were taken an erroneous evaluation of the
response to treatment was obtained. This is because post-treatment
persistence of infection (bacterial as well as chlamydial) tends to
occur in the pharynx.
Pharyngeal cultures were not taken until the final year of this
study and so these figures probably underestimate the reisolation rate.
After treatment, chlamydiae were reisolated from 20 of 58 babies
who attended for follow-up (34.5%).
Thirty-one (53.4% of those followed) had had tetracycline eye
ointment alone prescribed for four weeks and reisolates were made from
12 of these (38.7%). One of these babies had been treated for only one
week. There was a reisolate from the pharynx in seven cases and in four
of five reisolates from the eyes, no culture had been taken from the
pharynx.
The other 46.6% (27) followed had had tetracycline eye ointment
and erythromycin syrup prescribed jointly for two weeks. Reisolates
were made in eight of these (29.6%), in six of whom treatment with
erythromycin had been inadequate. Equal numbers of reisolates were
made from the eyes and pharynx.
However, although combined treatment with chlortetracycline eye
ointment and erythromycin syrup appeared more effective than topical
tetracycline alone, the two schedules were not comparable because
only a minority had had pharyngeal swabs.
The high reisoiate rate in babies given only topical treatment
led to this practice being stopped and the combined regime of topical
tetracycline with systemic erythromycin was given, generally, for two
weeks.
81.
Neonatal chlamydial conjunctivitis - clinical signs modified




Baby J (not in present series) examined at three months, had had signs of
conjunctivitis at 4 days and was given various local antibiotics and a
7 day course of ampicillin finishing two weeks previously. There was a
history of recent bronchitis and C. trachomatis was isolated from the
pharynx but not from the conjunctivae. On the right side was slight
unilateral palpebral oedema, with mucopus at both inner canthi and slight
submucosal oedema. His mother had thought the right eye looked smaller
than the left.
81a
Effect of treatment on neonatal chlamydial conjunctivitis - before treatment
(a)
(b)
Baby B, examined 10 days after delivery, had been born at 36 weeks gestation
and had had signs of conjunctivitis at 7 days old, worse in the left eye.
(a) and (b) Pre-treatment
Gross palpebral oedema, upper worse than lower, with a thin
purulent discharge and submucosal oedema with bubbling
81b
Effect of treatment on neonatal conjunctivitis - after treatment






Even using the combined treatment, results were not good (30%
reisolation rate). Close questioning of their mothers revealed
that reisolates from babies given this therapy were usually due to
compliance failure. Reisolates have not been obtained from babies
who completed their combined treatment in special care baby units.
Discrepancies between mothers' and babies' results - Tables 51 and 52
There was failure to isolate chlamydiae in 19 mothers of babies
with chlamydial conjunctivitis. Nine had already had chemotherapy for
puerperal pyrexia. Another three had had chemotherapy (penicillin and
unknown) in late pregnancy and during delivery. In another the culture
was cytotoxic but she had received chemotherapy before it could be
repeated. Isolates were later obtained (at 35 and 84 days respectively)
in two but they too had been treated for presumptive chlamydial
infection meanwhile and as neither husband had till then been examined,
these were probably reinfections. Three of the remaining five negative
tests were not confirmed; in three, the membranes had been ruptured for
from 11 hours to seven days, without recorded chemotherapy and in one
the test was not carried out until the third post-natal month.
No isolate was obtained from six babies of chlamydia-positive
mothers. Two had had antichlamydial chemotherapy elsewhere and two had
had intensive penicillin chemotherapy for assumed or proven gonococcal
conjunctivitis. Another when tested had gonococcal conjunctivitis.
From the sixth, who had had no relevant antichlamydial chemotherapy,
only E. coli was isolated.
FINDINGS IN FATHERS OF BABIES WITH NEONATAL CONJUNCTIVITIS - Table 53
Twenty-seven fathers of chlamydia-positive babies were examined
and urethral cultures for chlamydiaewere taken. Symptoms were absent
or negligible in all but two (both chlamydia-positive).
Nine fathers were chlamydia-positive, 18 chlamydia-negative.
Excluding four of the chlamydia-negative who had had relevant chemo¬
therapy, the isolation rate was 9/23 (39.0%).
Although concurrent gonococcal infection in one, a long time
interval since original diagnosis in the child in others, and/or
other undisclosed chemotherapy may have been contributory factors, this
is significantly less than the maternal isolation rate (85%, x
15.2, 1 d.f.***).
83.
(c) (i) EPIDEMIOLOGICAL STUDIES IN LIVERPOOL WOMEN ~ Table 54
In male patients, the prevalence of NGU and the chlamydial isolation
rate therein has been seen to vary in different populations studied
according to geographical location, race, socio-economic status etc.
These studies', therefore, were carried out to investigate the prevalence
of chlamydial infection in other groups of women in the population from
which our NGU contacts were drawn. They also included an estimated low
incidence group of infertility patients used as a control series.
(a) STD clinic population
The prevalence of chlamydial endocervicitis in 314 consecutive
female patients in our unit was 24%. The age range was 13-73 years
(mean 29.3).
(b) The age range of clinic patients taking oral contraceptives was
15-38 years (mean 22.6). The chlamydial isolation rate in this group
was 37.5%.
(c) Pregnancy in STD clinic population
The prevalence of chlamydial infection in 235 pregnant women in
our unit was 29%. In the first trimester, it was 33%, in the second,
21% and in the third, 33%.
The chlamydial isolation rate in pregnancy, in the presence of
ectopy, was 41%. The age range in pregnancy was 15-38 years (mean
22.6).
(d) Infertility patients
There were no signs of cervical inflammation and no chlamydial
isolates from 37 patients examined in the infertility clinic in this
hospital who were- used as a control group.
(ii) CLINICAL SIGNS AND SYMPTOMS IN THE PRESENCE OF CHLAMYDIAL INFECTION
AND GONORRHOEA IN THE STD CLINIC POPULATION - Table 55
Amongst patients in whom gonorrhoea was present but cultures
for chlamydia were negative, 48.9% were symptom free.
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Clinical signs were studied in four groups of patients.
(1) Those in whom both chlamydial infection and gonorrhoea were
present.
(2) Those in whom gonorrhoea was present and cultures for chlamydia
were negative.
(3) Those in whom chlamydial infection was present and gonorrhoea
was absent.
(4) Those from the general clinic population in whom cultures for
gonorrhoea and chlamydial infection had been negative.
Contrary to findings in chlamydial endocervicitis, in gonorrhoea
infection was not associated with a higher incidence of ectopy, either
superficial or hypertrophic, compared with the normal clinic population.
When chlamydial infection was also present the percentage ectopy was
significantly increased (x2 = 32.3, 1 d.f.***).
There was a significantly higher percentage of endocervical
mucopus present in gonorrhoea than in the ordinary clinic population
(X2 = 28.8, 1 d.f.***), but significantly more again when chlamydiae
were also present (x2 = 12.7, 1 d.f.***).
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PART I: CLINICAL RESULTS - TABLES
(a) Contacts of men with nongonococcal urethritis
C.t pos = culture-positive for C. trachomatis
C.t neg = culture-negative for C. trachomatis
Table 1 - Reason for attendance
Total C.t pos. C.t neg. C.t isolation rate
n n n
NSU contact 394 139 255 35.4%
Own accord 39 13 26 33.3%
Referred 22 8 14 36.4%
Table 2 - Group age
Group Age Total C.t pos. C.t neg. C.t isolation
Range n (%) n (%) n (%)
2 16-20 114 (25.1) 56 (35) 58 (19.7) 49.1%
3 21-25 •153 (33.6) 65 (41) 88 (29.8) 42.5%
4 26-30 82 (18.0) 22 (14) 60 (20.3) 26.8%
5 31-35 53 (11.6). 11 (7) 42 (14.2) 20.8%
6 36-40 22 (4.8) 3 (2) 19 (6.4) 13.6%
7 41+ 22 (4.8) - - 22 (7.5) -
Age unknown 9 (2.0) 3 (2) 6 (2.0)
Significance - C.t isolation rate in group 2/group 6, x2 = 8.06,
1 d.f.**. Total x2 = 23.9, 4 d.f.***. x2 f°r linear trend =
23.O, 1 d.f.***.
Table 3 - Marital status
Total C.t pos. C.t neg. C.t isolation X2(l d.f.)
n (%) n (%)
Single 229 (50.3) 99 (61.8) 130 (44.1) 43%-—73***
Married 179 (39) 46 (28)
Div/sep. 47 (10) 15 (9.3)








Total C.t pos. C.t neg. C.t isolation X2d d.f.
n (%) n (%) rate
Nullipara 245 (53.8) 100 (62.5) 145 41%
No full term 29 (6.4) 14 15 48% 9.47**
Vaginal delivery 171 (37.6) 44 (27.5) 127 26%
Caesarian
section only 4 (0.9) 1 3
Both vaginal and
C.S. delivery '6 (1.3) 1 5
Full-term pregnancy:
Total C.t pos. C.t neg. C.t isolation rate
n (%) n n
Parous 181 (39.8%) 46 135
1 59 24 35
2 64 13 51 > 29.9%
3 31 9 22
4 18 - 18
5 7 7
6 2 2
Miscarriages 25 (5.5%) 8 7
Terminations 28 (6.2%) 12 16
Ectopics 2 1 1
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Hormonal factors




























C.t pos. C.t ne
Premenarche • 1 (0.2) - 0.3
Post-menopausal 3 (0.7) - - 1.0
Regular
cycle 414 (91) 34.5% 89.4 86 .0
Irregular 26 (5.7) 50.0% 8.1 10.0
Pregnant 11 (2.4) 36.0% 2.5 2.6







0-7 days ago 99 (23.9) 33.3%
8-14 days ago 140 (33.8) 35.7%
15-21 days ago 100 (24.2) 40.0%
22-28 days ago 75 (18.1) 34.7%
(Total x2 = 1.06, 3d,.£. (N.S.))
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(ii) Oral contraception only






(Total x2 = 0.68, 3 d.f. (N.S.))











None 110 (24.2) 27 24.5% 16.9 28.1
o.c. 221 (48.6) 106 48% 66.2 39.1
o.c. within
one month 12 (2.6) 6 50% 3.7 2.0
IUCD 26 (5.7) 6 23% 3.7 6.8
Tubal ligation 26 (5.7) 5 19.2% 3.1 7.1
Barrier 30 (7.5) 8 23.5% 5.0 8.8
Unknown/
unrecorded 26 (5.7) 2 7.6% 1.2 8.1
Significance
Oral contraception (including within the past month)/no oral contraception
X2 = 25.2 1 d.f.***
Oral contraception (including within the past month)/barrier methods -
X2 = 4.1, 1 d.f.*
Oral contraception (including within the past month)/contraception other
than barrier methods or oral contraception - x2 = 23.5, 1 d.f.***
Barrier methods/no contraception - x2 ~ 0, 1 d.f.
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Table 8 - Symptoms
Total C.t pos. C.t neg. C.t isolation x2 (1 d.f.)
n (%) % % rate
None 244 (53.6) 45.6 58 29.9% — 5.87*
Any 211 (46.4) 54.4 42 41.2%
Discharge 131 (36.9) 24.4 28.8 45.0% 7.27**
Irritation 40 (12.5) 6.8 8.8 50% 3. 55 N.S.
Soreness 10 (2.5) 2.0 2.2 40% 0.00012 N.S
Dyspareunia 7 (2.5) 1.0 1.5 57.1% 0.69 N.S.
Post-coital
bleeding 8 (3.1) 1.0 1.8 5/8 1.59 N.S.
Menstrual 19 (3.1) 4.7 4.2 26.3% 0.34 N.S.
Urinary 46 (12.5) 8.8 10.1 43.5% 1.17 N.S.
Abdominal pain 27 (6.9) 5.4 5.9 40.7% 0.17 N.S.
Conjunctivitis 4 (0.6) 1.0 0.9 25% O.Ol N.S.
Rectal 3 (0.6) 0.7 0.7 1/3 0.29 N.S.
Infertility 4 - 1.4 0.9 - -
Warts 10 (3.1) 1.7 2.2 5/10 0.43 N.S.























































































































































































































Table 11 - Coital experience
(a) Last intercourse
Total C.t isolation C.t pos. C.t neg.
n (%) rate p,'o %
Less than one week ago 89 (19.6) 39.3% 21.9 18.3
One to two weeks 117 (25.7) 38.5% 28.1 24.4
Two to four weeks 76 (16.7) 39.5% 18.7 15.6
Four weeks to two mths 19 (4.2) 36.8% 4.4 4.1
Two to three mths 16 (3.5) 37.5% 3.7 3.4
Over three mths ago 3 (0.7) - 0 1.0
Unrecorded 135 (29.7) 27.4% 23.1 33.2
(b) Number of consorts
One regular 352 (77.4) 32.1% 70.6 81.0
Regular and other 52 (11.4) 50.0% 16.2 8.8
Casual only 2 (0.4) 1/2 0.6 0.3
Unrecorded 49 (10.5) 40.0% 12.5 9.8
(C.t isolation r^te in women with one consort/more than one -
X2 = 5.66, 1 d.f.*).
*
I
Table 12 - Clinical Signs
Cervix
(a) Ectocervix
Total C.t isolation C.t pos. C.t neg.
n (%) rate %
None (no cervix) 2 (0.4) - - 0.7
No ectopy 191 (42.0) 21.5% 25.6 50.8
Superficial
ectopy 200 (44.0) 38.5% 48.1 41.7
Hyper trophic
ectopy 58 (12.7) 72.4% 26.2 5.4
Unrecorded 4 (0.9) - - 1.3
Significance
No ectopy/superficial ectopy - x2 = 12.7, 1 d.f.'
No ectopy/any ectopy - X2 = 28.0, 1 d.f.***
No ectopy/hypertrophic ectopy - x2 = 49.7, 1 d.f.***
Superficial ectopy/hypertrophic ectopy - x2 = 19.5, 1 d.f.***
(b) The endocervical contents
***
Total- C.t isolation C.t pos. C.t neg.
n (%) rate % %
Clear 181 (39.8) 24.3% 27.5 46.4
Cloudy 143 (31.4) 25.2% 22.5 36.3
Mucoid 8 (1.8) 50% 2.5 1.4
Mucopus 98 (21.5) 72.4% 44.4 9.2
Blood only 22 (4.8) 22.7% 3.1 5.8
Unrecorded 3 (0.7) - - 1
Significance
Clear and cloudy mucus/mucopus - x2 = 72.6, 1 d.f.***
94.
Table 12 continued
Cervical signs and chlamydial infection
Total C.t isolation C.t pos. C.t neg.
n (%) rate % %
Hypertrophic ectopy
and/or mucopus absent 325 (71.4) 22.5% 45.6 85.4
Ectopy present
(hypertrophic or
superficial) 285 (56.7) 46.1% 74.4 47.1
Both hypertrophic
ectopy and mucopus





















































































































































































































Table 16 - Contraception and ectopy
Ectopy + O.C.
Ectopy - O.C.
No ectopy + O.C.
No ectopy - O.C.







Ectopy with/without O.C. - x2 = 6.56, 1 d.f.*
O.C. with/without ectopy - X2 = 6.51, 1 d.f.*
No ectopy with/without O.C. - X2 = 6.77, 1 d.f.**





























































































































































































































































































































































































































































































































































































































































































































































































































Total C.t isolation C.t pos. C.t neg.
n (%) rate % %
None 390 85.7 35.9% 87.5 84.7
Within last week 2 0.4 2% 1.2 0.0
Within last
two weeks 20.4 1/2 0.6 0.3
Within last
four weeks 19 4.2 36.8% 4.4 4.1
Within last
eight weeks 17 3.7 23.5% 2.5 4.4
Within last
8-12 weeks 16 3.5 18.7% 1.9 4.4
Unrecorded 92 33.3% 1.8 2.0
Source
Type
Cases % Total (56) % C.t pos.
STD clinic 7 12.5 4/7
G.P. 40 71 32.5
Hospital/clinic 5 11 -
Non-medic 12
Unknown 3 6 1/3
No. C.t pos.
Penicillin G. 11







Table 25 - Antibiotics - continued
Allergy Present




Cases % C.t pos.
1 day 6 3/6
1-4 days 5 1/5
5-14 days 39 28.2
> 14 days 1 -
108.
























































Any symptoms 2.497 87 F = 0.2848 (1 and 158 d.f.)
No discharge 2.431 101
Discharge 2.473 59 F = 0.0380 (1 and 158 d.f.)
No abdo pain 2.407 149
Abdo pain 2.979 11 F = 1.9429 (1 and 158 d.f.)
Cervical signs
Ectocervix
No ectopy 2.499 41
Simple ectopy 2.488 77 F = 0.0702 (2 and 157 d.f.)
Hypertrophic ectopy 2.390 42
Endocervix
Clear mucus 1.833 44 F = 3.6550** (4 and 155 d.f
Cloudy 2.719 36 \
Mucoid 2.208 4 t = 3.46, 155 d.f.***
Mucopus 2.680 71 ' comparing "clear mucus"and "mucopus"
Blood 2. 748 5
Other signs
Salpingitis
Absent 2.435 154 F = 0.3015 (1 and 158 d.f.)
Present 2.737
The combined effects of ectopy and the pill
(a) Ectopy present, O.C. absent
(b) Ectopy present, O.C. present
(c) Ectopy absent, O.C. absent





Comparing (b) and (c), t = 1.119, 281 d.f. (N.S.)
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Table 26 - Whole coverslip count - continued
Other infections
TV Absent 2.507 137
. Present 2.087 23
Candidiasis Absent 2.298 102
Present 2. 708 58
GC Untreated 1.427 3
2.0092 (1 and 158 d.f.)N.S.
3.6373 (1 and 158 d.f.)N.S.
2.5169 (1 and 3 d.f.) N.S.
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Table 27 - Follow up (total women - 166)
(a) C.t status sequence
First test Intermediate test where
applicable (may have been
repeated)
+ — + —
-/- 0 36 0 (36)
-/+/- 0 2 2 0
+/+ 9 0 (9) 0
■+/-/+ 3 0 0 3
+/-/+/- 15 0 0 15












In 121 women originally chlaroydia-positive, chlamydia negative later(*)






















n % n %
Candidiasis 46 (38) 15 (12)
Trichomoniasis 18 (15) 6 (5)
Warts 3 (2) 1 (1)
HSV 1 (1) 0 -
112.
Table 27 - Follow up continued
(d) Surveillance
Range (days) Mean (days)
Total - 121 women 5-632 198
—\
Interval between first one reisolate (17) 11-603 166
post-treatment culture two reisolates (1) - 77
and reisolate
Interval between first
and final cultures > one reisolate (17) 18-432 193
after retreatment
= 1Interval between firstculture after retreat- V two reisolates (1) - 225
ment and 2nd reisolate
Interval between 2nd
reisolate and final culture - 0
Table 28 - Reisolates
(a) Coital activity
Total Resumed Same partner New partner Unknown partner Information
S.I. Symptoms Symptoms missing
18 14 4 5 0 4 1 4
(b) Presence of endocervicitis
With first isolate With reisolate Same signs/other signs



































































































































































































































































































































































































































































PART I: CLINICAL RESULTS - TABLES
(b) Babies with neonatal conjunctivitis and their parents
Table 30 - Isolation rates
C.t pos = chlamydia positive
C.t neg = chlamydia negative
1. Total babies 129
chlamydia positive 70
chlamydia negative, given chemotherapy 2
C.t isolation rate 54% (corrected rate 55% - 70/127)
2. Total mothers 129
chlamydia positive 57
chlamydia negative, given chemotherapy within 4/52 16
within 8/52 17
within 12/52 21
C.t isolation rate 44% (corrected rate 53% - 57/108)
3. Mothers of chlamydia positive babies 70
chlamydia positive 51
chlamydia negative, given chemotherapy within 4/52 8
within 8/52 9
within 12/52 10
C.t isolation rate 73% (corrected rate 85% - 51/60)















Pregnancy Puerperium (M) Baby
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MOTHERS
Table 32 - Marital status
Total C. t pos C.t neg X2 CI
n (%) n (%) n (%)
Single 45 (34.9) 25 (43.8) 20 (27.7) -
^;2.2
Married 80 (62) 31 (54.4) 49 (68)
Separated 2 (1.6) 1 (1.8) 1 (1.4)
Divorced 1 (0.8) 1 (1.4)
Widowed 1 (0.8) 1 (1.4)

















Table 34 - Present pregnancy
Pregnant
1st postnatal month



























Table 35 - Last menstrual period
Total C.t pos C.t neg
n n n
0-7 days ago 1 1
8-14 3 - 3
15-21 2 - 2
22-28 3-3
29-35 1-1
>35 days, < 9 months 113 (87.6%) 55 (97%) 58 (81%)
Unknown/unrecorded 62 4
Table 36 - Contraception
Total C.t pos C.t neg
n (%) n (%) n (%)
None 117 (91) 55 ' (96.5) 62 (86.1)
o.c. 4 (3.1) - 4 (5.6)
O.C. past month 1 (1) - 1 (1.4)
IUCD 2 (2) - 2 (2.8)
Unrecorded/unknown 5 (4.3) 2 (3.5) 3 (4.2)
121.
Table 37 - Chemotherapy
Total C.t pos C.t neg Mothers of C.t pos




(a) in pregnancy 5/129 (3.9) n2
(b) in puerperium 26/129 (20.2) n5
74 75



























































Table 37 - Chemotherapy continued



















































































































































































































































































































































































































































































































Table 43 - Maternal antibodies
C.t state (M) PID LGVCFT
+ + 20 80 160 40 320
Ct+ PID Ct- Ct+ Ct-
+ 10 10 40
+ 10 40 20
- lO
+ - <10




+ 80 1280 320 160
(retained placenta) Ct+ Ct+ Ct- Ct-
+ +40
20







Table 44 - Cervical inflammation in C.t positive mothers (57)
Hypertrophic Mucopus Both Either
ectopy
At first visit
Followed up (25) -




























































































































40% (X2 = 0.83, 1 d.f.
(N.S.) )












88 (68) 58 (83)
49
36 (62% total)
13 (tetra x 1)
9
("tetra" - chlortetracycline eye ointment)






























Table 49 - Follow up periods after treatment
T = treated with tetracycline
T + E = treated with tetracycline and erythomycin
Weeks <4 4-7 8-11 12-23 24-25 36-52
T
Single isolate 1-3 5 6 4
Reisolate - - 1 6
T + E
Single isolate - 2 - 6 6 5
Reisolate - - 2* 1 1 1

















































































































































































































































































































































































































Table 53 - Results in fathers (F) of babies with chlamydial conjunctivitis
C.t status Chemotherapy (F) Symptoms etc (F)
Father Mother Child
x7 Pos. Pos. Pos. - in 1/7 men
x2 Pos. Neg. Pos. - -
xll Neg. Pos. Pos. - -
xl Neg. Neg. Pos. - -
xl Neg. Pos. Pos. — dysuria 2/12
baby treated
xl Neg. Pos. Pos. Penbritin -
xl Neg. Pos. Pos. - Gonorrhoea
xl Neg. Pos. Pos. Penicillin -
xl Neg. Pos. Pos. Oxytetracycline -
xl Neg. Pos. Pos. Penicillin -
138.
Table 54 - Epidemiology
(a) STD clinic population (n = 204)







(b) Pregnancy in STD clinic
Age range 15-38 years (mean 22.6 years)
Trimester (n = 235)
1st 2nd 3rd overall %
C.t status Pos 35 17 16
Neg 70 64 33
C.t isolation rate (%) 33 21 33 29
Total (%) 45 34 21 100











C.t status Pos 11 55%
Neg 9
Oral contraception (n ;= 80)
















Table 55 - Clinical signs in the presence and absence of infection in
STD clinic
General clinic pop.
Infections C.t+ GC+ C.t- GC+ C.t+ GC- C.t- GC-
Cases 192 182 160 134
No ectopy 27.6% 57.1% 25.6% 59.7%
Superficial ectopy 56.5% 36.8% 48.1% 36.6%
Hypertrophic ectopy 15.6% 6.0% 26.1% 3.7%
Endocervical mucopus 50% 31. 3% 44.4% 6.0%
Significance
1. Ectopy in gonorrhoea alone/concurrent gonorrhoea
and chlamydial infection - x2 ~ 32.3, 1 d.f.***
2. Ectopy in gonorrhoea alone/chlamydial
infection alone - x2 = 33.4, 1 d.f.***
3. Hypertrophic ectopy in gonorrhoea alone/
chlamydial infection alone - X2 = 25.0, 1 d.f.***
4. Hypertrophic ectopy in gonorrhoea alone/
concurrent gonorrhoea and chlamydial infection x2 = 7.8, 1 d.f.**
5. Hypertrophic ectopy in gonorrhoea alone/
clinic population - X2 = 0.44, 1 d.f. (N.S.
6. Mucopus in gonorrhoea alone/concurrent and
chlamydial infection - x2 = 12.7, 1 d.f.***
7. Mucopus in gonorrhoea alone/chlamydial
infection alone - x2 = 5.7, 1 d.f.*
8. Mucopus in gonorrhoea alone/clinic population x2 = 28.8, 1 d.f.***
Symptoms in patients with gonorrhoea whose cultures for chlamydia
were negative
Total 88
% symptom free 48.9
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PART II: LABORATORY RESULTS
Sensitivity of C. trachomatis to certain antibiotics
Erythromycin
1. To determine the minimum inhibitory concentration
Varying concentrations of erythromycin were added to MCC which
were immediately infected with TC 691 at a dose calculated to give
3000 inclusions after 48 hours incubation.
Results show a progressive decrease in inclusion count with
increasing concentration of erythromycin. At concentration 0.005 yg/ml,
the few persisting inclusions were only 5-6 microns in diameter,
(controls 15 microns) and light microscopy was needed to count them.
However, the inclusions and elementary bodies within them were not
abnormal in any way, unlike the effect of penicillin.
The MIC of erythromycin for Staphylococcus pyogenes is
0.01-1.6 yg/ml. Thus chlamydiae seem very highly sensitive in this
system.
2. To determine whether erythromycin has a chlamydistatic or
chlamydicidal effect
Duplicates of infected MCC with added concentrations of anti¬
biotic were removed from incubation after 48 hours. The antibiotic
was washed out with several changes of antibiotic-free medium and
replenished with this medium. They were then re-incubated for a
further 48 hours and then Giemsa-stained.
The amount of manipulation, chilling, pH change, mechanical
disturbance and extra incubation prevent this experiment from being
a true replication of the other. Fewer inclusions were seen in MCC
previously containing 0, O.OOl, O.OC5 yg erythromycin/ml growth
medium than in the first experiment. However, inclusions were
present (at 96 hours) where, after 48 hours continuous incubation
with 0.01 and 0.1 yg erythromycin/ml, the infection had apparently
been completely inhibited. The inclusion sizes in the control
(antibiotic free) at 96 hours were much larger than at 48 hours
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(20-30 microns instead of 15) whereas at concentrations 0.01 and 0.1
they were of a size previously seen at 48 hours (15 microns) as would
be expected of late developers resuming growth only when erythromycin
was removed.
Therefore during the exposure to erythromycin, some elementary
bodies were not killed, merely "latent".
3. To determine the effect of incubating MCC with erythromycin prior
to infection and so determine whether prior uptake of erythromycin
by the host cell causes C. trachomatis to be more susceptible
The MCC were exposed to varying concentrations of erythromycin for
four hours prior to infection at the same dosage as before and left
in these concentrations after infection. Inclusions were counted after
48 hours.
The effect was similar to the first experiment and thus there was
nothing to suggest that failure to kill all C. trachomatis was due to
delayed uptake of erythromycin.
4. To determine whether the effect of erythromycin depends on the
stage of C. trachomatis development
MCC were infected and incubated for 24 hours in medium without
erythromycin. The medium was then changed and incubation continued
in the presence of the range of erythromycin dilutions previously used,
for a further 24 hours. Cultures were stained and inclusions counted
48 hours after initial infection.
The results showed that there was no difference in the erythromycin
concentration required to inhibit C. trachomatis development from that
previously seen when incubation was in the presence of erythromycin
throughout. This was a most unexpected result and suggests that the
activity of erythromycin unlike chloramphenicol or even tetracycline
is not confined to an early biochemical event in chlamydial replication.
In conjunction with other workers in the laboratory, similar




1. To determine the minimum inhibitory concentration
Varying concentrations of benzylpenicillin (0.01 - 100 units per
ml medium) were added to MCC which were immediately infected with STU strain
at a dose calculated to yield 10,000 to 15,000 inclusions per coverslip.
Results show a drop in numbers of typical inclusions at 0.01 units
per ml and none were found at 0.1 per ml or above. However, abortive
inclusions, small and non-fluorescing (so visible only by light micro¬
scopy) and either empty or full of debris or swollen particles were
present from 0.01 to 10 penicillin units progressively increasing, with
the decreasing count of normal inclusions, from 2,000 to 5,000 per
coverslip but reduced at 100 units per ml.
Another experiment using closer spaced penicillin concentrations
between 0.01 and 0.1 units/ml determined the MIC more exactly.
2. To determine whether penicillin has a chlamydistatic or chlamydicidal
effect
Duplicate MCC from the previous experiment, at penicillin concen¬
trations where large numbers of abortive inclusions had been present,
were selected. After incubation for 48 hours, the antibiotic was
washed out as in the erythromycin experiment and, after reincubation
for 48 hours, the cultures were Giemsa stained.
No normal inclusions were present at 96 hours in cultures where they
had been absent in the presence of penicillin at 48 hours and so the
abnormal inclusions were assumed, within the limits of these experiments,
to have non-viable contents. Later work on this aspect will be described
at the end of the chapter.
3. To determine whether the effect of penicillin depends on the stage
of C. trachomatis development
Infected MCC were incubated for varying periods before the addition
of 0.1 or 1.0 units of penicillin per ml medium. All MCC were stained
and examined 48 hours after initial infection. Penicillin was added
to certain infected MCC only one hour before the cultures were stained.
This was to exclude the possibility that the abortive inclusions might
be the result of a direct destructive effect of penicillin against
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normal inclusions or to chemical interference with their staining
properties and fluorescence.
Results suggest that the inclusion-inhibiting activity of
penicillin depends on both the concentration of penicillin added and
upon the time in the growth cycle at which it is added. The later it
was added, the more normal inclusions were present in the final count.
The earlier penicillin was added,the more normal inclusions were
present. There was no direct effect of penicillin on normal inclusions.
Chloramphenicol
1. To determine the minimum inhibitory concentration
Varying concentrations of chloramphenicol sodium succinate were
added to MCC immediately before infection with TC 691.
The results after 48 hours incubation show a progressive decrease
in inclusion count with increasing concentrations of chloramphenicol.
Inclusions were not abnormal but smaller than usual. The MIC was
1.0 yg/ml whereas that of erythromycin was 0.01. The MIC of
chloramphenicol for Staphylococcus pyogenes is 4.0 to 12 yg/ml.
2. To determine whether chloramphenicol has a chlamydistatic or
chlamydicidal effect
Duplicate MCC for the MIC estimation experiment were removed from
incubation at 48 hours and then the antibiotic was washed out as in the
erythromycin experiment. After reincubation for 48 hours, the cultures
were Giemsa-stained.
At 96 hours, growth of chlamydiae was re-established in cultures
where 48 hours non-stop incubation with 1.0, 2.5, 5.0 and 10.0 yg per
ml chloramphenicol, had prevented signs of infection. As with
erythromycin, the inclusions sizes were smaller at those concentrations
than in the control as would be expected of "latent" inclusions
beginning to grow only after removal of chloramphenicol.
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Tetracycline
1. To determine the minimum inhibitory concentration of tetracycline
Varying concentrations of tetracycline hydrochloride were added
to MCC and infected with STU strain of chlamydiae at a dose calculated
to give 4000-6000 inclusions after 48 hours incubation.
The results show an abrupt fall in inclusion count between 0.005
and 0.01 yg tetracycline per ml medium.
2. To determine whether tetracycline has a chlamydistatic or
chlamydicidal effect
Two sets of MCC from the previous experiment were removed after
incubation for 48 hours. From one set, the antibiotic was washed out
as in the erythromycin experiment and the other set was left unwashed.
Both were reincubated for 48 hours and then the cultures were Giemsa-
stained.
There was no resumption of growth at previously inhibitory levels.
3. To determine whether the effect of tetracycline depends on the
stage of C. trachomatis development
MCC were infected with STU strain and incubated. At intervals,
certain infected MCC were removed, changed to fresh medium containing
tetracycline and then returned to incubation. All MCC were stained
after a total of 48 hours incubation from the time of infection.
Tetracycline was added to some cultures only one hour before
staining to exclude the possibility that antibiotic effects might be
due to chemical interference or degradative effects on the staining
properties of the inclusion.
The results suggested that the effects of tetracycline depend on
the stage of the inclusion development when it is added. Normal
inclusions similar to the controls, were present when tetracycline was
added after 24 hours incubation without antibiotics where previously
there had been complete inhibition. This was very different from the
results with erythromycin. (Tetracycline had no direct effect on the
























2. To determine whether erythromycin has a chlamydistatic or




Inclusion count at 96 hours per
















To determine any effect of erythromycin directly on the tissue
culture - pre-incubation with erythromycin 4 hours prior to infection
Concentration of erythromycin












3. To determine any effect of erythromycin directly on the tissue
culture - pre-incubation with erythromycin 4 hours prior to
infection - continued
Concentration of erythromycin









4. To determine whether the effect of erythromycin depends on the
stage of C. trachomatis development - prior infection for 24 hours
before the addition of erythromycin
Concentration of erythromycin
yg/mi
































































To determine whether penicillin has a chlamydistatic or chlamydicidal
effect - removal of penicillin after 48 hours
Initial concentration
























































































































































2. To determine whether chloramphenicol has a chlamydistatic














Count at 96 hours - 48 hours













1. To determine the MIC








2. To determine whether tetracycline has a chlamydistatic or
chlamydicidal effect - removal of tetracycline after 48 hours
Initital concentration of Count when washed Count after incubated
tetracycline at 48 hours to for 96 hours with






































































































These laboratory results will be discussed here. The conclusions
from the clinical results appear in the main discussion.
LABORATORY RESULTS: CONCLUSIONS
Penicil.lin, normally bactericidal against sensitive organisms,
showed similar irreversibility against C. trachomatis and abnormal
inclusions appeared to be dead chlamydiae. However, in later experi¬
ments (D. Hobson^personal communication) the addition of penicillinase
to these abnormal inclusions rendered them viable and allowed normal
growth to resume once in antibiotic-free medium and Ridgway195 found
they recovered their infectivity after multiple passage in anti¬
biotic-free media.
The inclusion-inhibiting activity of penicillin was greater when
added early in the growth cycle indicating that it prevents division
of initial bodies where new cell wall growth is involved and so
prevents the formation of a new generation of elementary bodies. The
discrepancies between tissue culture and clinical findings seem due
to the varying susceptibility of inclusions according to their age
and to failure to sustain sufficiently high penicillin tissue levels
long enough to deal with all the inclusions. A comparison of the
results in patients with co-existing gonococcal and chlamydial genital
infections treated with a week's course of penicillin with those given
only single dose penicillin therapy should support this.
The failure to eradicate chlamydial infection with chloramphenicol
is only partially explained. Its MIC was higher than that of
erythromycin and.tetracycline but easily attainable by chemotherapy
and although latency was induced, the MIC and MLC were not widely
different. Serial passage, not used in these experiments might
show "escape" at even higher concentrations of the antibiotic but
that is a cumbersome technique wherein contamination is difficult to
avoid.
The excellent response to tetracycline and erythromycin,
treatments of choice in chlamydial genital and conjunctival infections,
is not entirely explained by their low MIC. Erythromycin's effect
seems unrelated to the inclusions' age but that is probably because
it acts throughout the cycle not just at the transformation of
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elementary to initial 'body but also when the initial bodies divide,
whereas tetracycline acts at the first stage when the initial body is
formed. Tetracycline's effect seemed chlamydicidal which conflicts
with its generally bacteristatic action. However, tetracycline's
action on the host cell's protein metabolism may, indirectly, affect
C. trachomatis.
It seems probable that all MIC with C. trachomatis in vitro are
artificially low. As noted previously, these experiments have been
done with replicating cultures which are quite artificial systems with
single monolayers, on a single growth cycle, and where there is
significant competition between the host cell and chlamydiae. However,
later results in our own laboratory with cycloheximide-treated MCC
gave similarly highly sensitive results and thus it does not seem
that the amount of cell-replication or the degree of protein synthesis




At the time that the work for this thesis began in 1974 it was
either not known or not generally accepted:
(a) that C. trachomatis was a primary pathogen of the female genital
tract in its own right,
(b) whether the main site of chlamydial infection was the cervix rather
than the urethra or vagina,
(c) whether concurrent infection with other sexually transmitted
disease agents could seriously influence the expression of
C. trachomatis infection or its diagnosis,
(d) whether any physiological factors (e.g. pregnancy, menstruation)
in the woman could influence the establishment or outcome of
chlamydial infection,
(e) what clinico-pathological changes in the genital tract could be
attributed unequivocally to C■ trachomatis.
(f) what complications of C. trachomatis cervical infection might occur,
(g) what frequency of infection with C■ trachomatis occurred in women
in the U.K.,
(h) to what extent this chlamydial infection of women might spread to
their babies (i.e. what percentage of neonatal conjunctivitis is
caused by C. trachomatis),
(i) how efficacious various regimes of antibacterial antibiotics were
and why there were marked differences between drugs and between the
same drugs in vivo and in vitro.
The prime purpose of the thesis was to obtain answers to some of
these problems.
While this investigation in Liverpool has been in progress, there
has obviously been an increasing awareness of the importance of
C. trachomatis in several other large specialized centres in the United
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Kingdom and elsewhere. This has given the present author the opportunity
to compare her original findings with other concurrent or subsequent
observations elsewhere and these will be critically reviewed in the
following discussion.
The cervix, signs of inflammation
The cervix was considered as an organ affected by chlamydial
infection.
Highly significant positive correlation was found between the
isolation of C. trachomatis from the cervix and certain clearly defined
abnormal inflammatory signs, hypertrophic ectopy and endocervical muco-
pus, where they were .present. Previous reports (considered in detail in
the introduction to this thesis) had not differentiated between simple
ectopy which is physiological and abnormal findings described as "cervicitis"
and so a high proportion of their control groups were described as
showing signs of inflammation. In our control group of 37 infertility
patients where no chlamydial isolation was made, no signs of inflammation
were found.
In contrast, in 72.4% of women with hypertrophic ectopy, and in
81.3% with both hypertrophic ectopy and endocervical mucopus,
C. trachomatis was isolated from the cervix. There was, nevertheless,
a large percentage (46%) of women with chlamydial infection of the
cervix in whom such signs of inflammation were absent.
Other topics
The characteristics of patients with chlamydial infection of the
cervix and their contacts have been studied, along with factors
affecting the susceptibility of the cervix to chlamydial infection, the
symptoms and other clinical signs of infection, its interaction with
other genital infections, the effects of local spread of infection and
the serum antibody response.
C. trachomatis, a sexually transmitted agent
Many authors, whose work has been reviewed already in the intro¬
duction to this thesis, have suggested C. trachomatis is a major
o n r TOO
aetiological agent in nongonococcal urethritis, isolated in 25-29%
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men with that condition. That chlamydial genital infection is a sexually
transmitted disease is supported firstly by the increased incidence found
here in primary female contacts (55%) of men with NGU compared with
secondary contacts (37%) (confirming previous work111) and secondly by
the different chlamydial isolation rates occurring in populations of
varying promiscuity. Amongst our control infertility clinic group,
presumably single partner unions of long duration with no barrier or
other contraceptives, there was not one isolate. In Family Planning
Association (F.P.A.) clinic patients, the isolation rate had been
slightly lower (3%) 11(1 than in gynaecological outpatients (8-9%)220'128.
It was higher amongst patients in sexually transmitted diseases (STD)
clinics (18-31%)111'110 (currently in our unit 24%) and highest of all
in the presence of another sexually transmitted disease, gonorrhoea
(48-63%)227f110.
t
Susceptibility of columnar epithelium
Columnar epithelium is more susceptible to infection with chlamydiae
than stratified squamous epithelium. This may be due to biochemical
or physical factors (e.g. the superficial cells in columnar epithelium
are active and not overlaid by layers of dead ones). In the other two
main sites of chlamydial infection, the urethra and conjunctiva, only
columnar epithelium is involved. Columnar epithelium lines the endocervical
canal and appears on the vaginal aspect of the cervix in women with ectopy.
Effect of oral contraception
As discussed previously, ectopy is not a response to infection
as once was believed201'202. For example, it was found in 37%
symptom-free women attending an FPA clinic118. It was found there
and confirmed in this thesis that ectopy was commoner in young women
using oral contraception, which was found to lessen the tendency of
ectopy to diminish with age and parity. The progestational effect
of oral contraception on the cervix (during the time of this study)
resembled that of the first trimester of pregnancy, namely the
production of hyperplasia and oedema of the columnar epithelium and
eversion of the endocervix228. There was also an excessive outflow
of alkaline mucus from the endocervical glands which might alter
the anti-infective effect of the normally low vaginal pH. Delay in
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the reduction of ectopy might have been due to the alkaline cervical
mucus buffering the low vaginal pH which normally stimulates metaplasia
in the cervical columnar cells119a.
Hormonal effects
Direct hormonal effects enhancing chlamydial infection in vitro
had been reported229. Steroids were added to tissue cell cultures
infected with C. trachomatis and their presence throughout the growth
cycle increased the size and number of developing inclusions. In the
present clinical study, variations in hormone levels throughout the
menstrual cycle were not found to affect the chlamydial isolation rate.
A significant difference in incidence of C. trachomatis according to
the stage in the cycle had been reported by Hilton119 but only in women
using oral contraceptives^, whose hormonal constituents have changed over
the years. Furthermore, Hilton had found that the highest isolation
rates were in the week before, and the week of, the menstrual period.
The possible effect of menstrual blood on enhancement or depression of
chlamydial growth on tissue culture has yet to be studied.
Profile
The increased cervical ectopy and cervical mucus due to oral
contraception thus result in a particularly favourable environment
for infection in a young, nulliparous, sexually active girl whose
promiscuity exposes her to chlamydial infection. As she would be at
peak child-bearing age, she would be likely to infect her babies,
resulting in neonatal chlamydial conjunctivitis.
Chlamydial infection in pregnancy/O.C. users
In this present study, the incidence of chlamydial infection in
the presence of oral contraception was found higher (48%) than in
pregnancy (29%, x2 = 16.7, 1 d.f.***) which was not significantly higher
than in our clinic population (24%, x2 = 1 d.f., N.S.). Where
there was ectopy in pregnancy, the isolation rate (41%) approached
that in the presence of oral contraception (x2 = 0.77, 1 d.f. N.S.).
The populations had not been matched and although the mean ages of
the pregnant women and women taking oral contraceptives were identical
(22.6 years), that of the general clinic population was 29.3 years and
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other variables, such as promiscuity, were not recorded as numbers of
partners were unknown. In later pregnancy also, metaplasia tends to
replace ectopy which would almost certainly produce a less favourable
environment for growth of C. trachomatis; the duration of pregnancy
and so time of susceptibility to infection is slight compared with the
period for which most women take oral contraception; in pregnancy, there
is, as well as persisting vaginal acidity, an endocervical mucous plug
discouraging the spread of infection there.
Inclusion counts (a) ectopy
In another study by the Liverpool groupx , the chlamydial inclusion
counts, which are a measure of the degree of infection, were raised in
the presence of ectopy, although the present study showed no difference
in the rate of infection. Possibly columnar epithelium on the ecto-
cervix gave a larger area susceptible to chlamydial infection and
colonization and for swabbing on examination than when confined to
the endocervix.
(b) hypertrophic ectopy
Hypertrophic ectopy, evidence of cervical inflammation which was
very significantly associated with chlamydial infection, was not
associated with increased counts relative to superficial ectopy either
in this or the previous Liverpool studies9'126. Further studies are
needed to confirm this but, as has been previously found in acute and
chronic trachoma220, clinical signs in primary infections with NGU and
■j p 7
chlamydial conjunctivitis are usually acute, whereas recurrent
infections produce relatively minor signs, easily missed and are less
transmissible.
Some authors122'121 had found reduced chlamydial isolation rates
in men with a previous history of NSU but others102'221'122 had not.
Prentice222 had postulated that this might be due to the presence of
antibodies when he found that a significant number of isolate-negative
men (chlamydiae and other possible pathogens) had had previous attacks
of NSU. Higher isolation rates were found in our unit in Liverpool in
contacts of men with primary than recurrent NGU, confirming previous
work111.
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Hypertrophic ectopy may be a host response to a primary infection
seen less commonly in later infections because of the presence of local
cervical immunoglobulins in immunocompetent hosts. The decreasing
incidence and possible severity125 of chlamydial infections with age may
be another aspect of women's altered immunological reaction following
previous chlamydial infections. Humoral and cervical antibodies and
the cell-mediated immune response may all result in their more rapid
control.
(c) Endocervical mucopus
Endocervical mucopus, another indication of cervical inflammation
was also significantly associated with chlamydial cervicitis and the
inclusion counts were higher in its presence than in its absence in
this and previous126'9 studies in our unit. There are four possible
reasons for the importance of mucopus in chlamydial cervicitis. It
might yield a larger sample of cervical secretions and so more
chlamydial infective agents but, where it is thick and tenacious, a
smaller specimen is often obtained from it than from free-running clear
mucus. It might enhance the growth of chlamydiae but, added to
infected tissue culture, it inhibited their growth in vitro (Hobson D.,
Lee N., unpublished data). Mucopus might indicate the presence of
gonorrhoea or other concurrent infection which encourages chlamydial
replication. However, as will be described later, in chlamydial
infections, concurrent gonorrhoea seems to be merely a coincidental
sexually transmitted disease, common in such a population and signs of
cervical inflammation such as endocervical mucopus are attributable
more often to the chlamydial infection than to gonorrhoea. The most
likely explanation is that mucopus is a direct result of chlamydial
cervical infection and, as the inclusion counts suggest, its appearance
relates to the severity of the infection.
Cervical inflammation and reisolates
Signs of cervical inflammation were less frequently present
following treatment, remaining in only very few cases. In the group
of 166 women followed up in this study, reisolates were subsequently
made in 18 (10.8%) and, of these, signs of inflammation present in 9
(50%) with the original isolate were only found with the reisolate in
4 (22%). This lends support to the theory above of modified host response
and lessened severity of infection in recurrent infections.
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Other STD
The incidence of C, trachomatis cervical infection was found
higher in the presence of gonorrhoea11® and in trichomoniasis233 in this
study confirming previous work.
(a) trichomoniasis
Trichomoniasis produces an acute vaginitis and degeneration of
squamous epithelium. Endocervical inflammation is not prominent in
this infection but trichomoniasis is commonly associated with cervicitis
of various aetiologies and is a useful indication of exposure to
sexually transmitted diseases, whilst not in itself facilitating
chlamydial infection.
(b) gonorrhoea
There are two theories about the effect of gonorrhoea on chlamydial
infection. Richmond1®6'110 suggested that it caused, as may occur in
trachoma, a bacterial reactivation of a chronic latent chlamydial
infection. However, the ease of reisolation in untreated genital
chlamydial infection over many months, the disappearance of signs of
cervical inflammation with the eradication of chlamydiae where those
were the sole infective agents and the almost invariable chance of
reinfection (by untreated consorts or new partners) where reisolation
followed treatment, made this unlikely.
The incubation period for gonorrhoea23^ is shorter than that for
•7
chlamydial infection (as is most obvious in neonatal conjunctivitis).
When, therefore, there are concurrent gonorrhoea and chlamydial
infections, in urethritis and conjunctivitis particularly, clinical
signs of gonorrhoea may precede evidence of chlamydial infection. In
such double infections, suitable chemotherapy may eradicate chlamydial
infection without the diagnosis ever having been made; conversely, abnormal
signs, due to gonorrhoea, may attract attention earlier and more
urgently but failure of such signs to clear up, after anti-gonococcal
chemotherapy, may lead to further investigation with the ultimate
diagnosis of chlamydial infection185 as i-n post-gonococcal urethritis.
For, as these present results show, although there was significantly
more mucopus in the presence of gonorrhoea than in its absence, the
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incidence of mucopus, as of hypertrophic ectopy, was significantly
higher with a mixed gonococcal and chlamydial infection.,(and even with
chlamydial infection alone) than with gonorrhoea alone.
Cervical host cell morphology
(a) in gonorrhoea
Electron microscopy studies235 had suggested gonococcal cervical
infection occurs not only in columnar epithelium but in stratified
squamous epithelium previously thought resistant to infection. Biopsies
had been taken from the squamo-columnar junction, however, and it seems
more probable that metaplastic cells were originally infected (using
the electron microscope, it may not always be possible to tell whether
the infective agent is intra- or extra-cellular). These, at certain
phases of metaplasia are actively phagocytic; they have been closely
studied in tracing the development of cervical malignancy and pre-
malignancy218.
(b) in chlamydial infection
Similar electron microscopy investigations regarding the site of
infection in the cervix would be most interesting.
As early as 1938, Braley42, an early advocate of the cervix
rather than the vagina as the site of genital chlamydial infection, had
examined cervical biopsies, using light microscopy, and found chlamydial
inclusions only in cells two to three layers deep in the transition
(now "transformation") zone, the site of metaplasia. Artefacts in
processing may have made the site appear falsely deep but he was
definite about the cell morphology and commented that few symptoms
could be anticipated when such a narrow area was involved.
Dunlop in 196493 had described naked eye changes in the cervix
at the cervical margin (i.e. the area of metaplasia) and, on cytological
examination, chlamydial inclusions had been found in columnar cells
and squamous para-basal cells which are difficult to distinguish from
metaplastic epithelium219.
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It would appear that only columnar cells, prior to or undergoing
metaplasia, may be infected by C, trachomatis and possibly metaplasia
may result from chlamydial infection. Any chronic intracellular
infection occurring during metaplasia may be incriminated in the
aetiology of carcinoma of the cervix especially when hypertrophic
changes occur. N, gonorrhoeae tends to cause a briefer more acute
infection and is intracellular only when phagocytosed by polymorpho¬
nuclear leucocytes, etc, and so is a less likely carcinogenic agent.
Cervical signs in gonorrhoea
We have found ectopy in gonorrhoea to be significantly less
common than in chlamydial infection. The incidence of ectopy rises
significantly when cervical gonorrhoea alone is compared with combined
infections. This may be because, as the electron microscopy studies
suggested, columnar epithelium does not facilitate gonococcal infections
as it does chlamydial. Possibly due to the relative unimportance of
superficial ectopy in gonococcal cervical infection, hypertrophic ectopy,
unlike endocervical mucopus is unrelated to the presence of gonorrhoea.
Persistence
We have previously observed the persistence of chlamydial
infection untreated over long periods due to patients' failure to keep
O
their follow-up appointments , although in this present study only
two were untreated for any marked length of time (15 and 54 weeks).
A study of the effect of time on cervical inflammation due to chlamydial
infection would be interesting but, due to good contact tracing and
the patients' cooperation, the numbers available to us would be too
small. (The risks of the spread of infection in the patient and to
her contacts and children make prospective studies unethical).
Symptoms of chlamydial infection of the cervix
The ease with which chlamydiae were reisolated in 19 untreated
Liverpool women, previously, indicates the reservoir of infection
remaining in women and yet, unfortunately, 46% of women with
chlamydial infection were symptom-free which is similar to findings
in gonorrhoea (49%) in our unit. Nevertheless, the presence of any
symptoms was apparently significantly related to chlamydial infection
(X2 = 5.87, 1 d.f.*).
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However, when symptomatic genito-urinary infections such as
trichomoniasis and candidiasis were excluded, any symptoms were directly
attributable to chlamydial infection alone. In these circumstances,
51% chlamydia-positive women were asymptomatic and the presence of any
symptoms was unrelated to chlamydial infection (x2 = 2.98, 1 d.f. N.S.).
Vaginal discharge (x2 = 7.11, 1 d.f.**) and post-coital bleeding
(X2 = 3.78, 1 d.f., M.S.) alone were suggestively associated with
chlamydial infection of the cervix.
The abnormal discharge may be due to the presence of large areas
of superficial ectopy. Where no pathogens have been found, these areas,
per se, are considered responsible for excessive vaginal discharge due
to increased cervical mucus production236'237. (There was found in
this study significantly more ectopy (x2 = 6.05, 1 d.f.*) and a signi¬
ficantly higher chlamydial isolation rate (x2 =7.23, 1 d.f.**) in
the presence of a discharge, when trichomoniasis was absent).
Post-coital bleeding had not been associated with ectopy in the
Edinburgh F.P.A. study^3 and may be directly related to chlamydial
infection and the inflammation that causes. (The numbers are too
small to be significant but, in this present study, no dysplasia was
found in Ayre smears from chlamydia-positive patients with post-coital
bleeding).
Reasons for attendance
Unless, therefore, attention is attracted by obvious pathology
in their partners or babies, women's genital chlamydial infection
commonly goes unrecognised. The majority of women with chlamydial
infection reach medical attention by one of two routes (a) when the
partners of men with NGU are treated epidemiologically, with or
without chlamydial investigation, or (b) on examining the cervix of
the mothers of new-born babies with chlamydial conjunctivitis.
Long-term consequences of neonatal chlamydial conjunctivitis
Full investigation of neonatal chlamydial conjunctivitis before
giving possibly suppressive chemotherapy .(to mother or baby or both)
is even more urgently required than treatment of NGU contacts.
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(a) pelvic inflammation
The aetiological role of C. trachomatis has been established in
pelvic infection by many authors95'129 whose work was reviewed in the
introduction to this thesis.
As the Liverpool group had found previously11*5'127 and this
study has confirmed and extended, in the puerperium, the incidence of
pelvic inflammation was high in women with evidence of chlamydial
infection of the cervix. Although, apparently due to previous
chemotherapy, C. trachomatis was not isolated from the cervix in all
these women with pelvic inflammation, high antichlamydial serological
antibody levels often were present and their babies all had neonatal
chlamydial conjunctivitis. The clinical presentation was often later
than bacterial post-partum infection185 due to a long incubation
period caused by the unique intracellular developmental cycle and
the baby may draw attention to hitherto unsuspected asymptomatic
genital infection in its mother.
(b) micropannus
Neglected or incompletely treated chlamydial conjunctivitis has
been reported as leaving residual scarring as in the form of
micropannus258'11*5, but in these families, the most serious conseque¬
nces are for the mother and already compromised babies who may be
susceptible to pneumonitis1'*'7.
(c) pneumonitis
Without systemic treatment, a child handicapped by prematurity,
poor nutrition, congenital defect, the presence of other pathogens
or any other cause may develop chlamydial pneumonitis. (The aetiology
of congenital cardiac defects in babies with chlamydial conjunctivitis
was beyond the scope of this study. However, such a child was included
in this group and three others, including two with possible pneumonitis
have been encountered since. Screening all babies with cardiac defects
and their mothers, in cooperation with the paediatric unit, is to be
undertaken shortly). The radiological changes in chlamydial pneumonitis
are nonspecific and the appearance of chlamydial antibodies, normally late
in premature infants may be modified by chemotherapy. In these babies, as
with neonatal conjunctivitis, identification of the pathogen and systemic
treatment with erythromycin is necessary.
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There are two other long-term effects of incomplete care of
neonatal conjunctivitis,
(d) pharyngeal infection
Chlortetracycline eye ointment will not eradicate pharyngeal
chlamydial infection which was present in 52% babies in a later study
in our unit151*. A baby persistently shedding chlamydiae, apart from
being at risk itself, may infect the rest of the family and one
infected 18-month old sibling has been seen.
(e) fathers
The other need is to examine the father. We saw 27 of a possible
70 but, particularly where the mother was unmarried, the father often
was unknown or not available for examination. Only two of those 27
(7%) had symptoms (previously ignored) but chlamydiae were isolated
from the urethra in 9 of 27 (33%). These men would have been a source
of reinfection for the mothers.
Premature rupture of membranes
Chorioamnionitis may result from cervical infection239 and an
association between localised chorioamnionitis and premature rupture
of membranes has been reported21+0 . In the present work there was a
significantly high incidence of prematurity in babies with chlamydial
(isolate positive) conjunctivitis compared with those in whom
chlamydiae were not isolated (y2 = 6.7, 1 d.f.**), confirming our
previous results127. This was not, apparently, because these babies
had prolonged surveillance in the special care nursery, since the age
at onset of chlamydial conjunctivitis in babies with premature rupture
of membranes was no different from that in all chlamydia-positive
babies.
Prematurity is a major factor in the infant mortality rate
(60% infant deaths occur in 10% infants prematurely born) and in
neurological damage in the newborn. As an extension of this work,
mothers with spontaneous premature rupture of membranes are presently
being screened for chlamydial infection by urethral culture, sero¬
logical studies and by examination of the placenta for chlamydiae
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after delivery. Passage of a speculum to examine and take cultures
from the cervix from these women in contra-indicated before delivery
and we have found elsewhere1'1411 that in the post-natal period
urethral culture results correlate well (95%) with those from the
cervix.
Amniotic fluid
In fact, in the puerperium, no chlamydiae~ were isolated from
the cervix of 7 mothers of babies with chlamydial conjunctivitis
whose membranes had ruptured 12 hours or more before delivery.
Previous obstetric teaching recommended oral penicillin to combat
ascending infection in these circumstances but, even where no chemo¬
therapy was recorded, the discrepancy between maternal and babies'
isolation rates persisted.
The effect of amniotic fluid on the growth of chlamydiae in
tissue culture has not been recorded. Obstetricians studying intra¬
uterine infections found that whilst the foetus gradually acquires
defence mechanisms of its own, these are inadequate and the amniotic
fluid itself exhibits antibacterial activity measurable from 28 weeks
gestation. It contains lysozyme, transferrin, a low concentration of
immunoglobulin, and, a low molecular weight family of polypeptides
of potent broad-spectrum bactericidal properties241. Leakage of
liquor containing this material through the os for several hours may
affect the growth of chlamydiae on the cervix.
Caesarian section
Intrauterine infection following chlamydial chorioamnionitis
established either before or after rupture of the membranes may explain
the source of infection of some of the babies delivered by caesarian
section who had chlamydial conjunctivitis. (There were two in this
study). Others may have been indirectly infected postnatally by
their attendants. The ante-partum inoculum will be less than that
from the cervix in an intrapartum infection which may explain the
later onset of conjunctivitis in these circumstances. Of the two
babies born by caesarian section included in this study, one developed
conjunctivitis aged seven days while still in the maternity hospital
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and the other at eleven days after discharge from the hospital at
ten days.
When, however, children are born following frank spontaneous
premature and prolonged rupture of membranes, the onset of neonatal
conjunctivitis may be earlier. In both gonococcal38 and chlamydial1*8
infections children have been born with fully developed conjunctivitis.
In Liverpool, after completion of this series, a child was seen aged
24 hours with chlamydial conjunctivitis and a history that the
membranes had ruptured over eleven hours prior to delivery.
Nevertheless, it was found in this study that the mean age at
onset of chlamydial conjunctivitis in seven babies where the membranes
had been ruptured for longer than twelve hours before delivery was
6.7 days, similar to that in the group of chlamydia-positive babies
as a whole.
Finding the patients
.In summary, to reduce the incidence of chlamydial infection in
women, thorough investigation of the possible index cases, babies
with neonatal conjunctivitis and men with primary as well as recurrent
NGU, and their respective mothers and contacts is essential.
Screening for chlamydial infection by culture and serological methods
of all women with pelvic inflammatory disease or residual post-
gonococcal signs of cervical inflammation will contribute to finding
and treating the maximum number of infected women.
Chemotherapy epidemiological and ideal
It may be necessary, due to lack of resources, merely to treat
NGU contacts epidemiologically and to treat men and women with
gonorrhoea with chemotherapy effective against both gonorrhoea and
chlamydial infections. The ideal therapy would be at least as
efficacious against both as specific conventional therapy against
O J, o
each separate infection is (i.e. eradicating 95% gonorrhoeae^ in men
and 85% NGU*78) and require minimum patient compliance. No treatment
has been found to equal Lyall's results*75 from this unit with a
combination of streptomycin and sulphathiazole. However, they were
achieved in 1953 before the development of decreased sensitivity
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of N. gonorrhoeae to penicillin and subsequently to streptomycin was
reported. Even then, in nonspecific genital infections, aetiological
agents, other than chlamydiae, may not have been eradicated.
Research arising from this study
Further research, projected or already begun, into many aspects
of chlamydial infection has already been outlined in this discussion.
(a) Colposcopy
Using the colposcope, an accurate assessment of the area of
ectopy might relate to the severity of chlamydial cervicitis as
measured by the inclusion counts. The effects of age, parity and
method of contraception could then be compared and their interaction
more clearly established.
(b) Screening studies
Chlamydial infection may be an aetiological factor both in
spontaneous premature rupture of membranes and in the production of
congenital cardiac defects. Results of screening mothers and babies,
where either condition occurs, (by serological and cultural methods
for chlamydial infection) will indicate whether there is any
significant association.
(c) Tissue culture
A clinical impression was obtained that the growth of chlamydiae
on the cervix was inhibited by amniotic fluid and others' results110
suggest it might be encouraged by the presence of menstrual blood.
In vitro experiments with infected tissue culture in the presence and
absence of amniotic fluid and menstrual blood would clarify these
points.
(d) Antibody levels
Chlamydial antibody levels (local and serological) in women with
pelvic infection and in babies with neonatal conjunctivitis and their
mothers have already been examinedll+ 0; a comparison of levels in pri¬
mary chlamydial.endocervicitis and in later attacks may reveal a pattern
of altered host response.
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In three other areas, studies in cooperation with the Department
of Obstetrics and Gynaecology are planned.
(e) Dysplasia screening
No evidence of dysplasia was found in the presence of chlamydial
infection, although the numbers examined were small. Retrospective
chlamydial investigation of patients with dysplasia may define a
possible effect of chlamydial infection on cervical carcinogenesis.
(In the presence of frank carcinoma, this information would be less
valuable as the average interval between dysplasia and carcinoma is
about ten years).
(f) Electron microscopy
Using electron microscopy, in conjunction with both gynaecologists
and pathologists, the site and host cell morphology of chlamydial
inclusions will be examined in material taken by punch biopsy from a
series of patients with chlamydial infection of the cervix.
(g) Ante-natal colposcopy and screening
Finally, colposcopy and screening for chlamydial infection
studies in an antenatal clinic population will enable the manner in
which the progestational changes of early pregnancy are replaced by
metaplasia to be studied. The effects of incidental chlamydial
infection on the cervical epithelium during its most dynamic phase
may then be studied.
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ABBREVIATIONS
ARM artifical rupture of membranes
ATP adenosine triphosphate
BHK continuous (transformed) tissue culture cell line
derived from baby hamster kidney
Candida sp. Candida species
Ct Chlamydia trachomatis
CMV cytomegalovirus
D and C dilation and curettage
DEAE-dextran die thy1amino e thy1-dextran
d.f. degree(s) of freedom
DNA deoxyribonucleic acid
FPA Family Planning Association
FT full-term
GC gonorrhoea
g (acceleration due to) gravity
GP general practitioner
HeLa continuous tissue cell line derived from human
cervical carcinoma
HSV II herpes simplex virus, type II (herpes genitalis)
IF immunofluorescence
IgA, IgG, IgM immunoglobulins, classes A, G and M
im intramuscular




LGVCFT lymphogranuloma venereum complement fixation test
LGWCC logarithm of whole coverslip count
IMP last menstrual period
(LS)CS (lower segment) caesarian section
MIC minimum inhibitory concentration




























































NS - X2 (1 d.f.) < 3.841, p-> 0.05
* - X2 (1 <3.f.) ^ 3.841, p > 0.01, < 0.05
** - x2 (1 d.f.) > 6.635, p > 0.001, < 0.01
*** - X2 (1 d.f.) > 10.827, p < O.OOl
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Chlamydial infection of the cervix in contacts of
men with nongonococcal urethritis
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SUMMARY An investigation of chlamydial infection in sexual contacts of patients with
nongonococcal urethritis (NGU) was carried out to determine the clinical signs of infection in the
cervix, and their response to chemotherapy, and the incidence of cervical infection in the presence
of ectopy and oral contraception.
In 202 consecutive female contacts of NGU the isolation rate of Chlamydia trachomatis was
35%. Hypertrophic ectopy and endocervical mucopus were present in 19% and 37% of
chlamydia-positive patients respectively and, in all but one, resolved after treatment. Only 14% of
those followed up after treatment developed yeast infections. The chlamydial isolation rate was
significantly higher in patients with hypertrophic ectopy and endocervical mucopus. Cervical
ectopy and oral contraceptives acted additively, each producing a significant effect on the
chlamydial isolation rate in the presence of the other but not when present alone.
Introduction
The clinical diagnosis of nongonococcal urethritis
(NGU) in men is often arbitrary and commonly
based solely on the finding of 10 polymoiphonuclear
leucocytes per high power field (x 100 objective) in a
urethral smear with no evidence of Neisseria gonor¬
rhoeae. However, strong evidence, recently reviewed
by Schachter,1 has now accumulated for a causative
role for Chlamydia trachomatis in up to 50% of men
with NGU and for the sexual transference of this
agent.
In women, the commonest site of chlamydial infec¬
tion (as in gonorrhoea) is the cervix,2 3 the site of
greatest coital contact, but C trachomatis may also
be isolated—although less frequently—from the
rectum,4 the urethra,5 and Bartholin's ducts.6
Criteria similar to those used in the diagnosis of
NGU in men cannot be applied to cervicitis because
the endocervical secretion contains polymorpho¬
nuclear leucocytes which vary in number according
to hormonal factors and coital history. Until the
clinical signs of infection and related symptoms were
investigated in conjunction with rapid tissue culture
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procedures for chlamydial isolation (based on
methods of Gordon and Quan7) the diagnosis of
nongonococcal cervicitis in women was unsatisfac¬
tory owing to the absence of a known aetiological
agent.
The difficulties associated with interpreting clinical
signs in the cervix have previously been discussed in
detail.8 The same method of categorising the state of
the ectocervix is used here; it is based upon the con¬
cept that ectopy (erosion) is not a pathological condi¬
tion but simply ectopic columnar epithelium which
extends from the endocervix to the ectocervix.910 The
redness which is associated with such ectopy—and
sometimes thought to represent inflamma¬
tion—results from the sub-mucosal capillary bed
being viewed through a single layer of columnar
epithelium instead of many layers of squamous
epithelium. Irregularity of outline with peninsulae
and islands of squamous epithelium together with
Nabothian follicles (ducts of mucus glands blocked
by metaplastic squamous epithelium) indicates
metaplasia which is, in most cases, physiological but
may be dysplastic." When an area of ectopy is
oedematous and congested and bleeds, we have
called it "hypertrophic". This appearance was first
described as "cobblestone" by Dunlop,12 who also
reported the presence of "follicles" on colposcopical
examination of the cervix. Together with mucoid or
37
38 IAnne Tait, Elisabeth Rees, D Hobson, Ruth E Byng, and M C K Tweedie
mucopurulent endocervical discharge these two
signs, singly or combined, indicate endocervicitis.
At present there is no consistent management of
sexual contacts of men with NGU. Some physicians
refer all contacts for investigation and give treatment
to all on epidemiological grounds, irrespective of
clinical or microbiological findings. Others are selec¬
tive in both their referrals and their treatment. Many
physicians have been deterred from giving
epidemiological treatment—in the absence of symp¬
toms—as candidosis might ensue. However, women
with gonorrhoea are commonly asymptomatic and
without clinical signs. They are treated when N
gonorrhoeae is isolated because it has been establish¬
ed that failure to treat may lead to serious conse¬
quences for the patient herself and for the com¬
munity. It is therefore important that the pathogenic
role of C trachomatis in women should be defined;
(a) to establish the need for the treatment of known
infections; and (b) to provide information for
physicians who may have to manage their patients
without isolation facilities.
This paper gives the results of an investigation of
chlamydial infection in 202 women who were sexual
contacts of men with NGU with particular regard to:
(a) the incidence of clinical signs and their response
to treatment in patients from whom C trachomatis
was isolated; (b) the presence of concurrent infec¬
tion; and (c) the incidence of chlamydial infection in
patients with cervical ectopy and in those taking con¬
traceptive steroids and the possible interrelationship




The group of women examined consisted of 202 con¬
tacts of men with NGU who attended Liverpool
Royal Infirmary consecutively on specified days. All
the male contacts had been diagnosed in sexually
transmitted diseases (STD) clinics where facilities for
isolation of C trachomatis were not available.
Women who had received antibiotics in the four
preceding weeks were excluded. Known cases or con¬
tacts of gonorrhoea were also excluded as that infec¬
tion can also cause endocervicitis.
In this group of women, 169 presented with
contact slips; the remainder attended of their own
accord, or were referred by another doctor, and gave
a history that their sexual contact was attending a
male STD clinic. In these cases, the diagnosis was
always obtained from the clinic named.
Swabs for detection of N gonorrhoeae were taken
from the urethra and endocervix on at least two
separate occasions and used to inoculate a selective
medium containing antibiotics (London Analytical
and Bacteriological Media Ltd, London) and make a
smear for Gram staining. All patients were investi¬
gated for syphilis by conventional methods and for
trichomoniasis and yeast infection by inoculation of
Feinberg-Whittington medium. (Yeast infection was
only recorded if cultures gave positive results even
when clinical signs and symptoms suggesting the con¬
dition were present.) Swabs for culture for C
trachomatis were taken from the endocervical canal
and, in addition, rubbed on any ectopic columnar
epithelium as previously described.6 Swabs were not
taken from the urethra.
LABORATORY TESTS
Swabs for culture for C trachomatis were immedi¬
ately placed in 2-3 ml of transport medium13 and
stored directly at 4°C until inoculated into tissue
culture. This was usually done two to four hours
after the swab had been taken but occasionally after
storage for 24 hours.
Swab contents were thoroughly dispersed into
transport medium and 0-4 ml were inoculated on to
each of two 16-mm coverslip cultures of replicating
McCoy cells (that is, cells not pre-treated by
jc-irradiation or any anti-replicative chemical agents).
Centrifugation-assisted absorption of the inoculum
on to the McCoy cells as well as incubation condi¬
tions and method of examination of inoculated
cultures after 48-72 hours' incubation have all been
described previously.14
In all cases, the total number of intracellular inclu¬
sions of C trachomatis recovered from each clinical
specimen on the McCoy coverslip culture was
counted. The inclusions detected represent a single
cycle of development; their number therefore reflects
the number of infective particles in the original
cervical swab and is a direct measure of the number
of particles being shed from the lesion. The purpose
of this quantitative procedure was (a) to check the
sensitivity and reproducibility of the laboratory
method and (b) to have additional data against which
the severity, response to treatment, and possibility of
relapse might be assessed.
In all cases, the results represent the primary
inoculation of specimens in tissue culture. No second
passage from tissue culture to further tissue culture
was performed to avoid any risk of false-positive
results by cross-contamination.
CLINICAL SIGNS
The clinical signs were recorded on the request form
and case sheet at the time of sampling.
The state of the ectocervix has been recorded in
three categories: no ectopy, simple ectopy, and
hypertrophic ectopy (Figs 1-3). The contents of the
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fig 1 Cervix showing no ectopy.
fig 2 Cervix showing simple ectopy.
fig 3 Cervix showing hypertrophic ectopy with
endocervical mucopus. (C trachomatis isolated.)
endocervix have been recorded in three categories;
clear mucus, cloudy mucus, and mucoid or muco¬
purulent discharge (Figs 4 and 5). In examining the
cervical contents, care was taken to remove discharge
) extruding from the cervix before the contents of the
canal were assessed and sampled. Cervical secretion
spreading from the os into the vagina becomes
contaminated by vaginal flora, thus appearing
mucopurulent in some cases, whereas behind this
clear mucus may be seen in the canal.
fig 4 Cervix showing clear mucus with simple ectopy.
treatment
Routine treatment of chlamydia-positive women was
with oxytetracycline hydrochloride tablets 250 mg
six-hourly for 21 days. Pregnant women were not
given oxytetracycline but received erythromycin BP
250 mg six-hourly. Treatment was given for 21 days
as this is the longest course advised for men with
NGU and we did not want possible inadequate treat¬
ment to be a cause of persisting clinical signs or
chlamydial reisolation or both.
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fig 5 Cervix showing endocervical mucopus with simple
ectopy.
Patient compliance can be a problem with such
prolonged treatment. To assess this, blood samples
were taken for serum tetracycline estimation at 14 or
21 days in 26 women. Patients were not told in
advance that the test was to be carried out; hence the
time of venepuncture varied from two to five hours
after the last dose. The range of tetracycline concen¬
trations was 0-53-2-Olpg per ml (mean= 1 -21). This
suggests that patient compliance was good and that
the serum concentration was satisfactory (minimum
inhibitory concentration of oxytetracycline for C
trachomatis = 0 • 2pg/ml15).
FOLLOW-UP
All chlamydia-positive patients were asked to attend
for review to check whether or not candidosis had
developed and to assess the response to treatment on
day 14 (of the course of treatment), on day 28 (that
is, seven days after completion of treatment), twice
more at three-weekly intervals, and subsequently at
six weeks, a total of three months' post-treatment
observation. Several patients agreed to co-operate by
continuing to attend at three-monthly intervals and
others returned with fresh symptoms or requesting
reinvestigation within that time.
Specimens were taken for culture for C tracho¬
matis, N gonorrhoeae, Trichomonas vaginalis, and
Candida species on each post-treatment visit.
STATISTICAL METHODS
Statistical comparisons were made using the x2 test
with Yates's correction.
Results
C trachomatis was isolated from 70 (35%) of the 202
women.
AGE
The age range for all 202 women was 16-46 years
(mean 25 years); in the chlamydia-positive group it
was 16-37 years (mean 23 years).
MARITAL STATE
One hundred and ten women were single (chlamydia-
positive 36%) and 68 were married (chlamydia-
positive 28%), 23 were divorced or separated




Five patients were pregnant; two (one chlamydia-
positive) were in the first trimester, two (both
chlamydia-negative) in the second, and one
(chlamydia-negative) in the third.
Menstrual cycle
No significant difference was found in the
chlamydial isolation rates in successive weeks of the
menstrual cycle.
In those 184 women with a regular cycle of 28 days
(± 2), the month was divided into four weeks, week 1
starting from the first day of menstruation. The week
in which the swab for C trachomatis was taken was
recorded in each case. The isolation rates are shown
in Table I. In 18 (21% chlamydia-positive) the cycle
was irregular.
table i Isolation of C trachomatis in relation to the week
of the menstrual cycle
Menstrual cycle (week)
Isolation 1 2 3 4 Total
No of patients 45 66 42 31 184
Chlamydia-positive (%) 17(38) 23(35) 15(36) 9(29) 64(35)
Oral contraception
At the time of examination, 99 women (48-7%
chlamydia-positive) were taking oral contraceptives.
The methods of contraception for all 202 patients
and the distribution of these methods in relation to
chlamydial isolation is shown in Table II.
The chlamydial isolation rate was significantly
higher in women taking oral contraceptives than in
(a) those not using oral contraception (x5 = 10-44,
p = 0-0012); (b) those using barrier methods
(xf =8-51, P = 0-0035); and (c) those using other
methods, excluding barrier methods (x? =5*91,
P = 0-015).
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table m Isolation of C trachomatis in relation to method
of contraception
Chlamydia-positive
Method of No of
contraception patients No %
None 52 15 29
Oral contraception 99 46 49
Stopped oral contraception
in past month 7 3 43
Barrier 18 1 5-6
Tubal ligation and IUCD 25 5 20
Not known 1
Total 202 70 35
IUCD = intrauterine contraceptive device
Despite the difference in percentage isolation
between those using barrier methods and those using
no contraception, the difference in proportions is not
significant at 5% (x? =2-90, P = 0-089) but the lack
of significance may be due only to the small numbers
in the group using barrier methods.
SYMPTOMS
The incidence of symptoms and their distribution in
relation to chlamydial isolation is shown in Table III.
No significant difference was found in the isolation
rates in relation to any particular symptom.
table in Distribution of symptoms, appearance of the
ectocervix, contents of the endocervix, and incidence of
concurrent infections in relation to isolation of C
trachomatis
No
No of chlamydia- % of
patients positive positive
Symptoms*
None 103 34 49
Discharge 61 22 31
Irritation and soreness 31 17 24
Urinary 24 11 16
Abdominal pain 17 5 7
Postcoital bleeding 3 1 ' 1-4
Dyspareunia 3 2 3
Appearance of ectocervix
No ectopy 95 21 30
Simple ectopy 87 36 51
Hypertrophic ectopy 17 13 19
Not known 3 0 0
Total 202 70 100
Endocervical contents
Clear 101 27 39
Cloudy 56 14 20
Mucopus and mucoid 35 26 37
Blood 10 3 4
Total 202 70 100
Concurrent infections
None 110 40 57
Candida spp 61 16 23
Trichomonas vaginalis 15 10 14
Warts (cervical and vulval) 10 4 6
Other 0 0 0
Total 70 100
*Patients may have had more than one symptom
CLINICAL SIGNS
Ectocervix
The appearance of the ectocervix in relation to the
chlamydial isolation rate is shown in Table III. The
isolation rate was significantly higher in those with
(a) ectopy (simple and hypertrophic), 47%
(xJ = 12-5, P = 0-0004); (b) simple ectopy, 41%
(xi =6-97, P = 0-0083); and (c) hypertrophic ectopy,
76% (xJ = 17-67, P = 0-000026) than in those with no
ectopy, 22%.
Endocervical contents
The distribution of contents in relation to the
chlamydial isolation rate is shown in Table III. The
isolation rate was significantly higher in those with
mucopus (74%) than in those with clear and cloudy
mucus (26%) (x? =27-14, P = 0-0000045).
Salpingitis
Seventeen patients complained of abdominal pain or
discomfort (five were chlamydia-positive). Only four
of these had clinical signs of salpingitis (two were
chlamydia-positive.)
EFFECTS OF ORAL CONTRACEPTION/CERVICAL
ECTOPY ON CHLAMYDIAL ISOLATION
To assess the possible interrelationship between oral
contraception and cervical ectopy, both of which
individually were found to be highly significant in the
isolation of C trachomatis, the four possible
categories were compared and analysed statistically
(for this purpose simple and hypertrophic ectopy
were combined) (Table IV):
(1) The isolation rates in patients with (57-1%)
and without (30-2%) oral contraception in the
presence of cervical ectopy (x? =6-06, P = 0-014);
(2) The isolation rates in patients with (57-1%)
and without (27-3%) ectopy in those taking oral
contraception (x? =6-3, P = 0-012);
(3) The isolation rates in women with (27-3%) and
without (16-4%) oral contraception in the absence
of ectopy (x\ =0-97, P = 0-32);
(4) The isolation rates in patients with (30-2%)
and without (16-4%) ectopy in the absence of oral
contraception (x?=2-06, P = 0-15).
Thus neither oral contraception in the absence of
ectopy, nor ectopy in the absence of oral contracep¬
tion, is associated with a significant increase in the
isolation rate. On the other hand, a significant
increase is associated both with oral contraception
when ectopy is present and with ectopy when oral
contraception is being used. Oral contraception and
ectopy may be said to act additively, neither being
associated with a significant increase in the isolation
rate when acting alone but jointly being associated
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with a significant increase when acting simul¬
taneously.
The isolation rates in the above categories (Table
IV) differ to a very highly significant extent
(Xj =22-95, P = 0-000041).




Comparison patients No %
Ectopy 99 45 45-5
With OC 56 32 57-1
Without OC 43 13 30-2
No ectopy 94 19 20-2
With OC 33 9 27-3
Without OC 61 10 16-4
Total
With OC 89 41 46-1
Without OC 104 23 22-1
OC = oral contraception
CONCURRENT INFECTIONS
The presence of concurrent infection in relation to
chlamydial isolation is shown in Table III. Only
normal flora was found in only 110 patients (35%
chlamydia-positive). A significant increase in the
isolation rate was found only in the presence of
T vaginalis (x] =5-89, P = 0-15). Ngonorrhoeae was
present in seven patients, of whom three were
chlamydia-positive at the time of their first visit.
WHOLE-COVERSLIP COUNT (WCC)
The range for the 70 chlamydia-positive patients was
1-100 000 inclusions per whole coverslip. The
possibility that the degree of infection (as represented
by the WCC) may vary according to conditions such
as the presence or absence of oral contraception and
clinical signs in the cervix was considered. The mean
counts of the WCC in these conditions are given in
Table V.













Thirty-eight women were followed up for 2-14
months. C trachomatis was reisolated from five
patients (Table VI) and there was a strong possibility
of reinfection in four of the five cases.*





















Two reisolates from one patient
Clinical signs
Ectocervix. Of 12 patients with hypertrophic ectopy,
11 reverted to simple ectopy and metaplasia was com¬
plete in one.
Contents of the os. Of those patients followed up
after treatment, of 20 endocervices previously con¬
taining mucopus, eight became clear, 11 became
cloudy, and one contained mucoid material.
Yeast infection
Of 70 chlamydia-positive patients, 16 had positive
cultures for Candida species when the chlamydial
infection was diagnosed; twenty-five patients who
had negative results for yeasts initially did not attend
for follow-up investigations. Of the remaining 29
chlamydia-positive women with negative results for
yeasts, who were treated either with tetracycline
hydrochloride or erythromycin (two), four (14%) (all
taking tetracycline) developed yeast infection.
Discussion
C trachomatis was isolated from 35% of the 202
female sexual contacts of unselected men with NGU.
Isolation rates of 22-42%3 l6'18 have previously been
reported in different parts of the world. Differences,
*Details of personal case histories may be obtained from
Dr I A Tait.
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however, occur in the reporting of clinical signs in the
cervix associated with chlamydial infection. Signs of
cervicitis have been recorded in 62-89%17 19 20 but
were also present in 58% of uninfected women who
were contacts of NGU17 and in 56% of control
women attending a family planning clinic.20
However, cervical ectopy (erosion, cervical discon¬
tinuity) was included as an abnormal clinical sign in
all these reports and may account for these
differences.
The site of the squamocolumnar junction is laid
down at the time of organogenesis and ectopy is
found in infants, children, and virgins.9 At certain
times, particularly at puberty and first pregnancy,
the ectopic columnar epithelium is replaced by
squamous epithelium (squamous metaplasia, Fig 6)
with the result that ectopy is less common in the older
woman.9 In a study planned to determine the
prevalence and significance of cervical ectopy in
women attending family planning clinics in
Edinburgh, ectopy was found in 37% of 1400 women
and was significantly associated with younger age
groups, greater parity, and oral contraception.21
There was no significant association with the
presence of aerobic or anaerobic bacteria, T
vaginalis, or yeasts.
If signs of cervicitis are narrowly defined on
macroscopic examination as endocervical pus within
the canal and oedema of the areas covered by
columnar epithelium (hypertrophic ectopy or
cobblestone appearance as described by Dunlop)12
there is a highly significant association between
cervicitis and the isolation of C trachomatis. In this
series of consecutive cases, mucopus was found in
37% of chlamydia-positive cases compared with 7%
of chlamydia-negative cases (P = 0-0000045), and
oedema (hypertrophic ectopy) in 19% of chlamydia-
positive compared with only 3% of chlamydia-
negative cases (P = 0-000026). The incidence of
endocervical mucopus is similar to that found in
women with chlamydia-negative gonorrhoea
examined in this unit. In each infection, macrosopic
evidence of the endocervical infection is absent in
50-60%. After treatment of the chlamydial infection,
clinical signs of oedema and mucopus disappeared in
all but one patient.
Symptoms associated with endocervicitis are
difficult to interpret because the area of susceptible
columnar epithelium, and therefore the consequent
amount of mucopus which may be produced, is
relatively small. Excessive mucus production by the
cervical columnar epithelium due to the pro¬
gestational effect of contraceptive steroids, or due to
a large area of ectopy, may result in a discharge
which is not associated with infection of any kind. In
addition, even a mild vaginitis due to common
vaginal pathogens such as T vaginalis or yeasts may
result in a noticeable discharge owing to the large
area of squamous epithelium of the vagina affected.
Consequently, symptoms may bear little relation¬
ship to cervical pathology in a large number of
women. In this series, no significant relationship was
found between the presence of chlamydial infection
in the cervix and any of the symptoms. Similar
findings have been reported by others.20 22 23 Indeed
Burns et a/16 reported a significant absence of
symptoms in the presence of chlamydial infection.
However, Paavonen et a/19 found chlamydia-positive
gynaecological patients had significantly more ocular
and urethral symptoms than chlamydia-negative
patients.
Thus, C trachomatis infection appears to be
associated with certain well-defined signs of cervicitis
in some patients and probably these signs are caused
by that infection. On the other hand, with ectopy
there is also a definite relation to chlamydial infec¬
tion but, for reasons already discussed, simple ectopy
cannot be considered to be part of the sign-complex
of cervicitis. It seems possible that ectopy may be one
of many possible interrelated factors which allow
infection to be more easily acquired. For example,
the virulence of particular serotypes of chlamydia,
the immune status of the patient, and anatomical and
histological variations may all influence the ease with
which infection of the tissues is established.
Harkness24 found a higher prevalence of hypospadias
fig 6 Cervix showing metaplasia and simple ectopy with
clear mucus.
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(a condition in which columnar epithelium extends to
the external urethral surface since the fossa
navicularis is absent) in patients with NGU and
gonorrhoea than in the normal population. Cervical
ectopy may have a similar effect in chlamydial infec¬
tion and may be more important than in gonorrhoea
because of the intracellular developmental cycle of
chlamydia.
Our findings indicate that only in patients in whom
the two factors, contraceptive steroids and ectopy,
are present is there a significant increase in the
isolation rate of C trachomatis (p = 0-00004). Neither
factor in the absence of the other is significant. Apart
from an implied absence of any barrier to infection
of the cervix, oral contraceptive steroids may
facilitate cervical infection by their progestational
effect, which is similar to that produced in the first
trimester of pregnancy. They produce an excessive
outflow of alkaline mucus from the endocervical
glands and increase the bulk of the cervix, producing
eversion with further ectopy. It is noteworthy that
steroids added to McCoy tissues cultures infected
with C trachomatis increase the size and number of
inclusions developing.25
The interdependence of several varying factors
may explain some of the disparity about the effect of
oral contraceptives on the chlamydial isolation rate
previously reported.16 17 20 23
Like Oriel et al,23 but unlike Hilton et al,20 we
found no variation in the isolation rate according to
the week of the menstrual cycle.
The increased chlamydial isolation rate in the
presence of T vaginalis may reflect the frequency
with which multiple sexually transmissible agents are
isolated in promiscuous patients.26 Others have
found no relation between the chlamydial isolation
rate and any other concurrent nongonococcal infec¬
tion.23
The mean whole-coverslip counts were raised in
patients taking oral contraceptive steroids and in the
presence of endocervical mucopus but not in the
presence of hypertrophic ectopy. It is possible that
oral contraceptive steroids facilitate chlamydial
cervical infection, and the presence or absence of
endocervical mucopus indicates the severity of the
infection, whereas hypertrophic ectopy merely
indicates a general host-response to infection in some
patients. The possible influence of these clinical
factors on the degree of chlamydial replication in
infected women will be discussed separately.
In addition to causing acute cervicitis C
trachomatis has been isolated from the fallopian
tubes in cases of pelvic inflammatory disease con¬
firmed at laparoscopy and associated with a four¬
fold rise in chlamydial antibody titre.27 Clearly, it is
potentially a serious pathogen in women.
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Quantitative aspects of chlamydial infection of the
cervix
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Liverpool Hospital, Liverpool
SUMMARY In 580 women with Chlamydia trachomatis infection of the cervix, the degree of the
infection was assessed by counting the number of chlamydial inclusions which developed in
McCoy cell monolayers inoculated with cervical swab material under standardised conditions.
In 34% of these women inclusion counts were <100 per monolayer whereas in 36% the counts
were ^1000. Clinical features in each of these groups were compared to see if certain factors could
be identified as the cause, or the result, of high-grade rather than low-grade infection.
A significant association was found between high inclusion counts and the presence of cervical
mucopus or cervical ectopy. Oral contraceptives acted additively with ectopy but had no signifi¬
cant effect alone. Concurrent gonorrhoea did not affect the degree of chlamydial infection. High
inclusion counts were more common in women under 20 years of age than in older women.
Introduction
Over the past five years, our combined clinical and
laboratory investigations of women with genital tract
infections with Chlamydia trachomatis have shown
large variations between individual infected patients,
both in the number and severity of clinical signs' and
in the number of chlamydial inclusions obtained
from cervical swabs inoculated into McCoy cell tissue
cultures.2 In a group of 202 sexual contacts of men
with nongonococcal urethritis (NGU), women who
had cervical mucopus, or those who had cervical
ectopy and were also using oral contraceptives,
showed a significantly higher prevalence of
chlamydial infection than did women without these
clinical features.3 It seemed of interest to determine if
these or other clinical factors might be correlated not
only with a high rate of infection but with a more
severe infection than in women in whom these factors
were absent.
In McCoy cell tissue cultures infected with C
trachomatis only a single cycle of development of the
agent occurs, and each intracellular inclusion found
after incubation represents a single infective
chlamydial particle in the original inoculum. Thus,
when standard amounts of material from cervical
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swabs are inoculated and incubated under constant
conditions in coverslip monolayers of McCoy cells
the final total number of inclusions found over the
whole cell sheet should give a direct quantitative
measure of the number of infective chlamydial
particles in the cervical secretions of each patient.
The sensitivity and reproducibility of the
laboratory method we have used has been
investigated previously;2 4 for example, in 48 McCoy
cultures inoculated with a single sample of C
trachomatis the counts on individual coverslips
varied from the mean by a maximum of only ±23%,
and, when a second swab was taken seven days after
the first swab from 106 untreated infected women,
the inclusion counts were of the same magnitude in
both swabs in 92-5% of cases. Thus, the wide varia¬
tions in inclusion counts we had observed between
patients might be the result of differing degrees of
infection in the cervical mucosa in individual
patients.
The aim of this study was to see if certain clinical
factors might be caused by, or be the cause of, high-
grade rather than low-grade infection. In particular it
seemed essential to consider (a) the physical state of
the cervix—that is, whether or not mucopus or
ectopy were present; (b) hormonal effects on cervical
epithelium—that is, whether or not the patient was
using oral contraceptives; (c) if chlamydial infection
might be enhanced opportunistically by concurrent
infections, especially gonorrhoea; and (d) the age of
the patient.
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Accordingly, clinical and laboratory data were
compared in the total of 580 women from whom C
trachomatis had been isolated in this laboratory
between January 1975 and December 1978. This
series excludes only women with postpartum
infection and those who had recently received
antibiotic treatment, but it was not restricted to
women with a definite history of sexual contact with




The 580 women consecutively found to have
chlamydial infection on laboratory examination were
all patients attending the sexually transmitted disease
(STD) clinics at the Liverpool Royal Infirmary or the
Royal Liverpool Hospital or who had been referred
to the Liverpool Women's Hospital from various
sources because of suspected genital tract infections.
Only women whose infections were first diagnosed in
the puerperium, or who had been given chemothera-
peutic agents within the previous four weeks, were
excluded.
Clinically, the group consisted of 70 women from a
consecutive series of sexual contacts of men with
NGU, whose clinical findings have been compared
with those of contacts without chlamydial infection,3
together with 49 infected women examined in a con¬
secutive unselected series of patients attending a
single STD clinic of the Royal Infirmary on specified
days (Davies et at, unpublished data).
The remaining 341 women were not seen con¬
secutively in the clinics; in fact, they had often been
deliberately selected for laboratory investigation
because they did show certain clinical signs of genital
infection, or because they were contacts of men with
NGU or with gonorrhoea, or for various other
reasons which made it important to confirm or
exclude chlamydial infection in their differential
diagnoses and to assess its severity if present. This
element of clinical selection does not affect the pro¬
posed correlation of laboratory findings with the
clinical features presented by the patients, since the
investigation is based on the laboratory's total
number of chlamydia-positive specimens, unselected
and completed in advance of the clinical data being
known. Obviously, the proportion of women with
such features as cervical mucopus, cervical ectopy, or
concurrent gonorrhoea cannot be taken as com¬
parable with that in clinically unselected patients seen
consecutively in studies designed for clinico-
epidemiological purposes.13
CLINICAL EXAMINATION
Examination of the patients' clinical signs was made
and recorded in the standardised pattern described
earlier.3
COLLECTION OF SPECIMENS
Swabs for chlamydial isolation were taken only by
medical staff of the clinic experienced in the
standardised technique previously described,5 which
ensures that both the contents of the endocervical
canal and the whole of any area of ectopic columnar
epithelium present are sampled.
Swabs for Neisseria gonorrhoeae isolation and
investigations for syphilis, trichomoniasis, or yeast
infections were performed on all patients as
previously described.3
LABORATORY INVESTIGATIONS
The procedures for the isolation of C trachomatis
and subsequent counts of the total number of
chlamydial inclusions recovered have been previously
described in detail.24"6 Briefly, particular attention
was paid to the quantitative reproducibility of the
isolation procedure—for example, immediate immer¬
sion of the swab into fluid transport medium, rapid
transport to the laboratory and inoculation usually
2-4 hours after the swab was taken but occasionally
after overnight storage at 4°C, followed by inocula¬
tion of a standardised amount of homogenised swab
material with centrifuge-assistance on to McCoy cell
coverslip monolayers of constant age and cell
density. For the first 260 swabs, untreated McCoy
cells were used, but cells treated with cycloheximide
were used for the final 200 specimens, and both
methods were used simultaneously for the remaining
120 specimens. Cycloheximide treatment has been
adopted because chlamydial inclusions can be
identified more rapidly and easily than in fresh cells;
the total number of inclusions recovered was
consistently higher in treated cells, but rarely by more
than twofold, so that the log frequency distribution
of counts did not vary significantly between the two
methods.
In all cases, the inclusion counts recorded repre¬
sent the primary inoculation of the first cervical swab
to be taken from each patient during her attendance
in the clinic. All swabs were allocated serial
laboratory numbers, and isolation and inclusion
counting procedures were completed before the
patient's identity and clinical features were reviewed
in the laboratory.
STATISTICAL METHOD
The x2 test was used for statistical comparison.
Results
INCLUSION COUNTS AND CLINICAL FEATURES
The wide range of inclusion counts found on culture
of the primary cervical swabs for the whole group of
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table i Distribution ofchlamydial inclusion counts and clinicalfactors in 580 women with C trachomatis infection of the
cervix
iwc No of women
% of women* with positive clinical factor
Mucopus Ectopy OC Gonorrhoea Aged <20 years
<10 84 36 58 49 38 23
10 + 112 36 63 50 35 24
100 + 178 44 67 54 44 26
1000 + 133 69 79 62 44 35
10 000 + 73 66 75 66 34 40
Total No
of women 580 290 402 306 232 168
iwc = No of inclusions per whole coverslip McCoy culture inoculated with cervical swab material
OC = Oral contraceptives
*In each inclusion-count group
580 women is shown in table I. Although the counts
ranged from only one inclusion per whole coverslip
(iwc) to >75 000 they showed a substantially normal
distribution with a median count of 450 inclusions;
476 (85-5%) of the swabs yielded >10 iwc and 207
(36%) gave >1000 iwc.
The distribution of the main clinical factors is also
outlined in table 1. The overall incidence of
mucopus, ectopy, and gonorrhoea was high, as was
to be expected by the clinical selection of these
women. Nevertheless, certain clinical factors were
not uniformly distributed among the whole group.
The greater the inclusion count, the greater was the
proportion of patients who were under 20 years of
age, showed cervical ectopy or mucopus, or were
taking oral contraceptives. There did not however
seem to be any significant correlation between the
height of the inclusion count and concurrent
gonorrhoea.
These observations suggest that the degree or
severity of infection in the cervical mucosa varied
according to the presence or absence of certain
clinical factors affecting the cervix. To evaluate their
table n Distribution of clinical factors in relation to low
or high inclusion counts
No of women with inclusion counts
Clinical Low High
factor (<100 iwc) f>1000 iwc) Total
Mucopus + 70 140 210
- 126 67 193
Gonorrhoea + 64 79 143
- 132 128 260
Ectopy + 120 160 280
- 76 47 123
Oral
contraception + 94 130 224
- 102 77 179
Age (years) <20 38 76 114
>20 158 131 289
Total (%) 196 (34) 207 (36) 403
interactions more precisely the clinical features of
women at the opposite ends of this frequency distri¬
bution of inclusion counts—that is, those with low
counts of <100 iwc and those with high counts of
>1000—were compared (table II).
Cervical mucopus/concurrent gonorrhoea
The amount of chlamydial growth in the cervical
mucosa was significantly greater in women with
mucopus than in those without (table II; xi = 41 • 1,
P<0-001). A heavy chlamydial infection could be the
actual cause of the mucopus but alternatively some
other clinical factor could be the cause of both the
mucopus and the high chlamydial count. For the
latter reason, the fact that 143 (35%) of the 403
women had gonorrhoea concurrently with their
chlamydial infection had to be taken into account.
Gonorrhoea itself is obviously a common cause of
cervical mucopus and chlamydial infection might
possibly be enhanced opportunistically in tissues
already being damaged by N gonorrhoeae.
However, high chlamydial counts were not signifi¬
cantly more frequent in women with associated
gonorrhoea than in women with chlamydial infection
alone (xf = 1- 33, P>0-1) (table II). Furthermore, the
table ill Prevalence of cervical mucopus in relation to
inclusion counts in women with or without concurrent
gonorrhoea
























+ Present - absent
iwc = inclusions per whole coverslip (10 mm diam)
+ Present - absent
iwc = inclusions per whole coverslip (10 mm diam)




association between mucopus and high chlamydial
counts was not dependent on a concomitant infection
with N gonorrhoeae, as was shown by evaluating
separately the data in the groups of women with and
without gonorrhoea (table III).
Mucopus was present in a high proportion of all
the women studied (210/403, 52%); this could be
partly due to the clinical selection of the cases before
referral for laboratory diagnosis. However, the pro¬
portion of cases with mucopus was similar in women
with chlamydial infection alone (127/250, 65%) and
in chlamydia-positive women with concurrent gonor¬
rhoea (83/143, 70%) (x5 =3-13, P>0-05). Moreover,
there was a significant association between the
presence of mucopus and high inclusion counts
whether or not the woman had a chlamydial infection
alone (x? =23-36, P<0-001) or concomitant gonor¬
rhoea (x? = 17-14, P<0-001).
Cervical ectopy/oral contraceptives
When these clinical factors were considered separ¬
ately (table II) each showed a significant association
with the height of the inclusion count. There was
little difference between simple ectopy or hyper¬
trophic ectopy in relation to inclusion counts and
both have been combined for statistical analysis.
Because of the clinical selection cervical ectopy was
present in over two-thirds of the 403 women studied
(table II). However, 57% of these women had high
inclusion counts compared with 38% of women
without ectopy (x? = 12-3, P<0-001). Oral
contraceptives were being used by 56% of the 403
women and 58% of these patients had high inclusion
counts compared with 43% of women not taking oral
contraceptives Od =8-98, P<0-01).
However, cervical ectopy and oral contraceptives
were obviously not independent variables, since only
106 (38%) of the 280 women with ectopy were not
taking oral contraceptives and only 50 (22%) women
using oral contraceptives did not have cervical
ectopy. In fact, the association between the use of
oral contraceptives and the presence of ectopy was
highly significant (x? =47-08, p<0-001); thus these
two clinical factors probably interact in their effect
table iv Interaction of cervical ectopy, oral contraceptives, and inclusion counts
on the height of the inclusion count, as they have
previously been shown to affect the incidence of
chlamydial infection.3 To assess this interaction, the
four possible combinations of the two factors were
further analysed (table IV):
1. In patients without cervical ectopy, high counts
were found in 32% of women not taking, and in
48% of women taking, oral contraceptives. The
effect of oral contraceptives alone was not signifi¬
cant (x5 =3-42, p>0-05).
In patients with cervical ectopy, high counts were
found in 51% of women not taking, and in 61%
of women taking, oral contraceptives. The effect
of oral contraceptives alone was not significant
(X? =2-67, P>0-1).
In patients with oral contraceptives, high counts
were found in 48% of women without ectopy and
in 61% of women with ectopy. The effect of
ectopy alone in these women was not significant
(X? =2-66, P>0-1).
In patients without oral contraceptives, high
counts were found in 32% of those without
ectopy and in 51% of those with ectopy. This
effect of ectopy alone was significant (x? =6-67,
P = 0-01).
When the patients with neither ectopy nor oral
contraceptives were compared with those with both
ectopy and oral contraceptives, the difference in the
proportion of cases with high inclusion counts, 32%
and 61% respectively, was significant (x? = 17-8,
PCO-001).
These results suggest that ectopy and oral con¬
traceptives acting jointly are likely to be associated
with high chlamydial counts and that ectopy alone
can result in high counts even if the ectopy has not
been produced by, or the cervical mucosa has not
been acted upon by, oral contraceptives. The effect
of oral contraceptives on chlamydial counts appears
to be indirect by way of its capacity to produce
ectopy. When these possible effects are discounted,
by dividing the women into groups (table IV), oral
contraceptives appear to have no significant direct
effect on the degree of chlamydial infection.







_ _ 50 23 73 32
- + 26 24 50 48
+ — 52 54 106 51
+ + 68 106 174 61
Total 196 207 403
+ Present - absent
iwc = inclusions per whole coverslip (10 mm diam)
OC = Oral contraceptives
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Age factor
Of the total of 403 women with chlamydial infec¬
tions, 114 (28%) were under 20 years of age (table
II); of these, 76 (67%) had high inclusion counts
compared with 131 (45%) of the 289 women over 20
years of age (xi = 14-9, P<0-001).
Despite this significant difference in the degree of
infection between the under-20 age group and older
women, no significant differences emerged in any of
the other clinical features (table V).
Other clinical features
There were 119 women with one or more previous
children and 22 pregnant women in the group
examined; 36 women had associated trichomonal
infections, 89 were infected with yeasts, and 31 had
signs or symptoms suggesting salpingitis. There was
no evidence that the frequency of high chlamydial
counts was greater in these women than in women
without these clinical features. However, the small
numbers limit conclusive statistical analysis.
No significant difference was found in the propor¬
tion of women with high inclusion counts in suc¬
cessive weeks of the menstrual cycle. In the group of
403 women studied, 22 were pregnant, 32 had
irregular periods or amenorrhoea, and in 20 the date
of the last period was not recorded. In the 329 (82%)
women with a regular cycle of 26-30 days, the month
was divided into four weeks starting from the first
day of menstruation, and the cycle-week in which the
primary cervical swab for C trachomatis isolation
was taken was recorded against the inclusion count
obtained on culture (table VI).
Discussion
Current tissue culture methods for isolating C
trachomatis from cervical swabs of infected women
provide a quantitative means of monitoring the
reproducibility and sensitivity of the procedures
themselves in continued diagnostic use24 and of
detecting differences in the degree of infection
between individual patients, since the number of
inclusions which develop in McCoy cell culture is
directly proportional to the number of viable
chlamydial elementary bodies inoculated into the
culture.7
table v Distribution of clinical features in relation to age
% of women




Oral contraceptives 52 57
In the present series of 580 women with chlamydial
genital infections from whom a primary cervical
swab was taken for laboratory culture before they
had been given chemotherapeutic agents, the inclu¬
sion counts were normally distributed with a median
value of 450 iwc, but the range of counts obtained
was wide, with 73 (13%) of the group having counts
of ^10 000 iwc whereas 84 (14%) had counts of <10
iwc. When the inclusion counts in the individual
patients were related to the clinical features found at
the time the swab was taken, the degree of infection
(indicated by the inclusion count) apparently varied
according to the presence or absence of cervical
mucopus or ectopy, the use of oral contraceptives,
and the age of the patient.
The increase in inclusion counts in women with
cervical mucopus may be due to the following: (a) the
greater the amount of secretion in the cervical canal
the greater is the amount that might be collected on
the swab, and hence the greater the number of
elementary bodies available to infect the McCoy
coverslip culture; (b) the presence of mucopus might
non-specifically enhance the sensitivity of McCoy
cells to chlamydial infection, resulting in a higher
proportion of the potentially infective particles
inoculated successfully forming inclusions in McCoy
cells; (c) mucopus may be merely an indicator of
another concurrent infection, especially gonorrhoea,
which might be capable of enhancing the chlamydial
infection—that is, C trachomatis might thus show
the characteristics of a secondary opportunistic
invader; and (d) mucopus might in fact be the direct
result of chlamydial infection and thus occur most
frequently in those with the greater degree of infec¬
tion, as indicated by the inclusion count.
In our experience the thick tenacious nature of the
mucopus often results in rather less than more
cervical secretion being obtained per swab and limits
the amount of homogenisation of material from the
swab before tissue culture inoculation. Suspensions
of cervical mucopus from patients with STDs but
without current chlamydial infection are slightly but
consistently inhibitory to the growth of laboratory
strains of C trachomatis in McCoy cultures (Hobson
and Lee, unpublished data).
table vi Inclusion counts in relation to menstrual cycle
Week of cycle*
I 2 3 4 Total
No of patients 60 112 79 78 329
No with high count (>1000 iwc)-f 31 60 40 42 173
% with high count 52 54 51 54 53
*At the time of primary cervical swab
■f Inclusion count in primary cervical swab
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Concurrent infection with trichomonads, yeasts,
or N gonorrhoeae appeared to have no effect on the
degree of chlamydial infection. It is interesting
however that women with gonorrhoea have pre¬
viously been found89 to have a higher rate of
chlamydial cervical infection than have contacts of
men with NGU or attenders of STD clinics without
gonorrhoea. This incidence may be increased because
coincidental infections in the more promiscuous
STD clinic patients, who must frequently be exposed
to both types of infective agent, are highly likely
rather than because gonorrhoea predisposes to or
stimulates a previously latent or low-grade
chlamydial infection. Furthermore, women who had
concomitant infections did not develop mucopus
more frequently than did women with chlamydial
infections alone; in both groups the presence of
mucopus was associated with high chlamydial
inclusion counts. These results thus suggest that the
presence of mucopus in a woman with gonorrhoea
may, in certain cases, be the result of an associated
chlamydial infection rather than due to the
gonococcal infection alone.
There is a highly significant association between
the chlamydial isolation rate and the incidence of
cervicitis in contacts of men with NGU,310 and treat¬
ment of the chlamydial infection is quickly followed
by disappearance of mucopus.3 The present results
support and extend these findings—that is, C
trachomatis can cause endocervicitis and the greater
the degree of infection the more likely are the signs of
endocervicitis to be present.
In contacts of men with NGU seen in Liverpool3 a
higher rate of chlamydial infection was found when
both cervical ectopy and contraceptive steroids were
present than when either occurred alone or when
neither was present. All the infected women from this
smaller study group3 are included in the present
larger and more varied series, which shows that not
only the incidence but also the degree of chlamydial
infection was greater in women with ectopy and con¬
traceptive steroids than in women with neither. Oral
contraceptives alone did not appear to have any in¬
fluence on the degree of infection but, in contrast,
the inclusion counts were significantly higher in those
with ectopy alone—even in the absence of oral con¬
traceptives—than in women without ectopy. Since
the site of the squamo-epithelial junction is deter¬
mined during fetal life," infection with C
trachomatis cannot be a cause of cervical ectopy,
although infection may convert a small area of
simple ectopy to a larger area of hypertrophic ectopy
as a result of oedema and congestion.3
The most likely explanation of the significant
association between the presence of ectopy and both
an increased rate of infection3 and an increase in the
degree of that infection demonstrable in tissue
culture is simply that the greater the area of columnar
epithelium exposed on the vaginal aspect of the
cervix the greater is the chance that infection will be
acquired after coitus with an infected man, the
greater is the number of susceptible columnar cells
available for progressive growth cycles of the
infective agent, and the greater is the area that can be
sampled by taking swabs.
The role of oral contraceptives is more difficult to
determine and is almost certainly multifactorial. The
frequency and size of cervical ectopy is itself in¬
creased by the use of contraceptive steroids,1213 and
thus the chlamydial inclusion count is likely to be
significantly increased if oral contraceptives are con¬
sidered overall, but much of this increase may be the
result of the ectopy associated with the use of oral
contraceptives and not uniquely due to the drugs.
However, oral contraceptives may possibly also have
direct hormonal effects on columnar epithelium in
vivo which increases the chance that a highly produc¬
tive infection with C trachomatis will develop.
Contraceptive steroids have a progestational effect,
producing a large outflow of alkaline mucus from the
endocervical glands.12 The addition of steroids to
McCoy cell cultures increases their susceptibility to
infection with laboratory strains of C trachomatis,
resulting in an increase in the number of infective
progeny produced by the inoculation of a given
number of elementary bodies.14 Thus, as suggested
by the present findings, the hormonal effects of oral
contraceptives would be seen most clearly when
acting in conjunction with cervical ectopy, especially
since the action of these steroids increases the bulk of
the cervix and produces eversion.12 However, in the
present series of women there was no significant
association between the height of the inclusion count
and other hormonal influences, either in the normal
menstrual cycle or in pregnancy, although a much
larger series of women would need to be examined to
confirm the latter.
A further feature needing more extensive investiga¬
tion is the highly significant association between the
age of the patient and the degree of her infection in
the present series of women. This association might
possibly reflect anatomical and physiological,
including hormonal, differences between women
under 20 years of age and older women, but the
present findings do not suggest that the increased
inclusion counts are the results of a greater use of
oral contraceptives or of a greater frequency of
cervical ectopy than in women between 21-45 years of
age. However, the exact area of ectopy was not
measured in these women. The size of cervical ectopy
diminishes with age owing to metaplasia, whereby
columnar epithelium is gradually replaced by
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squamous epithelium, and this process is often
initiated at puberty or in the first pregnancy." Thus,
possibly the area of ectopic columnar cells, rather
than the frequency of ectopy, may vary between
young and older women to influence their differing
degrees of chlamydial infection.
It is also possible that this age difference may have
an immunological basis. In girls aged between 14-20
years a greater proportion of the infections are pro¬
bably the first chlamydial infections to which they
have been exposed than is the case in older women
with a longer period of sexual activity. Thus, the
replication of C trachomatis may be less likely to be
brought quickly under control by humoral or cervical
antibody or by cell-mediated immune responses in
young women than in older women with a greater
chance of previous immunological experience.
Humoral antibody against C trachomatis is frequent
and persistent in women attending STD clinics and its
frequency increases with age.15"17 Although it is not
yet clear that antibody acquired by previous
experience will prevent infection, the possibility that
it might modify the degree of infection and hence the
clinical signs associated with high-inclusion count
infection merits further study.
This work was supported by a project grant from the
Medical Research Council.
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Urethral Syndrome Associated with Chlamydial
Infection of the Urethra and Cervix
Case Report
A 21-year-old single girl gave a 3-year history of
recurrent increasing frequency and dysuria. She took
oral contraceptives and had been treated for gonorrhoea
in 1972. There was no significant bacteriuria or pyuria.
Ail other investigations were normal. Cystoscopy
revealed only intense urethritis with some basal cystitis.
At the Department of Sexually Transmitted Diseases,
oedema of the length of the urethra was palpated
through the anterior vaginal wall and discharge was
expressed on massage (Fig.). A large hypertrophic
erosion and endo-cervical mucopus were found.
Chlamydia trachomatis was isolated from the urethra
and cervix and all other microbiological investigations
were negative.
After 21 days oxytetracycline (250 mg 6-hourly) she
became symptom-free. The urethral oedema and dis¬
charge were minimal, clear mucus was present in the
endocervix and the oedema and congestion of the
cervical erosion had disappeared, i.e., the hypertrophic
erosion had become simple. Follow-up cultures for
chlamydia remained negative for a year. Urethral
Fig.
Chlamydia trachomatis culture from her consort was
negative due, possibly, to recent antibiotic therapy.
Comment
Chlamydia trachomatis has been isolated from
50% of men with non-gonococcal urethritis and
in one-third of their female partners (Hilton et
al., 1974). Its possible role in prostatitis, epidi¬
dymitis and salpingitis has not yet been evaluated.
Dunlop et al. (1972) reported the first isolation
of chlamydia from the female urethra in a patient
who was examined because her husband had a 6-
month history of chlamydial kerato-conjunctivitis.
She had recurrent dysuria and frequency. The
association of chlamydial infection of the cervix
with hypertrophic (oedematous and congested)
erosion and endocervical mucopus has been
reported (Rees et al., 1977).
This case is of interest in that co-existing
urethritis and cervicitis was observed by the
urologist and that chlamydia was isolated from
both sites. It is suggested that the possible
association of chlamydial infection with the
urethral syndrome requires further investigation.
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Persistence of chlamydial infection after treatment
for neonatal conjunctivitis
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summary A high incidence of pharyngeal infection was found in babies with isolation-positive
chlamydial conjunctivitis. Chlamydia trachomatis was isolated from the pharynx of 12 (52%) of 23
babies before treatment, and was reisolated from the eyes of 4 (12%) of 34 and from the pharynx of
14 (41 %) of 34 after treatment. C trachomatis was reisolated significantly more often from babies
treated only with topical tetracycline for 4 weeks (75%) than from those treated with both topical
tetracycline and oral erythromycin for 2 weeks (32%). Reisolation from the eyes was associated
with only minor clinical signs. Radiological signs of an inflammatory lesion in the chest were found
in 2 of 8 babies examined because of persistent cough. These signs were not associated with high or
rising titres of serum chlamydial antibody.
Chlamydial infection in children was recently
reviewed by Ridgway.1 Infection in the newborn
infant commonly presents as a severe purulent
conjunctivitis,2-3 although mild and subacute cases
have been reported. The condition is self-limiting
and may resolve spontaneously within a few months.
The sight is rarely compromised although micro-
pannus and palpebral scarring can occur particularly
in the absence of treatment.4-5
An association of chlamydial conjunctivitis with
lower respiratory tract infection was first suggested
by Schachter et alf' and was later supported.7-11
Harrison et alf reported that in 9 of 30 babies
admitted consecutively to the children's hospital in
Seattle with pneumonitis, Chlamydia trachomatis
was isolated from naso-pharyngeal swabs and
aspirates and high levels of chlamydial antibody were
associated.
The isolation of chlamydiae from the pharynx
when chlamydial conjunctivitis is present could
simply reflect their presence in secretions draining
from the eye via the lacrimal duct rather than
colonisation of the epithelium. However, C.
trachomatis has a high specificity for columnar
epithelium and active infection of the compound
columnar epithelium of the pharynx is indicated by
isolation from naso-pharyngeal aspirates of infants
with pneumonia in the absence of clinical and micro¬
biological evidence of conjunctivitis.7 9-11 A residual
pharyngeal focus may therefore be a source of lower
respiratory tract infection and reinfection of the
conjunctiva. Theoretically it is more likely to be
found in babies in whom conjunctivitis has been
treated only with topical tetracycline or with anti¬
biotics only partially active against C. trachomatis—
such as chloramphenicol.
The purpose of this investigation was to find out
(1) the pretreatment isolation rate of C. trachomatis
from the pharynx of babies with chlamydial con¬
junctivitis, and (2) the reisolation rate from the eyes
and the pharynx of babies who had received topical
tetracycline either alone or combined with oral
erythromycin.
The symptoms and signs associated with reisola¬
tion and the possible role of C. trachomatis in the
development of lower respiratory tract infections are
discussed.
Patients and methods
Pharyngeal and conjunctival swabs were taken at
each follow-up examination from 34 babies treated
consecutively for chlamydial conjunctivitis. The last
23 babies also had pharyngeal swabs taken at the
time of the primary isolation of C. trachomatis from
the eyes.
All babies had been referred by paediatricians: 24
had been examined in maternity units, 6 had been
referred from outpatient baby clinics of the units,
and 4 had been examined in children's hospitals to
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Table 1 Age at onset of conjunctivitis and at referral
from paediatric units of 34 babies
Referring unit Age (days)
Onset of Isolation of
conjunctivitis C. trachomatis
Range Mean Range Mean
Maternity (n=24) 1-10 6-1 4-14 8-2
Baby clinic (n =6) 2-7 5-6 12^9 20-7
Children's hospitals (n =4) 5-7 6-8 15-42 23-8
which they had been admitted after failure of treat¬
ment of conjunctivitis prescribed by the family
doctor before investigation for C. trachomatis. The
age at onset of conjunctivitis and at referral from
these units is given in Table 1.
For initial investigation of outpatients and for
follow-up examinations, babies and their mothers
attended the Nonspecific Clinic in the gynaecological
outpatient department at the Liverpool Royal
Infirmary and the Royal Liverpool Hospital, or the
Women's Hospital, Liverpool.
Our routine investigation of babies with con¬
junctivitis has been described.3 Pharyngeal specimens
were obtained with the same type of cotton-wool
tipped swab as that used for taking eye specimens.
Care was taken to ensure that the specimen was
obtained from the mucosal surface by gently
stroking the posterior pharyngeal wall. Swabs were
placed in transport medium12 and immediately
delivered to the laboratory; in a few cases swabs
were taken in the evening and stored overnight
at 4°C.
In the laboratory, specimens were inoculated into
cycloheximide-treated coverslip monolayers of
McCoy cells and incubated for 48 hours at 35°C,
after which they were Giemsa-stained and examined
by dark-ground microscopy for chlamydial inclusions.
The total number of inclusions which developed
in the whole coverslip was counted. Details of all
these procedures have been described.13-14 In most
cases the specimens were inoculated into McCoy
cells within 2 to 4 hours of being collected from the
child, but occasionally they were stored overnight
at 4°C.
Babies were examined during treatment and
swabs were taken at each subsequent outpatient
attendance. Each mother was asked to bring her
baby for examination at ages 4, 8, 12, 18, and 24
weeks. This period of observation was longer
if a reisolation was obtained. Examinations were
carried out by two of us (E R and I A T).
Babies were treated with either 1 % chlortetra-
cycline eye ointment inserted into both eyes 5 or 6
times daily for 28 days, or for 14 days with concurrent
erythromycin syrup 30 mg/kg daily in divided dosage.
A few of the earlier babies received only 7 days'
erythromycin with 14 days topical treatment. In
most babies treatment was given initially by nursing
staff in the maternity units, and was continued at
home by the mothers on discharge from hospital 2
or 3 days later.
No baby was left untreated. If a reisolation was
obtained the baby was recalled and given combined
treatment. There was delay in retreatment if a
mother failed to keep an appointment. Swabs were
repeated on reattendance to confirm the persistence
of infection.
Routine radiological examination of the chest of
babies who developed cough in the follow-up period
was instituted in the latter part of the study. Eight
babies were examined.
Clinical and laboratory investigations were carried
out routinely in all mothers and, wherever possible,
the fathers were examined for evidence of urethritis.
All infected parents were treated.
Results
The sites of primary isolation and reisolation of C.
trachomatis are shown in Table 2.
Primary isolation. Pharyngeal isolations were more
common in older babies, being obtained from 3 of 12
babies aged < 11 days, and from 9 of 11 babies aged
>10 days. The inclusion count, which is a measure
of the degree of infection,13-14 was low in the
pharynx (range 1-21, mean 7 • 6 inclusions) compared
with the eye (range 5-3077, mean 1210 inclusions).
There was no apparent correlation between the eye
count and the presence or count of C. trachomatis in
the pharynx.
Follow-up. The overall failure rate was 16 (47%)
of 34 babies (Table 3). Of the 11 babies whose
pharyngeal swabs were negative before treatment, 5
became positive during follow-up after treatment,
4 of whom had negative eye swabs. The reisolation
pharyngeal swabs gave much higher inclusion
Table 2 Sites ofprimary isolation and of reisolation
of C. trachomatis
Isolation Site of isolation
Eye Pharynx Eye and
pharynx
Primary (n=23) 11 0 12
Reisolation (n = 34) 2 12 2
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Table 3 Sites offirst reisolation of C. trachomatis
after treatment in 34 babies
Table 4 Age at reisolation of C. trachomatis in
16 babies (25 reisolations)
Treatment Site of reisolation Age (weeks)
Eye Pharynx Eye and <4 4-7 8-11 12-15 16-19 20-23 32-35
pharynx
Number 2 5 4 6 2 4 2
Topical (n = 12)
Topical and systemic
(n=22) Table 5 Period offollow-up after treatment
counts than the primary pharyngeal swabs (range
1-1887, mean 166-1 inclusions) suggesting an
established infection of the mucosa.
Reisolations from the eyes or pharynx, or both,
were obtained from 7 (32%) of 22 babies treated
with combined topical tetracycline and systemic
erythromycin and from 9 (75%) of 12 treated only
with topical tetracycline (yf = 4-21, 1 df; P =
<0-01). Initially, for the purpose of this investiga¬
tion, the two treatment schedules were given alter¬
nately but the high reisolation rate, particularly from
the pharynx, of babies given only topical treatment
led to our stopping this practice for ethical reasons.
There was persisting pharyngeal infection in two
babies, in one for 6 weeks and in the other for 34
weeks, but there was no reisolation from the eyes of
either. One, born by caesarean section to an un¬
married mother, was diagnosed aged 18 days in a
children's hospital and treated with topical tetra¬
cycline and oral erythromycin for 6 days in hospital
and subsequently at home by the mother. C.
trachomatis was reisolated from the pharynx at 1,
14, 18, and 35 weeks after treatment. There was
persistent cough but clinical and radiological
examinations of the chest were normal. The mother
admitted she had had great difficulty in administer¬
ing both oral and topical treatment.
The second baby received only topical treatment
on diagnosis. C. trachomatis was isolated from the
pharynx 6 and 12 weeks after treatment. No further
isolations were obtained after combined treatment.
A third baby, treated topically, had reisolations from
the pharynx at 5 weeks and from the pharynx and
eyes at 12 weeks. In this case there may have been
reinfection of the eyes from the pharynx.
Five babies were preterm. Gestation ranged from
32 to 35 weeks and birthweights from 1 -63 to 2-23 kg.
Four of the 5 received combined treatment and no
reisolations were obtained in follow-up periods of 8,
28, 34, and 34 weeks respectively. The fifth baby had
topical treatment and C. trachomatis was reisolated
only from the pharynx when aged 12 weeks.
The age at reisolation and period of follow-up
after treatment are given in Tables 4 and 5.
Treatment Time (weeks)




The initial response to treatment was equally prompt
with each treatment schedule. Although all babies
had acute purulent conjunctivitis (Fig. 1 a and b),
Fig. 1 (Case 1.) (a) Palpebral oedema and purulent
discharge. (b) Severe conjunctivitis with submucosal
oedema. C. trachomatis isolated.
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reisolation from the eye after treatment was associ¬
ated with only minor signs which were generally
intermittent. The mothers complained of seeing
'puffiness', slight inflammation, and slight discharge,
in some cases only when the baby was waking or
crying. Two mothers were very concerned because
each believed that one eye of her baby was smaller
than the other. This was due to slight unilateral
palpebral oedema. The clinical signs noted on eye
examination were slight palpebral oedema most
easily identified when unilateral, a little mucopus
usually at the inner canthi, and slight to moderate
conjunctivitis with or without slight mucosal
oedema (Fig. 2). One baby reattended 2 weeks after
treatment with bleeding from one eye for 8 hours
(Fig. 3). Examination of this baby showed only
slight palpebral and mucosal oedema, and moderate
conjunctivitis. The blood was derived from a single
bleeding point on the mucosa of the lower lid. C.
trachomatis was reisolated from the eye and the
Fig. 2 Slight conjunctivitis with a little submucosal
oedema. C. trachomatis reisolated.
Fig. 3 Blood presenting between the lids.
C. trachomatis reisolated.
pharynx. In our experience this finding differs from
the blood-stained discharge occasionally associated
with the primary isolation from an acute eye in
which blood 'weeps' from the acutely congested
and grossly oedematous mucosa. Clinical signs may
be absent as reported in an earlier series.15 Clinical
examination of the pharynx was limited to ensuring
that satisfactory swabs were taken. Observations on
the presence, or absence, of pharyngitis were not
made.
Upper respiratory tract infections were common
during the follow-up period. There was no significant
difference between their occurrence in babies from
whom reisolations were obtained and those from
whom they were not. However, many of these babies
were treated for cough with one or two courses of
ampicillin by the family doctor between follow-up
visits. This may have interfered with reisolation
although positive swabs were obtained within a few
days of the completion of such treatment in 2 cases
and during the course of treatment in 1 case.
No baby was admitted to hospital with lower
respiratory tract infection during the period of
observation. One was admitted with gastroenteritis.
None of the babies with cough failed to thrive or
had symptoms or clinical signs of serious infection.
Radiological investigations. Findings were normal in
6 of the 8 babies examined. Inflammatory shadowing
of the posterior segment of the right lower lobe was
reported in one baby aged 16 weeks. There was a
history of intermittent cough from age 6 weeks and
three separate courses of ampicillin had been given
by the family doctor. C. trachomatis was not re¬
isolated but a course of erythromycin syrup for 2
weeks was prescribed. The chest was x-rayed 4 weeks
later when it was reported that resolution was well
under way but as yet incomplete, and again a further
4 weeks later by which time no active pulmonary
disease was found. The second baby who had had
a cough, particularly troublesome at night, for
several weeks, was x-rayed at age 5 months when
C. trachomatis was reisolated from the eyes and
pharynx. A slight increase in the lung markings
compatible with a resolving simple inflammatory
lesion was reported. Chlamydial antibody levels were
low and remained so during follow-up in both babies.
IgM was not demonstrated.
Discussion
The results of this investigation indicate a high
incidence of pharyngeal infection in untreated babies
with isolation-positive chlamydial conjunctivitis and
in those babies treated only with topical tetracycline.
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Before treatment pharyngeal isolations were
obtained in 52% of babies. After treatment C.
trachomatis was reisolated from the eyes of 12%,
and from the pharynx of 41 % of the 34 babies
followed up. Failure to include routine pharyngeal
swabs would have resulted in a completely erroneous
evaluation of the response to treatment, since re-
isolation is generally associated with absent or
with only minor signs of conjunctivitis. Not sur¬
prisingly treatment with topical tetracycline and
systemic erythromycin combined for 2 weeks was
more effective than the 4-week course of topical
tetracycline which has until recently been standard
treatment and is still commonly used. C. trachomatis
was reisolated from 7 (32%) of 22 babies receiving
the former schedule and from 9 (75 %) of 12 receiving
the latter (yf = 4-21, 1 df, P = <0-01).
Reisolations from 32% of babies given combined
treatment is not a good result. Possible reasons for
this are inadequate treatment or failure in compliance.
A lower reisolation rate might have been achieved
had a 3-week course of treatment been given, al¬
though in adults with genital tract infection due to
C. trachomatis there was no great difference in cure
rate between 2 and 3 weeks of treatment. However,
persistence in the pharynx rather than the eye is the
problem, and failure to eradicate both aerobic and
anaerobic bacteria from the throat after a standard
course of the appropriate antibiotic is more common
than at other sites. The choice of 2 weeks was based
on the general principle that it is desirable to give
babies the shortest course of antibiotics consistent
with effective treatment. Compliance was certainly
a problem with some mothers, even though they
were carefully instructed and, in most cases, initially
supervised in the maternity units. Such mothers
were not irresponsible but many of them found it
difficult to insert eye ointment, particularly the un¬
supported mothers with first babies. Some babies
were said to spit out the erythromycin syrup, others
to enjoy it. It is perhaps significant that no reisola¬
tions were obtained from the 4 preterm babies
(birthweights 1 • 63—2-1 kg) who completed their
combined treatment in special care baby units.
Since the radiological signs of lower respiratory
tract infection in 2 babies were not associated with
high or rising chlamydial antibody titres, we have
no clear evidence of extension of infection from the
pharynx to the chest. However, our babies received
systemic antibiotics at an early age and this may have
modified both the clinical and immunological
response. In two recent prospective studies in the
USA10-11 maternal chlamydial infection diagnosed
during pregnancy was left untreated. Evidence of
chlamydial infection was reported in 70 and 61 %
of the babies. Only babies with conjunctivitis were
treated and topical tetracycline was used. Pneumonia
developed in 4 of 20 babies in one series and in 2 of
18 in the other.
The apparent rarity of chlamydial pneumonia in
babies admitted to hospital in this country compared
with the USA may be due to failure to consider
C. trachomatis as an aetiological agent in Britain.
However, this is unlikely in Liverpool, where the
referral by paediatricians of babies for investigation
of neonatal conjunctivitis has resulted in the isolation
of C. trachomatis in 90 cases. More probably it
results from a different pattern of primary medical
care in the UK. Only babies whose condition causes
anxiety are likely to be referred to hospital by the
general practitioner and chlamydial pneumonia has
been characterised as being nontoxic. Nevertheless,
persistent cough creates anxiety in the mother and
chlamydial respiratory tract infection may be a
serious additional factor in babies whose health is
compromised by other pathogens or by poor
nutrition. The importance of identifying the chlamy¬
dial infection lies in the need for treatment of the
respiratory infection with erythromycin rather than
other more commonly used antibiotics and the need
for systemic treatment of conjunctivitis.
Prevention is best achieved by treating infected
mothers with erythromycin before parturition. Such
treatment is necessary not only to prevent infection
of the baby but to reduce the risk of postpartum
pelvic infection which is a common complication in
untreated mothers.516-17 In addition examination
and treatment of the mother's sexual partner is
essential if she is not to be reinfected.
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SIMPLIFIED METHOD FOR DIAGNOSIS OF
GENITAL AND OCULAR INFECTIONS
WITH CHLAMYDIA
D. Hobson F. W. A. Johnson
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Liverpool L69 3BX
Elisabeth Rees I. Anne Tait
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_ The diagnosis of infections with
chlamydia related to the trachoma
agent is best confirmed by isolation of the organism
in tissue-culture. A simplified technique using con¬
ventional monolayers of McCoy cells can be used as
an alternative to current methods involving heavily
irradiated cells and appears to be of reasonable sensi¬
tivity. Chlamydial infection was confirmed in 38/190
females attending venereal clinics, in 22/35 patients
with hypertrophic cervical erosions, and in 7/18
infants with ophthalmia neonatorum.
introduction
Non-gonococcal genital infection is one of the
commonest forms of sexually transmitted disease in
the United Kingdom. Evidence that more than a
third of these infections may be associated with group-
A chlamydia is now being provided by laboratories
able to use a somewhat complex tissue-culture pro¬
cedure. The clinical value of this approach has
recently been reviewed.1 However, these novel tech¬
niques 2 involve the pre-inoculation irradiation of
McCoy-cell cultures with 4000-6000 rads, a high
dosage only likely to be achieved by repeated access
to a cobalt-60 source and with the participation of
radiophysicists. Smaller general laboratories, distant
from specialist radiotherapy centres, have thus not
considered it feasible to engage in diagnostic and
epidemiological studies on chlamydial infections in the
general population.
2
We suggest here that useful data in this field could
be provided by any laboratory with routine tissue-
culture capability. There is no specific restriction
of chlamydia to growth in irradiated cells or even in
McCoy cells. Standard laboratory strains of
chlamydia grow well in cell lines such as HeLa or
BHK.3 4 Indeed, the McCoy cell line, once thought to
be derived from human synovial tissue, is now recog¬
nised to be antigenically similar to the mouse L-cell
tumour line, which has long been used for the cultiva¬
tion of chlamydia.
Our preliminary results with conventional unirra¬
diated cultures of McCoy cells in the clinical investiga¬
tion of non-gonococcal cervicitis are presented below.
MATERIALS AND METHODS
Many steps in the general diagnostic procedure are
similar to those described by Richmond5 with irradiated
tissue-cultures, but with the following points of difference.
McCoy cells (initially obtained from Flow Laboratories,
Irvine, Scotland) have since been serially propagated in
'Medium 199' (Wellcome) plus 10% fetal calf serum
(Flow) and 0-02M sodium bicarbonate, with vancomycin
and streptomycin each at 100 pig. per ml. Cell sus¬
pensions of 1-5 X105 cells per ml., obtained from con¬
fluent monolayer cultures by conventional trypsinisation
techniques, were dispensed in 2 ml. amounts in 1 oz.
(universal) screw-capped glass bottles containing a 16 mm.
circular glass coverslip covering the bottom of the bottle.
After incubation at 37 °C for 24 hours, the medium was
replaced by 2 ml. of the same medium plus 0-5% final
concentration of glucose and 50 pi per ml. nystatin just
before inoculation of the clinical specimen. Cervical
swabs were taken into 2 ml. of transport medium5;
0-4 ml. was inoculated into each of two coverslip cultures,
which were centrifuged at 2500 g for 1 hour on the
swing-out head of an M.S.E. Major centrifuge, at room
temperature. Inoculated bottles were then incubated at
37 °C in a constant atmosphere of 5% carbon dioxide in
air, with the bottle tops loosened, to maintain the medium
at a constant pH of 7-0-7-4. After 48 hours the tissue-
culture fluid was removed and the coverslip stained by
the Giemsa method. Large intracytoplasmic inclusions
packed with basophilic particles can easily be seen by
light microscopy with the 40 X objective, and under dark-
ground microscopy, where chlamydia particles give an
intense lemon-yellow fluorescence sharply distinct from
the dull green-brown appearance of McCoy cells.
Strict precautions were taken to minimise the risk of
cross-infection. No standard reference strains of chlamydia
have been used here since this work began. Fresh clinical
specimens were inoculated at a different time and in a
different laboratory from that in which incubated specimens
3
were harvested. During centrifugation, bottle-tops were
tightly sealed. Control McCoy bottles were inoculated
with transport medium, centrifuged, and incubated with
each batch of specimens. All remained negative.
RESULTS AND CONCLUSIONS
Cervical swabs were examined from 190 women
with various gynaecological complaints or a history of
contact with genital infection. Chlamydia were iso¬
lated from 38 (20%), and the number of inclusions
ranged from 2 to 18,000 per coverslip (median count=
900). 64 of these women were unselected contacts of
males with non-gonococcal urethritis; 15 (23-5%) of
them yielded positive cultures. In 35 women with
hypertrophic cervical erosions chlamydia were isola¬
ted from 22 (63%). Further pre-treatment swabs
were obtained within 5-15 days from 21 positive
cases, and 20 were again positive, with similar inclu¬
sion-counts to those in the first examination. After
treatment for 3 weeks with oxytetracycline, repeated
swabs from all the previously positive patients gave
negative results over the following 2 months.
Chlamydia have also been isolated (60-9000 inclu¬
sions per coverslip; median count=1350) from con¬
junctival swabs from 7/18 (39%) infants found to
have a mucopurulent conjunctival discharge within
a few days of their birth in hospital. Subsequently,
chlamydia were isolated from the cervix of 3 mothers
of infected infants, and from the urethra of the hus¬
band of one of these women. No other fathers were
available; 3 further mothers tested were negative,
but 2 had received systemic antibiotics before the
swab could be taken. Eye swabs became negative
shortly after local chlortetracycline therapy in 5 of
the infected babies, but, in the other 2, chlamydia
were re-isolated 2 weeks after treatment.
Much more work is needed to determine the fre¬
quency of chlamydial infections in ocular and genital
disorders in the unselected general population. These
preliminary results suggest that such studies are well
within the scope of the average laboratory without
special facilities for radiobiology, especially overseas,
where classical trachoma may also require investiga¬
tion.
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Chlamydia in Relation to Cervical Infection and
Pelvic Inflammatory Disease
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Assessment of the pathogenic roie of Chlamydia trachomatis in the cervix is
important for three reasons: (i) because of the possible carcinogenic-'effect of a
deoxyribonucleic acid vector which has an intracellular developmental sequence
and is associated with coitus: (ii) because of the effect on the fetus—prenatal or
intrapartum; and (iii) because of the effect on fertility if ascending infection to the
fallopian tubes occurs.
CERVICAL INFECTION
Novak and Woodruff (1). reviewing the pathogenesis of carcinoma of the cervix,
stated that at present the evidence is very strong in favor of the theory that infec¬
tion, possibly viral, plays a major role in the production of this disease, which ac¬
counts for 50% of all primary malignancy in the pelvis. Evidence that an inflamma¬
tory process can occur in the cervix in association with the presence of C.
trachomatis was provided by Dunlop et al. in 1966 (2). They described follicles
at the margins of the cervix seen with a colposcope, and later Ashton et al. (3)
and Swanson and his colleagues (4) reported inflammatory changes in biopsy
specimens from these areas and the identification of chlamydiae on electron
microscopic examination.
The association of "cervicitis," variously defined, but including simple erosion,
has been reported in several studies. Hilton et al. (5) found the cervix eroded and/or
appearing "infected" to the naked eye in 82% of 34Chlamydia-posit\ve women, but
56% of their control group of 54 women attending a family planning clinic showed
similar changes in the absence of Chlamydia or other organisms, as did 56%
of 115 women at a clinic for sexually transmitted diseases. Similar findings were
reported by Oriel and his colleagues (6). The high incidence in the control group is
probably due to the inclusion of simple erosion in the category "abnormal," al¬
though this is not considered to be a pathological condition in its common non¬
ulcerative form, but simply ectopic columnar epithelium (7, 8). The present study
was undertaken to determine the possible association of clinical signs in the cervix
with the presence of C. trachomatis, to determine the effect of treatment on the
signs when present and on the subsequent isolation of the organism, and to observe
whether or not C. trachomatis persists in the cervix in the absence of treatment and
of other infection.
Materials and Methods
Patients. We have isolated C. trachomatis from 228 of 729 (31.2%) selected
patients examined in a clinic for sexually transmitted diseases and from 52 of 145
(35.9%) consecutive contacts of patients with nongonococcal urethritis (NGU)
(primary and secondary contacts of first and recurrent attacks). For the purpose
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of observing clinical signs, we selected the whole group of 127 Chlamydia-posiwe
NGU contacts because we wished to exclude known cases or contacts of
gonococcal infection, which also causes endocervicitis. They have been paired with
127 consecutive Chlamydia-negative NGU contacts, none of whom had received
antibiotics for 4 weeks prior to their attendance. All patients were investigated for
gonorrhea, trichomoniasis, and candidiasis by conventional methods.
Specimens for culture of Neisseria gonorrhoeae were taken on at least two
occasions and were inoculated directly onto modified Thayer-Martin medium.
Specimens for C. trachomatis culture were placed in transport medium and
inoculated onto cover-slip cultures of replicating McCoy cells, i.e.. not pretreated
by irradiation or other antimitotic agents (9). The total number of chlamydial
inclusions per cover slip (IFU/WC) was counted on every specimen after 48 h of
incubation. < .
Endocervical smears were not examined for a pus cell count, as pus cells are a
normal constitutent of cervical secretion and their presence is not a reliable guide to
an inflammatory process. Their numbers exhibit physiological variation with the
stage of the menstrual cycle and the presence of degenerating spermatazoa.
The clinical examination of the vaginal cervix (ectocervix) was recorded as no
erosion, simple erosion (ectopic columnar epithelium), hypertrophic erosion
(edematous and congested erosion), and chronic cervicitis (lacerated with
ectropion or nabothian follicles with metaplasia). The endocervical contents were
recorded as clear mucus, cloudy mucus, mucoid discharge (white), or mucopus
(yellow). The findings were recorded at the time of taking the specimen for
Chlamydia on both the laboratory request form and the case sheet. Colposcopic
examination was not carried out.
As a basis of comparison with a known pathogen of the cervix, the cervical
findings in 100 consecutive cases of gonorrhea diagnosed during the period of this
study were analyzed. Routine tests forC. trachomatis were not carried out in this
group, and it will, therefore, contain some cases of concurrent infection.
The presenting symptoms in the 127 Chlamydia-positive NGU contacts are
compared with those of 326 consecutive gonorrhea patients attending the same
clinic. In some cases symptoms may be due to concurrent trichomoniasis or
candidiasis rather than gonococcal or chlamydial infection.
Treatment. Routine treatment consisted of the oral administration of oxytet-
racycline hydrochloride, 250 mg every 6 h for 21 days. Pregnant women were given
a similar course of erythromycin.
Follow-up. All Chlamydia-posilive patients were requested to attend for
observation for 12 months unless it was judged that such a prolonged period of
attendance would be bad for psychological reasons. Finnerty et al. (10) have shown
the importance of clear communication with the pauent in reducing the drop-out rate
during observation, and care was taken to explain to patients that we were trying to
assess the effect of treatment in a new condition which we were now able to
recognize and that their cooperation would be of great assistance. They were asked
to refrain from sexual intercourse for the 21 days of treatment, if possible, and then
to resume when their husband or consort had permission. Alcohol was not
forbidden. Patients were asked to attend for post-treatment tests at 2. 5. 8. 14. 26.
38. and 52 weeks during the latter part of the study, but were seen more frequently
during the early part. Some patients volunteered to continue for longer periods and
others re-attended with fresh symptoms or following new contact) -Swabs for
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Table 1. Clinical signs in the cenix in 254 NGU contacts (127 C. trachomatis positive
and 127 C. trachomatis negative)
No. of contacts
Chlamydia Chlamydia Percent
Clinical sign positive negative positive
Ectocervix
No erosion 28 61 31.5
Erosion
Simple 53 51 50.9
Hypertrophic 40 6 86.9
"Chronic cervicitis" .... 5 9
Not recorded 1 0
Endocervical contents
Clear mucus 31 76 28.9
Cloudy mucus 28 36 43.7 '
Mucoid 5 0
Mucopus 59 11 84.0
Blood 4 3
Not recorded 0 1
culture of C. trachomatis, A". gonorrhoeae, Trichomonas vaginalis, and Candida
species were taken on each occasion.
Results
Clinical findings. C. trachomatis was isolated from cervices exhibiting no clinical
signs of infection (Table 1) and in this is closely paralleled by gonococcal infection
(Table 2). The high isolation rate associated with hypertrophic erosion (86.9%) and
endocervical mucopus (84%) suggested that these signs might be attributable to the
presence of the organism and could be observed for a response to treatment.
The number of IFU/WC varied between 1 and 112,000. The number was not
directly related to the clinical findings. The highest count was recorded in an
uneroded cervix containing sticky mucopus.
Isolation of other organisms. In the group of 127 Chlamydia-positive NGU
contacts, N. gonorrhoeae was isolated from 4 (3 on the second time of testing and
Table 2. Clinical signs in the cervix in 100 consecutive patients with gonorrhea
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from the urethra as the only positive site in 2). T. vaginalis was present in 17 patients
and Candida species, in 45.
Presenting symptoms. As shown in Table 3. 49fc of Chlamydia-positive patients
and 53% of patients with gonorrhea denied any symptoms (Table 3). When there
was more than one symptom, the first or more severe was recorded as the
presenting symptom. A lower incidence of lower abdominal pain, which indicates
possible pelvic infection, was found in the Chlamydia-positive group. Postcoital
bleeding, found in 3.29c of the latter group, was associated with hypertrophic
erosion or ectopv of endocervical mucosa.
The gonorrhea group was not screened for C. trachomatis.
Effect of treatment on clinical signs. Thirty-one cases exhibiting hypertrophic
erosion have so far been followed for longer than 4 weeks. In 27 cases the
hypertrophic erosion became and remained simple (Fig. 1 and 2). In four cases (one
of whom was initially pregnant), no erosion was present at the end of the period of
follow-up. metaplasia having taken place. Forty-five cases in which mucoid or
mucopurulent discharge was found in the endocervi.x have completed at least 4
weeks of follow-up. The cervical secretion became clear in 25 cases (Fig. 3),
became cloudy in 19, and remained mucoid in one patient from whom Chlamydia was
reisolated. The change in the type of cervical secretion took place during the course
of treatment.
Effect of treatment on the isolation of C. trachomatis. The method of culture for C.
trachomatis used in this study has been shown to be highly reproducible and
sensitive (Johnson et al.. p. 309. this volume). A total of 161 Chlamydia -positive
sexually transmitted disease patients have been followed for periods up to 20
months. Patients who attended for fewer than two post-treatment tests have been
excluded. Two to four tests were carried out on those attending for less than 3
months, and 3 to 12 tests were made on those attending for a longer period. C.
trachomatis was reisolated in only 16 (Table 4). In this group of 16 patients, three
re-attended as contacts of men treated for gonorrhea and four as contacts of men
with NGU (one Chlamydia negative, three not tested). When the asymptomatic
consorts of three were examined, pus cells were present in shreds in the urine and C.
trachomatis was isolated. One consort was said to have attended a clinic with
symptoms but was not traced. Three patients had a new consort who did not attend
for examination. Both of the remaining two patients were having intercourse with
their original consort, neither of whom attended for examination.
Table 3. Presenting symptoms in 127 Chlamydia-positive NGU contacts and








Abdominal pain 3.9 9
Urinary 3.9 5
Irritation/soreness 6.4 3
Postcoital bleedinc 3.2 ( f
Warts L5 f
Abscess • 0 )
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Fig. 1. IA) Hypertrophic erosion with endocervical mttcopus before
treatment. C. trachomatis isolated. (B) After treatment. Simple erosion with
clear mucus in the endocervix. C. trachomatis not isolated.
Effect of physiological stress. C. trachomatis was not reisolated from one patient
who became pregnant and three who were pregnant at the time of treatment. All
were observed until after parturition, and no isolate was obtained from the mothers
or from the babies on conjunctival swabbing. No isolate was obtained from one
patient who acquired gonorrhea.
Persistence of C. trachomatis in the absence of treatment. Having early in the study
observed the resolution of clinical signs after treatment, on ethical grounds we did
not feel that treatment could be withheld once the diagnosis was made. However, in
19 cases either the patient failed to re-attend in 1 week for the results of her
investigation, or treatment was delayed because she was under investigation for
another condition, and Chlamydia was reisolated on one or two subsequent
occasions (Table 5).
Discussion
The clinical findings suggest that edema, congestion, and mucopurulent
discharge are associated with chlamydial infection of the cervix in a proportion of
cases and that these signs regress after treatment. In the majority of cases,
hypertrophic erosion became and remained simple during the period of
observation. In 4 of the 31 cases metaplasia took place. If there should be an
association between carcinoma of the cervix and C. trachomatis infection, it is
possible that these four cases would carry the greatest risk if the hypothesis of
Coppleson and Reid (11) is accepted.
The lack of correlation between the number of IFU/WC and the tissue response
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Fig. 2. fAj Hypertrophic erosion with marginal follicles and endocervical
mucopus before treatment. C. trachomatis isolated. (B) After treatment.
Simple erosion with areas ofmetaplasia. Cloudy mucus in the endocervix. C.
trachomatis not isolated.
suggests that the latter may be due to a host factor or to variations in response to
different immunotypes of C. trachomatis. It is unlikely to be'due to sampling, as
repeat specimens, usually taken 1 week later, showed little variation in count. The
higher isolation rate from NGU contacts with simple erosion compared with no
erosion may be due to the fact that columnar epithelium is more receptive to C.
trachomatis and infection is more easily achieved. This would explain the higher
isolation in women on oral contraceptives reported by Hilton et al. (5), in that the
development of ectopic columnar epithelium is influenced by hormonal factors (12).
Our findings do not support the view of Hilton et al. (5) that C. trachomatis
infection is latent but reactivated by other infection. We found signs of severe
inflammation in the cervices of a group of women free from other known
infection, and these signs responded to therapy. Reisolation of C. trachomatis
occurred in only 16 of 161 women followed for periods up to 20 months and was
associated with a high probability of reinfection rather than relapse. The
physiological stress of pregnancy and parturition in four cases and gonococcal
infection in one did not result in reisolation. Conversely, the persistence of C.
trachomatis with isolation on two or three occasions over periods up to 19 months
in 18 patients and 12 months in one suggests its persistence in an infective form in this
small group of patients available for observation. The isolation of C. trachomatis
from three asymptomatic male consorts examined because of reisolation of the
organism in women on long follow-up suggests that the asymptomatic male may be
a source of infection to the female.
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Fig. 3. I A) Simple erosion with endocendcal mucopus before treatment.
C. trachomatis isolated. (B) After treatment. Simple erosion, clear mucus in
the endocen ix. C. trachomatis not isolated.
PELVIC INFLAMMATORY DISEASE
There are two major difficulties in considering a possible relationship between the
presence of C. trachomatis in the cervix and pelvic inflammatory disease: (i) the
difficulties associated with the differential diagnosis of pelvic pain of a subacute
character, which are appreciated by physicians in all the disciplines involved—
gynecologists, urologists, venereologists, surgeons, and general physicians; and (ii)
the low isolation rate of organisms from fallopian tubes which show objective signs
of infection at laparoscopy or laparotomy, combined with the fact that these
procedures are not usually carried out prior to antibiotic therapy when the diagnosis
is clear. Curtis (13). in the pre-chemotherapeutic era, investigated the bacteriology
and pathology of fallopian tubes removed at operation and concluded that
gonococci live only a short time in the tube. M&rdh and Westrom (14) confirmed a
clinical diagnosis of salpingitis on laparoscopic examination and took swabs for
bacteriological investigation from 50 patients in whom there was marked reddening
and swelling of the tubes. No growth was obtained in 39 (78%). These findings
suggest the presence of potent antibacterial factors in luminal fluid and the
difficulties likely to be encountered in isolating C. trachomatis from the fallopian
tube of a women with salpingitis. There is historical evidence of an association
between chlamydial cervicitis and pelvic inflammatory disease, particularly in
relation to maternal infection and neonatal chlamydial conjunctivitis (2, 15). We
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Table 4. Follow-up of 161 sexually transmitted disease clinic female patients
after treatment for C. trachomatis infection of the cer\hx
Time
after treatment










have investigated the prevalence of pelvic infection in 127 Chlamydia-positive
NGU contacts and 24 mothers of babies with neonatal conjunctivitis from whomC.
trachomatis was isolated.
Results
NGU contacts. Pelvic infection was diagnosed in 5 of 127 women with chlamydial
cervicitis. Two were wives of men who admitted extramarital contact. Both were
found to have a hypertrophic erosion of the cervix and endocervical mucopus. The
erythrocyte sedimentation rate (Westergren) (ESR) was 13 and 57. respectively.
Tests for A7, gonorrhoeae were negative. There was no previous history of pelvic
infection. The symptoms settled rapidly with tetracycline therapy. Two women
were the regular consorts of men with NGU. They admitted no other recent sexual
contact. On examination neither cervix was eroded: one contained blood-stained
mucus and the other, cloudy mucus. The ESR was 13 and 25, respectively. Tests for
N. gonorrhoeae were negative. There was no previous history of pelvic infection,
but pn^ had a history of gonorrhea. The fifth case gave a history of discharge and of
cramplike pain in the right and left iliac fossae for 3 weeks, severe at onset but now
low grade. On examination of the lower genital tract, there was a simple erosion of
the cervix. The endocervix contained clear mucus but bled easily. Mucopus was
present on the rectal mucosa. The ESR was 19. Tests for N. gonorrhoeae were
negative. C. trachomatis was isolated from the cervical and rectal swabs. The
Table 5. Persistence of C. trachomatis in the absence of treatment
Time after initial
isolation (weeks) No. of cases
Isolations
x 2 x 3
52 1 I
19 2 i 1
14 1 1
12 3 2 1
7-8 4 4
5-6 3 7 1
3-4 5 1 3
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consort had NGU, and C. trachomatis was isolated. The psittacosis/
lymphogranuloma venereum complement fixation test was carried out at the start
of treatment, and 1 and 4 months later. The titer was 320, 320, and 80, respectively.
Mothers of babies with neonatal chlamydial conjunctivitis. Among 24 mothers of
babies with neonatal chlamydial conjunctivitis examined. 16 developed postpartum
infection. Seven were already receiving antibiotics for infected lochia or pyrexia.
Nine of the remaining 17 mothers developed pelvic infection. They had already
been discharged from hospital when the diagnosis of chlamydial conjunctivitis was
made in the babies who had remained in hospital because of prematurity. The onset
of pain varied between 13 and 38 days postpartum and was of such severity in two
cases that they were admitted to hospital for curettage to exclude retained products
of conception. None was found on histological examination of the curettings. N.
gonorrhoeae was isolated from two mothers whose babies had concurrent
gonococcal and chlamydial conjunctivitis. C. trachomatis was isolated from the
cervix of seven of the nine mothers. The two negative mothers were already taking
antibiotics prescribed by the family doctor for pelvic infection. In four cases blood
was sent for p^ittacosis/lymphogranuloma venereum group antibody estimation
before treatment and again after treatment in two cases (Table 6).
Discussion
The prevalence of pelvic infection in the 127 NGU contacts with chlamydial
cervicitis was 3.9%. This is lower than is found with gonococcal cervicitis (16. 17).
The frequency of pelvic infection in mothers of infected infants causes concern. The
group antibody titers, high in two cases and showing conversion in one, suggest the
association of the chlamydial infection with the pelvic inflammatory disease.
These findings lend support to the theory that chlamydiae may ascend to the
upper genital tract. Further support is given by the development in a special-care
unit of chlamydial conjunctivitis in a baby delivered by caesarean section 11 days
previously (Rees et al., p. 140, this volume). If the organism can reach the fallopian
tubes and if a similar pathological process can occur there as has been found in the
cervix, then its etiological role in nongonococcal salpingitis would not be
surprising.
Table 6. Psittacosisllymphogranuloma venereum group antibody titers in four
women with postpartum pelvic infection11
Patient Day postpartum Antibody titer Contact
M.C. (-, AB) 39 640 Husband ( + )
90 320
135 80
M.W. ( + ) 44 320 Husband ( + )
M.L. (+) 9 <10 Consort (NE)
26 20
46 10
M.F. (-. AB) 28 40 Consort ( + )
a For the patients and contacts: + = C. trachomatis isolated: - = C. trachomatis
not isolated: AB = on antibiotics; NE = not examined.
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CONCLUSION
The findings in this study suggest that C. trachomatis is a pathogen in the female
genital tract and that it provokes, in some cases, a well-marked tissue response to
infection in the cervix.
The treatment of all women from whom C. trachomatis is isolated is strongly
indicated, and facilities for diagnosis should be generally available.
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Perinatal Chlamydial Infection
ELISABETH REES. I. ANNE TAIT. DEREK HOBSON
xnd F. WILLIAM A. JOHNSON
The presence of an inflammatory process in the cervix may affect the fetus in the
prenatal, intrapartum, or neonatal period. In the prenatal period, the fetal
environment mat be compromised through bacteremic spread in the mother or
ascending infection from the cervix, resulting in chorioamnionitis. The latter
commonly develops after prolonged rupture of the membranes, but infection across
intact membranes also occurs, and. on examination of placentas, limitation of the
chorioamnionitis to the portion of the membranes overlying the os is often found
(1!. Premature birth is likely, possibly due to rupture of-the weakened and inflamed
membranes at this site (2).
The most important factor influencing the health of the infant is premature birth.
In the neonatal period. 6077 of deaths occur in the 1 OTP of infants born prematurely.
In addition to increased mortality. neurological sequelae are more frequent >:?/.
In considering chlamydial cervicitis in pregnancy, therefore, the relative
incidence of prematurity not associated with general factors affecting maternal
health, such as toxemia, may be of importance. Ascending infection due to
Chlamydia trachomatis. in either the pregnant or nonpregnant woman, has not yet
been established. Chlamydial conjunctivitis in an infant delis erec by caesarean
section is suggestive, but postnatal transmission by fingers of the attendants cannot
with certainty be excluded, although the chances of this are more remote if the
infant is transferred to a special-care unit immediately after birth.
Neonatal conjunctivitis and associated infection in the parents has been
recognized since 1907. when Halberstaedter and von Prowazek (4) described
inclusions in eye and genital exudate. Since the development of sensitive tissue
cultufie techniques, the epidemiological pattern of the disease and the clinical
manifestations and sequelae of infection in infants referred to departments of
ophthalmology have been defined (5. 6).
.An investigation into the presentation of chlamydial conjunctivitis in maternity
units was undertaken to examine the perinatal factors influencing the clinical
picture, the response to treatment, and the pattern of infection in the parents.
MATERIALS AND METHODS
Of the 81 babies examined between October 1973 and March 1976. 74 were
referred by pediatricians. 3 were referred by ophthalmologists, and 4 were
examined because their mothers had been treated for chlamydial cervicitis (3 during
the pregnancy and 1 before pregnancy). Four attended as outpatients. The group
forms a selected series of cases of conjunctivitis referred mainly because of failure
to respond to routine treatment or because no bacterial growth was reported on
bacteriological investigation. A few'case's were seen because of very .early
development of signs, the youngest being 6 h. In the United Kingdom, cases of
gonococcal conjunctivitis are usually referred to the venereologist.
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Specimens were obtained with cotton wool-tipped swabs from the mucosal
surface of the lower lids in all cases, and from the upper lids when possible, and
were examined microscopically and by culture for Neisseria gonorrhoeae and other
bacteria. Stuart's medium was used for transport, but most gonococcus swabs were
inoculated directly onto modified Thayer-Martin medium. Swabs for C.
trachomatis were put into transport medium for culture in untreated replicating
McCoy cells (7). Specimens for herpes simplex virus identification by electron
microscopy and culture were taken in some cases.
Mothers were investigated in the maternity unit when possible, but mothers of
premature babies had usually been discharged and were requested to attend as
outpatients. All were investigated for syphilis, gonorrhea, chlamydial cervicitis,
trichomoniasis, candidiasis, and, in a few cases, genital herpes. When possible,
fathers were similarly investigated if the infant and mother had gonococcal,
chlamydial, or syphilitic infection. Chlamydia-positive mothers and infants were
requested to attend once during treatment and then 2, 5, 8, 16, 28, 40, and 52 weeks
post-treatment. Swabs for C. trachomatis were taken from the infant on each
occasion. Swabs from the mother were taken for C. trachomatis, gonococcus,
Trichomonas vaginalis, and Candida species at each visit after treatment.
I
RESULTS
Babies. C. trachomatis was isolated from 29 babies, and N. gonorrhoeae was
isolated from 9. Delivery was by caesarean section in four cases: N. gonorrhoeae
was isolated from one of these babies, and Chlamydia was isolated from one.
In the 29 Chlamydia-positive babies, the onset of discharge varied between 3 and
13 days (mean. 6.9 days) (Table 1). Early onset was associated with concurrent
bacterial infection, which was not common. N. gonorrhoeae was isolated in three
cases, Staphylococcus aureus in two, S. albus in two, N. pharyngis in one,
diphtheroids in one, and Streptococcus faecalis in one. No swab was taken in one
case treated by the general practitioner after discharge from hospital. In the re¬
mainder, the laboratory reported no bacterial growth or no pathogens grown. Late
onset at 9, 11, and 13 days occurred in three babies treated at birth with intramus¬
cular cloxacillin and ampicillin for prematurity associated with prolonged rupture
of the membranes.
C. trachomatis was isolated from both eyes in 18 cases, the right eye in 7. and the
left eye in 4. The inclusion count per whole cover slip (IFU/WC) varied between 1
Table 1. Day of onset of discharge in 29 cases of neonatal chlamydial conjunctivitis
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and 86,000. and was low in cases which had received prior antibiotic therapy other
than topical neomycin.
All babies developed edema of the lids and a purulent discharge, which was often
thin and watery in the absence of concurrent bacterial infection. In two cases it was
blood stained. Localized "bubbling" of the mucosa was a marked feature in the
more severe cases and in those in which the request for investigation was late (Fig. 1).
Twenty-two cases had received prior topical treatment as follows: neomycin. 13:
chloramphenicol. 5: neomycin and chloramphenicol. 2: gentamicin and chloram¬
phenicol, 1: penicillin and tetracycline, 1. Neomycin had no effect on the
development of the conjunctivitis, but babies receiving chloramphenicol at the time
of taking swabs usually had no discharge and were said to be improving. Slight to
moderate lid edema and slight to severe conjunctivitis and mucosal edema v. ere
found on examination, depending on the duration of therapy (Fig. 2).
Diagnosis was delayed until 30 days in one ill premature baby (30-week gestation)
who developed conjunctivitis at 3 days and was treated with intramuscular
penicillin and kanamycin for 5 days followed by gentamicin for 5 days for
Escherichia coli infection. Streptococcus faecalis was then isolated, and
chloramphenicol eye drops were given for 5 days. The conjunctivitis subsided, but
recurred and was retreated twice. Chlamydia was isolated on the second and fifth
days of the third course of chloramphenicol. Herpesvirus particles were identified
on electron microscopy. Only slight edema of the lids and slight conjunctivitis were
present. No discharge was seen. The mucosa was edematous, and "bubbling" was
present.
One baby (35-week gestation) was delivered by caesarean section because of fetal
distress 3 h 15 min after spontaneous rupture of the membranes. The baby was
nursed in the special-care unit where, at 11 days, slight edema of the lids of one eye.
conjunctivitis, and mucopurulent discharge developed. This failed to respond to
neomycin eye drops, and only scanty Staphylococcus albus was grown on culture.
C. trachomatis was isolated from swabs taken on the 13th day (Fig. 3). No other
baby was under treatment for chlamydia conjunctivitis in the unit. The mother
developed pyrexia on the third day and was treated with ampicillin. 500 mg every 6 h
for 7 days.
Treatment and follow-up. Tetracycline eye ointment five times daily for 4 weeks
was prescribed. Babies attended for follow-up for periods up to 11 months.
Chlamydia was reisolated from four infants 1 to 6 weeks after cessation of
treatment. One had received treatment for 2 weeks, one for 3 weeks, and two for 4
weeks. Isolates were obtained from both eyes of the caesarean baby on relapse,
although only one eye had shown clinical or bacteriological evidence of infection
initially, and both eyes had been treated. Two mothers reported slight intermittent
swelling of the lids and discharge. Slight conjunctivitis was present in only one.
Prematurity. Twelve of the 29 babies were premature (41.497). The gestation
period was 30 to 32 weeks in five. 33 to 34 weeks in four, and 35 to 37 weeks in three.
None of the mothers of these babies had toxemia of pregnancy. Two babies had a
ventricular septal defect. In addition, one Chlamydia-poshive mother had a baby
who died of cardiac failure at 3 days and was found at postmortem examination to
have a hypoplastic left ventricle, patent ductus arteriosus, and preductal
co-arctation.
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Fig. 1. Baby K. 32-week gestation. (A) Onset ofpurulent discharge and
palpebral edema at 6 days. No response to topical neomycin for 2 days. S.
albas isolated. IB) Severe mucosal edema with bubbling. C. trachomatis
isolated at S days.
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Fig. 2. Baby R, 40-week gestation. (A) Onset ofpurulent discharge and
palpebral edema at 5 days. Treated with topical neomycin for 2 days (no
response) and topical chloramphenicol for 5 days with improvement. (Bi
Mucosal edema with bubbling, no discharge. C. trachomatis isolated at 12
daxs.
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Fig. 3. Baby C, 35-week gestation, delivered by caesarean section. (A)
"Sticky eye" at II days. Early palpebral edema ofright eye. No response to
topical neomycin for 2 days. (B) Typical mucosal edema, scanty
mucopurulent discharge in right eye. C. trachomatis isolated at 13 days.
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Mothers. Twenty-four mothers, aged 17 to 36 years, were examined, of whom 14
were married and 10 were single. Seven had received antibiotics prior to
examination. The cervical specimen from one mother was cytotoxic. Among the 16
remaining patients. C. trachomatis was isolated from the cervix of 15 and N.
gonorrhoeae from 3. Postpartum infection occurred in 16 (66.697). Seven mothers
received antibiotics in the maternity unit for pyrexia (3) or offensive lochia (4). High
vaginal swabs were reported as follows: no pathogens, three: Staphylococcus
aureus, one: gonococci, one: alpha-hemolytic streptococci, one: and anaerobic
streptococci, one. Nine mothers developed pelvic infection after discharge from
hospital (13 to 38 days postpartum), and details of this group are reported else¬
where in this volume (Rees et al.. p. 67). One mother was treated with anti¬
biotics for a wound infection.
Fathers. Eleven fathers of Chlamydia-pos\ti\e babies were examined. All were
asymptomatic. Two were gonococcus positive, and one of these admitted
extramarital contact 3 months earlier. Of 10 examined for C. trachomatis. 4 were
positive 24, 36.59. and 84 days after the birth of the baby. The IFU WC counts were
low. being 3. 2. 10. and 420. respectively. No discharge was found, but shreds
containing pus cells were present in the urine. One gonococcus-positiv e father was
Chlamydia negative.
DISCUSSION
The actual incidence of neonatal chlamydial conjunctivitis is difficult to assess
because of the late onset of clinical signs and the early discharge from hospital of
healthy babies.
In the United Kingdom, treatment of conjunctivitis is usually undertaken by the
general practitioner unless the condition is refractory, in which case the infant is
referred to an ophthalmologist. Investigation of parents is then unlikely to be carried
out.
Nine of 24 mothers (37.5^7) of infants with neonatal chlamydial infection
developed pelvic infection 13 to 38 days postpartum, one having been treated w ith
ampicillin for infected lochia prior to discharge from hospital. Six additional
mothers (25.097) were treated for pyrexia and infected lochia in the maternity unit.
This confirms the association of neonatal conjunctivitis with maternal pelvic
infection reported in several studies (8. 9). Mordhorst and Dawson (9) found pelvic
infection before and after the birth of the infected child in 4 of 16 mothers. They
suggest that the physiological stress of childbirth may reactivate a subclinical
genital infection. In our group of 81 infants, four of the mothers had been treated for
chlamydial cervicitis, three during pregnancy and one 2 months prior to pregnancy.
Chlamydia was not reisolated during or after the pregnancy, and swabs from the
babies were all negative. The four pregnancies continued to term.
The high incidence of prematurity in this series. 12 of 26 babies with chlamydial
infection having gestation periods of 30 to 37 weeks, could be attributed to the fact
that their longer stay in hospital allows conjunctivitis to develop and an accurate
diagnosis to be made. However, the possibility of ascending cervical infection being
a contributory factor to premature rupture of the membranes should be considered.
The possible infection in utero of one baby delivered by caesarean section lends
support to the hypothesis that chlamydial infection may ascend from the cervix and.
therefore, may be directly involved not only in chorioamnionitis but also in the
development of nonspecific salpingitis.
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The asymptomatic nature of both the gonococcal and chlamydial infections in the
fathers underlines the importance of investigating them to prevent reinfection of the
mother.
It is suggested that the treatment of pregnant women infected with C. trachomatis
is strongly indicated. Tetracycline should be avoided in pregnancy because of its
effect on the bones and teeth of the fetus. Erythromycin is not contraindicated and
has given satisfactory results in the small number of cases in which we have used it.
In summary, in a selected series of 81 babies C. trachomatis was isolated from 29
in the neonatal period. In the Chlamydia-positive group, concurrent gonococcal
conjunctivitis was present in three and herpesvirus particles were identified by
electron microscopy in one. One baby was delivered by caesarean section. The
onset of conjunctival discharge varied between 3 and 13 days postpartum (mean. 6 to
8 days). Concurrent bacterial infection and prior antibiotic therapy influenced the
clinical presentation. After treatment with oculentum tetracycline prescribed for 4
weeks, C. trachomatis was reisolated in four cases during follow-up extending to 11
months. A high incidence of postpartum maternal infection occurred. Four fathers
with chlamydial infection and two with gonococcal infection were asymptomatic.
Accurate diagnosis of neonatal conjunctivitis is important in assessing the need for
family investigation. The treatment of pregnant women with chlamydial cervicitis is
strongly indicated.
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Effect of Penicillin on Chlamydia trachomatis
In Vitro and In Vivo
DEREK HOBSON. ELISABETH REES. F. WILLIAM A. JOHNSON.
and I. ANNE TAIT
Concurrent genital infections due to Chlamydia trachomatis and Neisseria
gonorrhoeae are common in women (1. 2). The diagnosis of gonococcal infection
can frequently be made immediately by smear and can be confirmed rapidly by
bacteriological culture. Hence, many of these patients may be treated immediately
by administration of a single large dose of penicillin in the clinic before it is realized,
that C. trachomatis is also present in the genital tract.
Clinical results in men with double infections have suggested that, although
single-dose penicillin treatment is effective in curing gonorrhea, it may fail to
eradicate concurrent chlamydial urethritis. For example. Richmond et al. found
that postgonococcal urethritis occurred more often in men in whom both .V.
gonorrhoeae and C. trachomatis had been present before treatment (3), and
Holmes et al. isolated C. trachomatis from 9 of 20 men who developed
postgonococcal urethritis 1 to 6 weeks after treatment of gonorrhea with penicillin
(4). Oriel (p. 38. this volume) has shown that even a single dose of 2 g of ampicillin
given together with 1 g of probenicid failed to cure C. trachomatis infection as¬
sociated with gonorrhea in 14 of 15 men. although the latter was cured in all cases.
It is thus of practical importance to consider the clinical results of using a single
dose of penicillin to treat women with concurrent gonococcal and chlamydial
infections of the cervix, as well as the effect of this antibiotic on Chlamydia in vitro.
This report gives preliminary data on both these aspects.
A series of McCoy monolayers was simultaneously infected with C. trachomatis
SAL strain at a dilution calculated to contain 10.000 inclusion-forming units (1FU)
per culture after 48 h of incubation at 37°C. No antibiotics were used other than
benzylpenicillin. which was added at the time of infection. Details of our procedure
are described elsewhere (5).
The effect of incubation throughout the whole growth period with increasing
concentrations of penicillin from 0.1 to 1.0 U/m! was progressive in the sense that
normal inclusions, containing Giemsa-stained elementary bodies (EB) which
fluoresced brightly under dark-ground microscopy, decreased in numbers and
could not be found at penicillin concentrations greater than 1.0 U/ml. However, this
decline in the number of normal inclusions was accompanied by a rising number of
small abnormal inclusions, which did not fluoresce under dark-ground illumination
and which contained only a few large swollen particles'staining a reddish color with
Giemsa. instead of the normal packed mass of deep blue-stained EB. It was difficult
to count these abortive inclusions accurately, but in cultures incubated with 0.5 to
1.0 U of penicillin per ml. where their numbers were highest, they represented over
50% of the number of IFU of C. trachomatis originally added to the culture. Even in
infected cultures incubated with penicillin concentrations from 5 to 100 U ml.
abnormal inclusions were found, but they became progressively fewer and their
contents became increasingly sparse and abnormal, with amorphous red-staining
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debris replacing the particulate forms. However, even at 100 U of penicillin per ml.
the number of abortive inclusions represented approximately 10of the number of
1FU of C. trachomatis originally inoculated.
It seems probable that the effect of penicillin on chlamvdiae is exerted only at the
stage where the progeny growing within the McCoy cell are beginning to synthesize
their compact cell wall and become definitive EB. Thus, the abnormal swollen
bodies seen within the abortive inclusions in penicillin-treated McCoy cells
probably represent initial bodies, the further maturation of which is arrested
(Manire. p. 167. this volume). It might thus be expected that normal maturation,
with the development of infective EB. would be resumed when the penicillin is
removed. So far. we have failed to confirm that reversion can occur in vitro.
However, in the very different intracellular environment of chlamydiae growing in
columnar epithelium of the genital tract in vivo, it seems probable that similar
abnormal inclusions may develop under the effect of penicillin, but that maturation
to EB may recommence after the last traces of the antibiotic have disappeared from
the system. It is thus of interest to look at the effect of single-dose therapy with
penicillin in patients with both gonococcal and chlamydial genital infection.
In our preliminary studies we followed the course of events in 22 women with
proven gonococcal infection who were treated at once for this infection with
procaine penicillin (1.2 megaunits) plus amoxycillin (500 mg) before it was sus¬
pected that a concurrent infection with C. trachomatis might be preser.;. In all
these patients, penicillin eradicated the gonococcal infection.
In 12 of these women. C. trachomatis was in fact isolated from pretreatment
swabs, but only after penicillin had already been given for the gonococcal infection.
In five of them. C. trachomatis was not reisolated after penicillin adminstration
during subsequent periods of observation of 22 days to 9 months. The number of
post-treatment swabs was five in one case, four in two cases, and three and two in
one case each. In the other seven of these women with proven gonococcal plus
chlamydial infection. C. trachomatis was reisolated in swabs taken 5 to 28 day-,
after penicillin treatment. In one of these patients, although C. trachomatis was not
isolated 7 days after penicillin administration, it was recovered from later swabs. In
the other six patients the first post-treatment swab was positive, and in one case the
inclusion count was significantly higher than in the pretreatment swab (IS.000 and
900 per cover slip, respectively).
In a further eight women there had been no pretreatment investigation tor
chlamydiae. but there was persistent pus in the endocervical canal after the
gonococcal infection had been eradicated by penicillin. C. trachomatis was isolated
from all eight women from swabs taken 15 to 34 days after penicillin administra¬
tion. In five of these cases. C. trachomatis remained present in second confirma¬
tory swabs taken from 28 to 130 days after penicillin administration, before the
beginning of oxytetracycline therapy for their chlamydial infection.
In the remaining two patients in this series. C. trachomatis was isolated 20 and 2
days, respectively, after penicillin administration, although they had had no signs or
symptoms of cervical infection. This is commonly the case in women where
gonococci or chlamydiae. or both, are found in the cervix (Rees et al.. p. 67. this
volume).
These preliminary results suggest that many women who present themselves at
STD (sexually transmitted disea.se) clinics, and who are in reality intectixe
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reservoirs of both gonococci and chlamydiae, may be recognized and treated only
for gonococcal infection. The chlamydial infection may persist undiminished for
weeks or months after the gonococcal infection has been cured: in some but not all
cases, the clinical signs may persist, and there would seem to be a distinct risk that
many of these women, after treatment for gonococcal infection, could return to
iheir community as persistent but unsuspected disseminators of chlamydial STD.
Because of the recent emergence of /3-lactamase-producing strains of N.
gonorrhoeae (6), the single-dose regimen of penicillin for the routine treatment of
gonorrhea may in the near future need to be replaced by some other form of
antibacterial therapy. It is to be hoped that any new antibiotic or new regimen
devised for this purpose will take account of the frequency with which gonorrhea is
accompanied by infection due to C. trachomatis, the eradication of which cannot
necessarily be guaranteed by treatment with antibiotics active against Neisseria.
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Quantitative Aspects of the Growth of Chlamydia
trachomatis in Diagnostic Tissue
Culture Procedures
F. WILLIAM A. JOHNSON, DEREK HOBSON,
ELISABETH REES, and I. ANNE TAIT
Tissue culture (TC) techniques for isolating Chlamydia trachomatis are of proven
value in epidemiological surveys in large research centers. In the next few years,
they are certain to be widely adopted for the routine investigation of all patients with
suspected sexually transmitted disease. In the scaling-up process, some; form of
quality control is desirable to ensure that the sensitivity and reproducibility of the
present procedures is being maintained at a constant high level and that any future
technical modifications, to conform with different laboratory facilities and practice,
do not affect these parameters.
Comparison of isolation rates of C. trachomatis between successive groups of
patients or between patients in different clinics can only give information of limited
value. Independent proof of infection (e.g.. by direct smear or serology) is rarely
feasible in all patients (Schachter and Dawson, p. 337, this volume). Hence, the true
base rate of chlamydial infection is unknown, and it is difficult to interpret either
concordance or divergence of laboratory results with different patients at different
times in different cities.
However, the nature of the current TC procedures provides an inbuilt
quantitative means of monitoring their efficiency. Since C. trachomatis gives only a
single cycle of development (1), the number of inclusions finally detected in TC is
directly proportional to the number of viable chlamydial elementary bodies
originally inoculated. Thus, a sensitive early warning of any change in laboratory
precision can be obtained by determining the overall efficiency of plating, by
regularly titrating low-passage laboratory strains of C. trachomatis, and by testing
repeated swabs at short intervals from known positive, untreated patients.
This paper presents such an investigation of a technique with replicating McCoy
cells used for the past 3 years in the diagnosis of chlamydial infections of women in
Liverpool (2, 3; Rees et al.. p. 67, this volume).
MATERIALS AND METHODS
Details of the preparation of cover slip monolayer cultures of replicating McCoy
cells (MCC), media, diluents, and the isolation procedure for clinical specimens
have been published (2, 3; Rees et al., p. 67, this volume).
The isolation, propagation, and storage of the laboratory strain SAL of C.
trachomatis isolated in Liverpool, and methods of investigating its growth under
different cultural conditions (pH, incubation temperature, medium, etc.). have
previously been described (3). Other technical procedures are described below.
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RESULTS
Variation between cover slip cultures. A single batch of MCC was prepared
under standard conditions (3). Random samples were stained to confirm that >90%
of the cover slip was covered evenly by cells with well-spread cytoplasm. All were
then inoculated simultaneously with a single dilution of SAL strain estimated to
yield 3.000 inclusions per MCC. .After incubation for 48 h at 37°C. all MCC were
Giemsa stained, and the total number of inclusions per MCC was counted
under x400 bright-field microscopy. The 48 cover slip counts followed a normal
distribution pattern (range. 2,817 to 4,143: mean. 3.200: standard deviation. 325).
and 93% of the observed counts were within = 20% of the mean value.
Effect of different stains and time of examination. A single batch of MCC was
inoculated simultaneously with a single dilution of SAL strain estimated to yield
40.000 inclusions per cover slip. All were incubated at 37°C. and randomly ^elected
MCC were removed after 24. 48. or 72 h for staining with iodine. Giemsa. or
carmine (4). Total inclusion counts per MCC were calculated from counts of 150
randomly chosen microscopic fields in each of two MCC for each stain and time.
The mean size of inclusions was determined by measuring the diameter of 100
randomly selected inclusions in each MCC. with the use of an eve-piece micrometer
(Table 1).
Giemsa staining at 48 h revealed the highest inclusion count. Even at 24 h. most
of the inclusions were already detectable, but their small size made counting slow
and fatiguing. By 72 h. inclusions were big and easy to count, but many were
bursting, and presumably other infected McCoy cells had already ruptured and
dropped off the glass, since the total count had fallen to 25% of the 48-h value.
Carmine staining was less effective than Giemsa for detecting inclusions at 24 h.
but gave similar results at 48 and 72 h. The bright-red inclusions were clearly
distinguished against the light-brown staining of the McCoy cells.
Table 1. Comparison of number and size of inclusions of C. trachomatis SAL in
simultaneously infected McCoy monolayers stained by different methods









Iodine -n « 10 4.25-7.25 6
48 10.250 4-18.75 8.75
-n 8.700 5.5-26.25 11.85
Giemsa -> < 44.500 0.87-12 5.25
48 49.600 7-41.75 12.75
7 n 12.120 9.25-38.25 24.27
Carmine 24 11.100 2.0-11.0 5.6
48 45,100 4.5-46.2 12.85
72 12.180 8.25-32.75 18.15
" Total count per 16-mm cover slip. Mean of two cover slips.
s Mean of two diameters of each of 100 inclusions per cover slip.
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Iodine resulted in significant underestimation of the number of inclusions present
even at 48 h, and seemed incapable of allowing detection of early inclusions or
many of the large late inclusions. This may be because of the variability in timing
and amount of the glycogen-rich matrix in C. trachomatis inclusions in TC (5, 6).
Effect of changing laboratory conditions. Inclusion counts produced by a
constant inoculum of SAL strain were determined after various modifications of the
standard procedure (3). For each variable factor, two to four MCC were compared
with the same number of MCC infected and incubated under standard conditions.
The results summarized in Table 2 indicate the large decrease in the sensitivity of
McCoy cells to C. trachomatis infection that can result from comparatively small
changes in the isolation technique. The only factor which was found to increase the
inclusion count significantly was the use of increased force or time of
centrifugation. These effects are discussed in greater detail elsewhere (3).
Clinical specimens. C. trachomatis was isolated from the cervix of 153 contacts
of men with nongonococcal urethritis (NGU) within 2 to 3 days of their first visit to
the sexually transmitted disease clinic. On their next visit 7 to 10 days later, a
Table 2. Effect of modifications of the standard tissue culture procedure" on







2,500 x g, 15 min 2,120
2.500 x .g. 3 h. 19,830







NaHC03 concentration at pH 7.2
0.025 M 2,932
0.005 M 405
Medium (+ 10% calf serum, etc.E
Eagle MEM 1.646
BME 204
McCoy: initial cell count
5 x lOVml 633
5 x 10s ml 1,250
McCoy: age of monolayer when
infected, 5 days 1.204
" In the standard procedure, McCoy cell cultures were prepared from 2 x 105 cells ml
and incubated for 24 h at 37°C. They were then inoculated, centrifuged at 2.500 x g
for 1 h, and incubated for 48 h at 37°C. The standard medium was medium 199
plus 10% fetal calf serum and 0.02 M NaHC03.
" Mean of 40 cover slips in replicate experiments by standard procedure. Mean of two
to four cover slips for each modification.
c MEM = minimal essential medium; BME = Eagle basal medium.
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second cervical swab was taken and again examined by the standard procedure.
There had been no intervening systemic or local therapy. The repeat swab was
again positive in 141 (92.5%) of the women: the 8 patients with negative second
swabs had inclusion counts of only 2 to 30 per MCC on the first occasion. In a group
of 82 NGU contacts with negative primary swabs, the repeat swab was positive in
only 2 (2.5%) women, with counts of two and eight inclusions per MCC.
In 98 women with a constant 7-day interval between two positive swabs,
inclusion counts were closely similar in most cases on both occasions (Table 3). The
overall distribution of counts in the whole group showed little change: only 8% of all
swabs yielded fewer than 30 inclusions, whereas 75.4% of primary swabs and 69.8%
of second swabs gave 100 or more inclusions per MCC.
DISCUSSION
Current TC techniques for isolating C. trachomatis are now well within the scope
of any laboratory equipped for routine virological diagnosis. However, compara¬
tively small changes in the detailed procedure or in the staining technique can
significantly reduce the number of countable inclusions obtained from a given
number of viable elementary bodies (3.9: Rota. p. 314. this volume) and might thus
impair the chance of diagnosing a patient with an early, low-grade, or imperfectly
treated chlamydial infection.
The present results suggest that quantitative inclusion counts on all clinical
specimens, and on low-passage laboratory strains of C. trachomatis at regular
intervals, could provide a simple check on the confidence limits of the overall
working procedure w ithin the laboratory and. indirectly. on the quality of the
specimens reaching the laboratory. Such routine counts may be of future clinical
value in estimating the extent and severity of the infection and the possibility of
relapse after chemotherapy.
The present methods seem capable of isolating a substantial number of infective
particles of C. trachomatis from the majority of infected women, and it does not seem
that small reductions in the sensitivity of the procedures would be reflected by any
significant fall in the total number of new sexually transmitted disease patients
found positive. However, a sustained high efficiency of plating is necessary (i) to
insure against the marked loss in viability of chlamydia in specimens which need to
Table 3. Distribution of inclusion counts in cen ical swabs from 98 untreated
women with C. trachomatis infection
Inclusion counts per
cover slip0
Percentage of women witn stated









" Each cover slip was inoculated with one-twelfth of the secretion recovered from each
swab.
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be sent to distant laboratories and stored overlong before TC inoculation, and (ii) to
confirm that chemotherapy has eradicated the patient's infection and not merely
depressed it to levels undetectable by the laboratory but still capable of causing
clinical relapse at some later date.
The beneficial effect of increasing centrifugation demonstrated here confirms
earlier findings (3, 8, 9) and suggests that current techniques may isolate only a
fraction of the total number of infective particles shed by the patient. For most
laboratories centrifugation of specimens at more than 2,500 x g for 1 h is
impracticable. but it seems worthwhile to explore further methods of increasing the
efficiency of adsorption of C. trachomatis to TC cells, to help minimize the effect of
the many other variations in laboratory and clinical conditions which can affect the
isolation rate of chlamydiae in genital infections.
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Neonatal conjunctivitis caused by Neisseria
gonorrhoeae and Chlamydia trachomatis
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summary In a selected group of 103 babies referred with neonatal conjunctivitis Neisseria
gonorrhoeae was isolated from 11 and Chlamydia trachomatis from 33. Concurrent infection was
present in three. One toddler sibling developed chlamydial conjunctivitis. After treatment C.
trachomatis was re-isolated from six babies during the follow-up period. The discharge'started one
to three days after delivery in only three babies with gonococcal conjunctivitis and at five to eight
days in eight babies. One baby was delivered by caesarean section. N. gonorrhoeae was isolated
from four asymptomatic fathers, all of whom had urethritis. The mean onset of discharge in the
33 babies from whom Chlamydia was isolated was 7T days. One baby was delivered by caesarean
section. Chlamydial conjunctivitis was associated with a high incidence of prematurity and of
postpartum infection in the mother. Ten fathers of Chlamydia-positive babies were examined.
C. trachomatis was isolated from four, all of whom were asymptomatic but had low-grade urethritis.
These findings confirm the pathogenic role of C. trachomatis in the cervix and indicate the importance
to the family of an adequate microbiological investigation of neonatal conjunctivitis.
Introduction
Infants often develop mild inflammation of the eye
a few days after birth. Usually this is due to trauma
or transient infection and resolves quickly without
treatment. However, more severe forms of purulent
conjunctivitis of the neonate are seen and some
fail to respond to routine antibiotic treatment.
It has long been recognised that neonatal con¬
junctivitis could follow intrapartum contamination
of the eye with cervical secretion if the mother had a
previously unrecognised and untreated genital
infection acquired by sexual contact. In the late
nineteenth century gonorrhoea was undoubtedly the
commonest cause of this condition as well as being
the easiest causative organism to identify. As early
as 1909, however, Halberstaedter and von Prowazek
recognised an abacterial form of infection, and
inclusion bodies were identified in the epithelial
cells of the infant's conjunctiva and in cellular
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scrapings of the genital tract of the parents (Lindner,
1910). This was confirmed by Jones et al. (1959)
when it became possible to grow the agent (trachoma-
inclusion conjunctivitis (TRIC) agent, or Chlamydia
trachomatis) in the laboratory in chick embryos.
More recently, C. trachomatis has been isolated in
40 to 50% of cases of non-gonococcal urethritis
(NGU) in the male by tissue culture techniques
(Dunlop et al., 1972; Oriel et al., 1976). Infection
is transmitted sexually to female partners of men
with NGU, and C. trachomatis can be isolated from
the cervix in up to 37% of such women (Hilton
et al., 1974; Holmes et al., 1975). If left untreated
these women can act as chronic reservoirs of
infection and can infect more men or their own
infants. The increase of NGU in men by 159%
during the past 10 years compared with an increase
of only 29 % in gonococcal urethritis (Department
of Health and Social Security, 1965, 19761 is
probably a measure of .the failure to identify and
treat these women. Thus it is likely that paedia¬
tricians, obstetricians, and general practitioners will
see an increasing number of infants with neonatal
conjunctivitis. Those caused by C. trachomatis do
not respond, to conventional treatment with eye
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drops of neomycin, chloramphenicol, gentamicin,
or penicillin and persistent infection may result.
Some cases progress to palpebral scarring and
micropannus similar to, although less in degree than,
the sequelae of tropical trachoma (Freedman et ah,
1966; Mordhorst and Dawson, 1971). The eyesight
is rarely affected.
Infection of the infant with sexually transmissable
agents such as N. gonorrhoeae or C. trachomatis
implies that the mother had a cervical infection at
the time of birth and that the father may have a
persistent but unrecognised urethritis. N. gonorrhoeae
can cause pelvic infection and an association between
pelvic infection and chlamydial cervicitis has been
suggested (Westrom, 1975; Miirdh et a!., 1977). A
high incidence of postpartum infection in mothers of
infants with chlamydial conjunctivitis has been
reported (Dunlop et al., 1966; Rees et al., 1977a).
Thus failure to establish quickly the aetiology of
neonatal conjunctivitis may have serious sequelae in
the mother. The purpose of this paper is to present
the results of an investigation into the clinical
patterns of neonatal conjunctivitis caused by
gonococci and Chlamydia, and the clinical and
microbiological investigation of the parents.
Patients and methods
One hundred and three babies and three toddlers
were examined between October 1973 and July 1976.
Ninety-five were referred by paediatricians and four
by ophthalmologists. Four babies and one toddler
sibling were examined because their mothers had
been treated for chlamydial cervicitis, three during
and one before pregnancy. Two toddlers with
conjunctivitis were investigated as contacts of a
neonatal sibling. Seven were seen in children's
hospitals, four in an eye hospital, 74 in maternity
units, and 21 attended as outpatients.
The group forms a selected series of cases of
conjunctivitis referred mainly because of failure to
respond to routine treatment or because no bacterial
growth was reported by the laboratory. A few cases
were seen because of unusual presentation or a
history of sexually transmitted disease (STD) in
the mother.
Specimens were obtained with cottonwool-tipped
swabs from the mucosal surface of the lower lids in
all cases and from the upper lids if possible, and
were examined microscopically and by culture for
gonococci, other bacteria, and for Candida species.
Stuart's medium was used for transport of bacteria
but most swabs for gonococcal culture were inocu¬
lated directly on to a selective medium containing
antibiotics (Lab M).
Swabs for chlamydial culture were kept at 4"C in
transport medium until they were inoculated into
tissue culture between 12 and 24 hours later (Hobson
et al., 1974). Immediately before inoculation the
swab contents were homogenised in the 2-5 ml of
transport medium: 0-4 ml aliquots were inoculated
on to each of two monolayer coverslip cultures
(MCC) of McCoy cells in 1 oz Universal bottles and
centrifuged at 2400 g for one hour. After 48 hours'
incubation at 37° the MCC were Giemsa-stained and
examined by light and dark ground microscopy for
intracytoplasmic chlamydial inclusions. Details of
the methods have already been described (Johnson,
1975; Johnson and Hobson, 1976). In all cases the
results described below represent the direct inocula¬
tion of the specimen into tissue culture. No second
passage from tissue culture to tissue culture was
performed to avoid any risk of false positive results
by cross-contamination, and known negative
material was inoculated, centrifuged, incubated, and
stained with each batch of MCC. All specimens
were given serial numbers on arrival in the laboratory
and examined in random order.
Specimens for identification of herpes simplex
virus by electron microscopical examination and
culture were taken in some cases.
Mothers were investigated in the maternity unit if
possible, but mothers of premature babies had
usually been discharged; these, and mothers whose
babies had late onset conjunctivitis, were requested to
attend as outpatients if either gonococci or Chlamydia
was isolated from the infant. All were investigated
for syphilis, gonorrhoea, chlamydial cervicitis,
trichomoniasis, candidiasis and, in a few cases,
genital herpes by conventional methods. If possible,
fathers were similarly investigated if the infant




N. gonorrhoeae was isolated from 11 babies and
C. trachomatis from 33 babies and one toddler.
Concurrent gonococcal and chlamydial infection
was present in three babies. In one case, herpes-like
particles were identified by electron microscopy, but
not grown in culture.
GONOCOCCAL CONJUNCTIVITIS
Ten of the 11 babies were delivered at term, and one
was premature (birth weight: 2T3 kg): seven were
diagnosed in the maternity unit, and four were
admitted to hospitals after being discharged from
the maternity unit (three to an eye hospital and
one to a children's hospital).
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The reported onset of exudate varied between one
and eight days after birth in those diagnosed in
maternity units (1 to 3 days in three cases; 6 to 8
days in four cases) and between five and six days in
the four cases admitted to eye or children's hospitals.
The day of onset in the concurrent gonococcal
and chlamydial infections was the sixth day after
birth in two cases and the seventh day in one. Three
of the four babies re-admitted to hospital had
developed discharge at six days and one at five days.
These four infants had been treated with topical
neomycin or chloramphenicol by the general
practitioner and were not admitted until seven to
twelve days after birth—that is, when it became
obvious that the treatment was failing: two of them
had concurrent gonococcal and chlamydial infection.
No signs were observed until the eighth day in the
baby delivered by caesarean section; the mother had
been treated with ampicillin for pelvic infection
from the second day postpartum. N. gonorrhoeae
was isolated from a high vaginal swab taken before
the start of antibiotic treatment. One baby had
developed an eye infection in the maternity unit at
six days. Gram-negative intracellular diplococci
were reported in the smear but because of the mild¬
ness of the clinical signs treatment was delayed
until full identification by culture and fermentation
tests was received two days later. No change in the
signs developed during this period.
Findings in mothers
All eleven mothers were examined: five were
married. N. gonorrhoeae was isolated from 10
mothers: no isolate was obtained from one mother
already receiving ampicillin for pyrexia in hospital.
Five mothers developed postpartum infection:
pyrexia (1), infected lochia (1), pelvic infection (3).
Three of the five had concurrent gonococcal and
chlamydial cervical infection.
N. gonorrhoeae was isolated from two other
married mothers whose babies were being treated
for conjunctivitis with topical chloramphenicol at
the time of examination. No isolate was obtained
from these babies then or later. The onset of exudate
was at three and nine days respectively. One mother
had concurrent chlamydial cervicitis and one
developed hepatitis during the pregnancy and was
hepatitis B antigen positive. One of the two fathers
had been treated for gonococcal urethritis, the other
was not available for examination.
Findings in fathers
N. gonorrhoeae was found in four of five fathers
examined. All were asymptomatic. One other father
had been treated for gonorrhoea shortly before the
birth and another had been treated for urethral
discharge.
CHLAMYDIAL CONJUNCTIVITIS
C. trachomatis was isolated from 26 babies in
maternity units, one in the eye hospital, four in
children's hospitals, and two attending as out¬
patients. An isolate was obtained from the 18-
month-old sister of a baby who developed con¬
junctivitis at home aged six days. The baby's
condition improved after treatment with chloram¬
phenicol, but signs recurred when she was 16 days
old and she was admitted to the children's hospital
where C. trachomatis was isolated. The toddler
developed conjunctivitis four days after the baby
had been admitted and was treated for several
weeks with eye ointment by the general practitioner.
Chlamydia was isolated eight weeks latea-. One baby
was delivered by caesarean section, and developed
conjunctival discharge in the special care unit aged
11 days (Rees et al., 1977b).
The onset of discharge varied between three and
13 days after the birth with a mean of 7T days, or
6-7 days if one excludes three cases given a five-day
course of cloxacillin and penicillin from birth, in
whom the onset was delayed to 9, 11, and 13 days
respectively (Table).
Table Onset ofdischarge in 33 cases of chlamydial
conjunctivitis
Day of onset
3rd 5th 6th 1th 8 th 9th llth 13th
No. of cases 1 5 11 7 3 2 2 2
Sixteen infants (48-8 %) were referred for investiga¬
tion within 10 days of birth: 26 (78 -8 %) were referred
within 13 days. Isolates were obtained at 17, 19, 20,
24 (2), 30, and 57 days in the remainder. Those in
whom referral had been delayed had been treated
with topical chloramphenicol with improvement
followed by recurrence on cessation of treatment.
All babies developed oedema of the lids and a
purulent discharge, which was blood-stained in two
cases. Mucosal oedema was present in all cases and
was associated with a localised bubbling appearance
in the more severe cases and in those in whom the
request for investigation was delayed, Fig. 1 a, b.
Topical chloramphenicol modified the picture.
Discharge often ceased, but mucosal oedema
persisted in varying degrees (Fig. 2 a, b, and Fig. 3
a, b). Neither neomycin nor gentamicin had any
effect.
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Results of treatment of chlamydial conjunctivitis
After treatment with tetracycline eye ointment
prescribed for four weeks, C. trachomatis was
re-isolated from six of 24 babies who attended for
follow-up. Two of these babies were inadequately
treated for only two and three weeks. After four
weeks' treatment, Chlamydia was re-isolated within
a further four weeks in three cases, one of which
was the baby born by caesarean section. Chlamydia
was re-isolated from another baby four weeks after
treatment in hospital and again five months after
being treated again for six weeks with topical
tetracycline. In five cases minor symptoms and signs
recurred on relapse.
Fourteen babies were premature (42-4%). The
gestation period was between 30 and 34 weeks in 10
and between 35 and 37 in four, birth weight was
between 1-5 and 2-7 kg. Excluding the four babies
examined as contacts because their mothers had
been treated for chlamydial cervicitis before or
during the pregnancy, the incidence of prematurity
in the group from whom neither gonococci nor
Chlamydia was isolated was nine of 58 cases (15 -5 %).
The difference in the incidence of prematurity in
chlamydial positive and negative babies is significant
(zls=6-7 p<0 01).
Findings in mothers of babies with chlamydial
conjunctivitis
Nineteen of the 33 mothers were married; 31 were
examined. One specimen was cytotoxic: Chlamydia
was isolated from the cervix in 20 of the remaining
30 mothers. Seven of the 10 negative mothers were
Fig. 1 Conjunctivitis aged 7 days. Treated with
neomycin eye drops for two days without response.
C. trachomatis isolated aged nine days.
(a) Palpebral oedema, (b) Severe mucosal oedema with
bubbling and mucopurulent discharge.
Fig. 2 Conjunctivitis aged 5 days. Treated with
neomycin eye drops for two days without response.
Chloramphenicol eye drops for five days; discharge
ceased, palpebral oedema lessened. C. trachomatis
isolated aged 12 days.
(a) Persisting but lessening palpebral oedema indicated
by slight wrinkling of skin. (b) Well-marked mucosal
oedema with bubbling on upper lid.
Fig. 3 Conjunctivitis aged 3 days. Streptococcus
faecalis isolated. Relapsed within 5 days of completion
of each of two 5-day courses of chloramphenicol eye
drops. C. trachomatis isolated cged 30 days on fourth
day of third course in special care unit.
(a) Minimal palpebral oedema. (b) Mild conjunctivitis
mucosal oedema with bubbling. Two possible early
follicles.
receiving, or had received, antibiotics for postpartum
infection. Nineteen of the 31 mothers developed
postpartum infection: pelvic infection (11), pyrexia
(3), infected lochia (4), wound infection (1).
C. trachomatis was isolated from eight of the 11
mothers with pelvic infection. All three negative
mothers had received or were receiving antibiotics
at the time of examination. One Chlamydia-positive
mother with pelvic infection had been treated with
ampicillin for infected lochia before discharge from
the maternity unit. Another mother of a premature
baby gave a history of severe lower abdominal pain
three weeks before she attended as an outpatient,
but no tenderness was found on pelvic examination
and she is, therefore, excluded from the group.
Sera were examined for psittacosis lymphogranu¬
loma venereum group antibody in nine of the 11
cases and all had levels of 1:20 or, higher with a
rising titre in early cases. Titres of 1:80 rising to
> 1:1280 were reported in two cases. (Full details of
group antibody levels will be reported elsewhere.)
Findings in fathers
C. trachomatis was isolated from four of 10 fathers
examined. All were asymptomatic but low grade
urethritis was found. One normal father had
recently taken antibiotics.
Discussion
The results of this investigation suggest that neonatal
eye infection caused by sexually transmissable
organisms is common. This infection is unlikely to
lead to impairment of sight unless neglected, but
failure to establish the cause before treatment may
have serious consequences to the mother in whom
risk of postpartum extension of infection from the
cervix appears to be high. Furthermore, the woman
can be reinfected by the untreated asymptomatic man
and both may be a source of infection to other
members of the family.
A surprising feature of this group of babies is the
late onset of gonococcal conjunctivitis. Only three
of the 11 babies developed discharge within three
days of birth and for this reason the diagnosis was
made after the baby had been discharged from the
maternity unit in four cases. It is, of course, possible
that infection was not intrapartum but followed
contact with infected hands or towels. Nevertheless,
in one case of mild conjunctivitis developing in
hospital at six days no increase in the slight con¬
junctival discharge occurred in the 48 hours during
which confirmation of the positive Gram-stained
smear was awaited. The baby delivered by caesarean
section developed conjunctivitis in hospital at eight
days. His mother started taking antibiotics 48 hours
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postpartum and was, therefore, non-infectious from
that time. (Gonococci were not isolated again.)
These cases suggest that gonococcal conjunctivitis
may in some cases have a comparatively long
incubation period and may not be acute. Alterna¬
tively. frequent postpartum transmission of infection
to the eyes of infants must be postulated. Gonococcal
conjunctivitis has in the past responded promptly to
topical and systemic treatment with penicillin.
Difficulties in treatment may be encountered in the
futureowing to infections with (3-lactamase producing
strains of gonococci which have been identified in
Liverpool since February 1976 (Percival, et al.,
1976).
Because of the late onset of chlamydial conjuncti¬
vitis (six to seven days after birth) most infected
babies will be seen by the general practitioner or at
the baby clinic. The high incidence of premature
babies in this series may simply mean that they are
more likely to be diagnosed than full-term babies
because they remain in hospital for a longer time
than the incubation period of the infection. How¬
ever, the possibility that chlamydial cervicitis might
involve the membranes overlying the internal os
and result in premature rupture has been suggested
(Rees et al., 1977b). Some support is given to this
suggestion by this investigation in which a signi¬
ficant difference in the prematurity rate for
Chlamydia-positive and Chlamydia-negative babies
was found. Thus the association between pre¬
maturity and conjunctivitis may be causal—that is,
the mother's chlamydial infection may be respon¬
sible for both conditions as well as for an increased
chance that she may develop postpartum infection.
In an epidemiological study, Watson and
Gairdner (1968) reported four definite and four
suggestive cases of chlamydial infection in 44 cases
of neonatal conjunctivitis screened for inclusions in
a maternity unit. Exudate was often scanty and not
obviously purulent : inflammation and palpebral
oedema were negligible. No attempt was made to
culture the agent. No specific treatment was given
but in two of the three cases followed for three to
24 weeks postpartum there was scarring of the
conjunctiva, and one of the two had a continuing
and active pannus. Such cases would not have been
referred for investigation in our selected series in
which all babies had purulent conjunctivitis with
well-marked mucosal oedema and, in untreated
cases, palpebral oedema.
Topical neomycin does not inhibit Chlamydia and
has a broad antibacterial spectrum. It is the first line
treatment cf choice in non-gonococcal conjunc¬
tivitis and babies who fail to respond should be
investigated for Chlamydia. Inadequate treatment
with chloramphenicol or short courses of tetra¬
cycline may suppress but not eradicate Chlamydia.
Palpebral oedema and conjunctival exudate may
clear but conjunctivitis often persists. The import¬
ance of everting the lids to examine the conjunctiva
of all babies treated for neonatal conjunctivitis and
as part of the general examination of babies before
discharge from the maternity unit is clearly indicated.
The isolation of Chlamydia from the 18-month-oId
sister of one infant admitted to hospital with severe
purulent conjunctivitis suggests eye to eye transr
mission such as occurs in hyperendemic trachoma
(Jones, 1975; Grayston et al., 1977).
The asymptomatic nature of both gonococcal
and chlamydial infection in eight fathers underlines
the necessity for early accurate diagnosis of neonatal
conjunctivitis. Only if gonococci or Chlamydia are
isolated will a full family investigation be carried out
and the risk of pelvic infection in the- mother be
reduced by early diagnosis and treatment. The fact
that nearly 60% of the mothers in this series were
married possibly reflects the degree of extramarital
contact occurring at the present time.
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